Envoy Medical (COCH) S-4/A 23 Aug 23 Registration of securities issued in business combination transactions (amended) Financial data

Document and Entity Information

Document and Entity Information	6 Months Ended
	Jun. 30, 2023
Document and Entity Information
Document Type	S-4/A
Entity Registrant Name	Anzu Special Acquisition Corp I
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Central Index Key	0001840877
Amendment Flag	true
Amendment Description	AMENDMENT NO. 3

Condensed Balance Sheets

Condensed Balance Sheets	Dec. 31, 2022 USD ($)
Current Assets:
Cash	$ 107,773
Prepaid expenses	112,649
Total current assets	220,422
Investments held in Trust Account	430,047,193
Forward purchase agreement assets	353,731
Total Assets	430,621,346
Current Liabilities:
Accounts payable	1,177,546
Accrued expenses	3,945,680
Working capital loan - related party	1,500,000
Income taxes payable	686,530
Total current liabilities	7,309,756
Deferred underwriting fee payable	10,412,500
Derivative warrant liabilities	1,066,667
Total liabilities	18,788,923
Commitments and Contingencies
Class A common stock subject to possible redemption, $0.0001 par value; 400,000,000 shares authorized; 4,312,774 and 42,500,000 shares issued and outstanding as of June 30, 2023 and December 31, 2022 valued at $10.34 and $10.11 redemption value, respectively	429,747,193
Stockholders' Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 0 issued and outstanding as of June 30, 2023 and December 31, 2022
Accumulated deficit	(17,915,833)
Total stockholders' deficit	(17,914,770)
Total Liabilities, Class A Common Stock Subject to Possible Redemption, and Stockholders' Deficit	430,621,346
Class A common stock
Stockholders' Deficit
Common stock	0
Class A common stock subject to possible redemption
Current Liabilities:
Class A common stock subject to possible redemption, $0.0001 par value; 400,000,000 shares authorized; 4,312,774 and 42,500,000 shares issued and outstanding as of June 30, 2023 and December 31, 2022 valued at $10.34 and $10.11 redemption value, respectively	429,747,193
Class B common stock
Stockholders' Deficit
Common stock	$ 1,063

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Apr. 17, 2023	Feb. 28, 2023	Dec. 31, 2022	Dec. 31, 2021
Class A common stock subject to possible redemption, par value (in dollars per share)				$ 0.0001
Class A common stock subject to possible redemption, shares authorized				400,000,000
Class A common stock subject to possible redemption, shares outstanding				42,500,000	42,500,000
Class A common stock subject to possible redemption, price per share				$ 10.11	$ 10
Preferred stock, par value (in dollars per share)	$ 0.0001			$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000			1,000,000	1,000,000
Preferred stock, shares issued	0			0	0
Preferred stock, shares outstanding	0			0	0
Class A common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.01		$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000			400,000,000	400,000,000
Common stock, shares issued	0			0
Common stock, shares outstanding	0		4,312,774	0
Class A common stock subject to possible redemption
Class A common stock subject to possible redemption, par value (in dollars per share)	$ 0.0001			$ 0.0001	$ 0.0001
Class A common stock subject to possible redemption, shares authorized	400,000,000			400,000,000
Class A common stock subject to possible redemption, shares issued	4,312,774			42,500,000	42,500,000
Class A common stock subject to possible redemption, shares outstanding	4,312,774			42,500,000	42,500,000
Class A common stock subject to possible redemption, price per share	$ 10.34			$ 10.11	$ 10
Class A common stock not subject to possible redemption
Common stock, shares issued	0			0	0
Common stock, shares outstanding	0			0	0
Class B common stock
Common stock, par value (in dollars per share)	$ 0.0001			$ 0.0001	$ 0.0001
Common stock, shares authorized	40,000,000			40,000,000	40,000,000
Common stock, shares issued	10,625,000			10,625,000	10,625,000
Common stock, shares outstanding	10,625,000			10,625,000	10,625,000

Unaudited Condensed Statements

Unaudited Condensed Statements of Operations - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023
Operating expenses:
Formation and operating costs	$ (98,596)	$ (2,591,177)
Loss from operations	(98,596)	(2,591,177)
Other income (expenses):
Interest earned on investments held in Trust Account	528,297	3,898,569
Change in fair value of Forward Purchase Agreements	(1,035,264)	(353,731)
Prepaid forward derivative	(144,770)	(144,770)
Change in fair value of warrant liabilities	(266,667)	(266,667)
Income (loss) before income tax expense	(1,017,000)	542,224
Income tax expense	(121,245)	(962,768)
Net income (loss)	$ (1,138,245)	$ (420,544)
Class A redeemable common stock
Other income (expenses):
Weighted average shares outstanding, basic	4,312,774	18,026,419
Weighted average shares outstanding, diluted	4,312,774	18,026,419
Class A common stock
Other income (expenses):
Weighted average shares outstanding, basic	4,312,774	18,026,419
Weighted average shares outstanding, diluted	4,312,774	18,026,419
Basic net income (loss) per share of common stock	$ (0.08)	$ (0.01)
Diluted net income (loss) per share of common stock	$ (0.08)	$ (0.01)
Class B common stock
Other income (expenses):
Weighted average shares outstanding, basic	10,625,000	10,625,000
Weighted average shares outstanding, diluted	10,625,000	10,625,000
Basic net income (loss) per share of common stock	$ (0.08)	$ (0.01)
Diluted net income (loss) per share of common stock	$ (0.08)	$ (0.01)

Unaudited Condensed Statement_2

Unaudited Condensed Statements of Changes in Stockholders' Deficit - USD ($)	Class B common stock Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2020	$ 1,208	$ 23,792	$ (701)	$ 24,299
Balance at the beginning (in shares) at Dec. 31, 2020	12,075,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)			(251,633)	(251,633)
Forfeiture of Founder Shares	$ (145)	145
Forfeiture of Founder Shares (in shares)	(1,450,000)
Accretion for Class A common stock to redemption amount		(23,937)	(37,232,253)	(37,256,190)
Balance at the end at Dec. 31, 2021	$ 1,063	0	(36,714,587)	(36,713,524)
Balance at the end (in shares) at Dec. 31, 2021	10,625,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)			12,461,381	12,461,381
Balance at the end at Mar. 31, 2022	$ 1,063		(24,253,206)	(24,252,143)
Balance at the end (in shares) at Mar. 31, 2022	10,625,000
Balance at the beginning at Dec. 31, 2021	$ 1,063	0	(36,714,587)	(36,713,524)
Balance at the beginning (in shares) at Dec. 31, 2021	10,625,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)				15,552,100
Balance at the end at Jun. 30, 2022	$ 1,063		(21,453,304)	(21,452,241)
Balance at the end (in shares) at Jun. 30, 2022	10,625,000
Balance at the beginning at Dec. 31, 2021	$ 1,063	0	(36,714,587)	(36,713,524)
Balance at the beginning (in shares) at Dec. 31, 2021	10,625,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)		0	19,233,710	19,233,710
Deemed dividend - increase in redemption value of Class A common stock subject to redemption		0	(434,956)	(434,956)
Balance at the end at Dec. 31, 2022	$ 1,063	0	(17,915,833)	(17,914,770)
Balance at the end (in shares) at Dec. 31, 2022	10,625,000
Balance at the beginning at Mar. 31, 2022	$ 1,063		(24,253,206)	(24,252,143)
Balance at the beginning (in shares) at Mar. 31, 2022	10,625,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)			3,090,719	3,090,719
Deemed dividend - increase in redemption value of Class A common stock subject to redemption			(290,817)	(290,817)
Balance at the end at Jun. 30, 2022	$ 1,063		(21,453,304)	(21,452,241)
Balance at the end (in shares) at Jun. 30, 2022	10,625,000
Balance at the beginning at Dec. 31, 2022	$ 1,063	0	(17,915,833)	(17,914,770)
Balance at the beginning (in shares) at Dec. 31, 2022	10,625,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)			717,701	717,701
Deemed dividend - increase in redemption value of Class A common stock subject to redemption			(2,025,746)	(2,025,746)
Balance at the end at Mar. 31, 2023	$ 1,063		(19,223,878)	(19,222,815)
Balance at the end (in shares) at Mar. 31, 2023	10,625,000
Balance at the beginning at Dec. 31, 2022	$ 1,063	$ 0	(17,915,833)	(17,914,770)
Balance at the beginning (in shares) at Dec. 31, 2022	10,625,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)				(420,544)
Balance at the end at Jun. 30, 2023	$ 1,063		(20,791,422)	(20,790,359)
Balance at the end (in shares) at Jun. 30, 2023	10,625,000
Balance at the beginning at Mar. 31, 2023	$ 1,063		(19,223,878)	(19,222,815)
Balance at the beginning (in shares) at Mar. 31, 2023	10,625,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)			(1,138,245)	(1,138,245)
Deemed dividend - increase in redemption value of Class A common stock subject to redemption			(429,299)	(429,299)
Balance at the end at Jun. 30, 2023	$ 1,063		$ (20,791,422)	$ (20,790,359)
Balance at the end (in shares) at Jun. 30, 2023	10,625,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flow from operating activities:
Net income (loss)	$ (420,544)	$ 15,552,100
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Amortization of prepaid expense	509,158	175,791
Change in fair value of warrant liabilities	266,667	(17,863,972)
Change in fair value of Forward Purchase Agreements	498,501	416,901
Interest earned on investments held in Trust Account	3,898,569	603,786
Changes in operating assets and liabilities:
Prepaid expenses	(661,433)	73,791
Accounts payable	254,027	265,849
Accrued expenses	(584,468)	108,315
Income taxes payable	1,178,139	702,114
Net cash used in operating activities	(2,858,522)	(1,172,897)
Cash flows from investing activities:
Trust account withdrawal for redemption of Class A Shares	387,606,836
Trust account withdrawal for payment of taxes	1,693,522
Net cash provided by investing activities	389,300,358
Cash flows from financing activities:
Proceeds from working capital loan-related party	1,190,000	1,500,000
Redemption of Class A Shares	(387,606,836)
Net cash provided by (used in) financing activities	(386,416,836)	1,500,000
Net change in cash	25,000	327,103
Cash at beginning of the period	107,773	149,845
Cash at end of the period	132,773	$ 476,948
Cash paid for taxes	$ 1,693,522

Organization and Business Opera

Organization and Business Operations	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Organization and Business Operations
Organization and Business Operations	Note 1 - Organization and Business Operations Organization and General Anzu Special Acquisition Corp I (the “Company”) is a blank check company incorporated as a Delaware corporation on December 28, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). Since completing the Company’s initial public offering (the “IPO” or the “Initial Public Offering”), the Company has reviewed, and continues to review, a number of opportunities to enter into a Business Combination with an operating business, but the Company is not able to determine at this time whether it will complete a Business Combination with any of the target businesses that the Company has reviewed or with any other target business. The Company intends to effectuate a Business Combination using cash from the proceeds of the IPO and the sale of the Private Placement Warrants (as defined below), the Company’s capital stock, debt, or a combination of cash, stock and debt. As of June 30, 2023, the Company had not commenced any operations. All activity through June 30, 2023 relates to the Company’s formation and the IPO described below, and, subsequent to the IPO, identifying a target company for a Business Combination. The Company does not expect to generate any operating revenues until after the completion of a Business Combination. The Company generates non-operating income in the form of interest income on proceeds from the IPO held in the Trust Account (as defined below). The Company’s sponsor is Anzu SPAC GP I LLC, a Delaware limited liability company (the “Sponsor”). Financing On March 4, 2021, the Company consummated the IPO of 42,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units, the “public shares”) and, on April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option. Each Unit consists of one share of the Company’s Class A common stock, par value $0.0001 per share, and one -third of one warrant (the “Public Warrants”) of the Company, with each whole warrant entitling the holder thereof to purchase one whole share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. The Units were sold at a price of $10.00 per unit, generating aggregate gross proceeds to the Company of $425,000,000 (see Note 3 and Note 7). Simultaneously with the closing of the IPO, the Company completed the private sale (the “Private Placement”) of 12,400,000 warrants (the “Private Placement Warrants”) to the Sponsor and, on April 14, 2021, simultaneously with the closing of the underwriters’ over-allotment option, the Company issued an additional 100,000 Private Placement Warrants to the Sponsor. The Private Placement Warrants were sold at a price of $1.00 per Private Placement Warrant, generating aggregate gross proceeds of $12,500,000 . Transaction costs of the IPO prior to the underwriters’ partial exercise of their over-allotment option amounted to $23,731,835 , consisting of $8,400,000 of underwriting commissions, $14,700,000 of deferred underwriters’ commissions and $631,835 of other offering costs. Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021 amounted to $280,500 , consisting of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. Trust Account Following the closing of the IPO on March 4, 2021, $420,000,000 ( $10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a U.S. based trust account (the “Trust Account”). Following the closing of the underwriters’ over-allotment option on April 14, 2021, an additional $5,000,000 ( $10.00 per Unit) from the net proceeds of the sale of the additional Units and Private Placement Warrants was placed in the Trust Account. The funds in the Trust Account are invested in a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended. The Company will not be permitted to withdraw any of the principal or interest held in the Trust Account except for the withdrawal of interest to pay taxes, if any. The funds held in the Trust Account will not otherwise be released from the Trust Account until the earliest of (1) the Company’s completion of a Business Combination; (2) the redemption of any public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the public shares if the Company does not complete a Business Combination within 24 months from the closing of the IPO or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; and (3) the redemption of the Company’s public shares if the Company has not completed a Business Combination by September 30, 2023 or during any Extension Period (as defined below), subject to applicable law. Based on current interest rates, the Company expects that interest earned on the Trust Account will be sufficient to pay taxes. Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds from the IPO, although substantially all of the net proceeds from the IPO are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a Target Business. As used herein, “Target Business” means one or more target businesses that together have an aggregate fair market value equal to at least 80% of the value of the assets held in the Trust Account (excluding taxes payable on the interest earned on the Trust Account) at the time of the signing of a definitive agreement in connection with a Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of a Business Combination, either (i) in connection with a stockholder meeting called to approve such Business Combination or (ii) by means of a tender offer. The public stockholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account, calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount to be distributed to the public stockholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. As a result, shares of common stock were recorded at their redemption amount and classified as temporary equity upon the completion of the IPO, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). The decision as to whether the Company will seek stockholder approval of a Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, in its sole discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval unless a vote is required by law or stock exchange listing requirements. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the shares of common stock voted are voted in favor of a Business Combination. However, in no event will the Company redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001 upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption of its public shares of common stock and the related Business Combination, and instead may search for an alternate Business Combination. The Company has until September 30, 2023 or such earlier date as determined by the Company’s board of directors (or such longer period as provided in an amendment to the Company’s amended and restated certificate of incorporation approved by the Company’s stockholders (an “Extension Period”)) to complete its initial Business Combination. If the Company does not complete a Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if it fails to complete its initial Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period. The initial stockholders (the Sponsor and the three directors that hold Founder Shares (as defined in Note 5) have entered into a letter agreement with the Company, pursuant to which they have waived their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete its initial Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period. However, if the initial stockholders acquire public shares, they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if the Company fails to complete its initial Business Combination within the allotted time frame. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than $10.00 per public share initially held in the Trust Account. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per public share or (2) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to have all third parties, including, but not limited to, all vendors, service providers (other than its independent registered public accounting firm), prospective target businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claims of any kind in or to any monies held in the Trust Account. On February 28, 2023, the Company reconvened its special meeting of stockholders, which was originally scheduled for February 9, 2023, adjourned until February 21, 2023 and further adjourned until February 28, 2023 (the “Special Meeting”). At the Special Meeting, the Company’s stockholders approved a proposal to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company has to consummate a Business Combination from March 4, 2023 to September 30, 2023 or such earlier date as determined by the Company’s board of directors (the “Extension”). Following the approval of the Extension, the Company waived its right under the amended and restated certificate of incorporation to withdraw up to $100,000 of interest from the Trust Account to pay dissolution expenses in the event of the Company’s liquidation. In connection with the Special Meeting, on March 7, 2023 stockholders holding 38,187,226 shares of the Company’s Class A common stock exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $387.6 million (approximately $10.15 per share of Class A common stock) was removed from the Trust Account to pay such holders and approximately $44.3 million remained in the Trust Account. Following the redemptions, the Company has 4,312,774 shares of Class A common stock outstanding. On March 21, 2023, the Company and the Sponsor amended the 2022 Promissory Note to extend the maturity date of the 2022 Working Capital Loan to the earlier of (i) December 31, 2023 or (ii) the consummation of a Business Combination. On April 17, 2023, the Company entered into a business combination agreement (the “Business Combination Agreement”) with Envoy Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”), and Envoy Medical Corporation, a Minnesota Corporation (“Envoy”), a U.S.-based medical device company that has developed and is in early clinical testing of an implanted device that already received “Breakthrough Device Designation” from the Food and Drug Administration. The transactions contemplated by the Business Combination Agreement are referred to herein as the “Proposed Business Combination.” Pursuant to the terms of the Business Combination Agreement, Merger Sub will merge with and into Envoy, the separate corporate existence of Merger Sub will cease and Envoy will be the surviving corporation and wholly owned, privately-held subsidiary of the Company (the “Merger”). The Company will change its name to “Envoy Medical, Inc.”, which will continue as the surviving public corporation after the closing of the Proposed Business Combination (the “Closing”). As a result of the Merger, among other things, (a) each share of Envoy common stock, par value $0.01 per share (the “Envoy common stock”), issued and outstanding (including Envoy common stock issued upon the exercise or conversion of Envoy warrants, Envoy convertible notes or Envoy preferred stock) shall be canceled and converted into the right to receive a number of shares of Class A common stock equal to the exchange ratio (as calculated pursuant to the Business Combination Agreement), amounting to aggregate closing Merger consideration of 15 million shares of Class A Common Stock (subject to adjustment as provided in the Business Combination Agreement); (b) each outstanding option to purchase shares of Envoy common stock will be cancelled in exchange for nominal consideration; (c) immediately prior to the effective time of the Merger, each outstanding Envoy warrant will automatically, depending on the applicable exercise price, be canceled or exercised on a net exercise basis and converted into shares of Envoy common stock in accordance with its terms; and (d) immediately prior to the effective time of the Merger, each outstanding Envoy convertible note will automatically be converted into shares of Envoy common stock in accordance with its terms. Risks and Uncertainties In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these unaudited condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements. On March 10, 2023, Silicon Valley Bank became insolvent. State regulators closed the bank, and the Federal Deposit Insurance Corporation (“FDIC”) was appointed as its receiver. The Company held deposits with this bank. As a result of the actions by the FDIC, the Company’s insured and uninsured deposits have been restored. Going Concern As of June 30, 2023 and December 31, 2022, the Company had $132,773 and $107,773 in its operating bank accounts, respectively, and working capital deficits of $8,949,755 and $7,089,334 , respectively. Prior to the completion of the Initial Business Combination, the Company’s liquidity needs had been satisfied through a contribution of $25,000 from Sponsor to cover certain formation and offering costs in exchange for the issuance of the Founder Shares (as defined in Note 5), the loan of up to $300,000 from the Sponsor pursuant to the Note (see Note 5), and the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). As of June 30, 2023 and December 31, 2022, there were amounts of $2,690,000 and $1,500,000 outstanding under the Working Capital Loans, respectively. The Company may need to raise additional funds through loans from its Sponsor and/or third parties in order to meet the expenditures required for operating its business. If the Company’s estimate of the costs of undertaking in-depth due diligence and negotiating the initial business combination is less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial business combination. The Sponsor is not under any obligation to advance funds to, or to invest in, the Company. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. If a Business Combination is not consummated by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period, there will be a mandatory liquidation and subsequent dissolution of the Company. Mandatory liquidation and liquidity condition raise substantial doubt about the Company’s ability to continue as a going concern through one year from the date of these financial statements if a Business Combination is not consummated. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s management plans to complete a Business Combination prior to the mandatory liquidation date and expects to receive financing to meet its obligations through the time of liquidation; however, no financing is currently committed. The unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.	Note 1 — Organization and Business Operations Organization and General Anzu Special Acquisition Corp I (the “Company”) is a blank check company incorporated as a Delaware corporation on December 28, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). While the Company may pursue a Business Combination target in any industry, the Company currently intends to concentrate its efforts in identifying high-quality businesses with transformative technologies. Since completing the Company’s initial public offering (the “IPO” or the “Initial Public Offering”), the Company has reviewed, and continues to review, a number of opportunities to enter into a Business Combination with an operating business, but the Company is not able to determine at this time whether it will complete a Business Combination with any of the target businesses that the Company has reviewed or with any other target business. The Company intends to effectuate a Business Combination using cash from the proceeds of the IPO and the sale of the Private Placement Warrants (as defined below), the Company’s capital stock, debt, or a combination of cash, stock and debt. As of December 31, 2022, the Company had not commenced any operations. All activity through December 31, 2022 relates to the Company’s formation and the IPO described below, and, subsequent to the IPO, identifying a target company for a Business Combination. The Company does not expect to generate any operating revenues until after the completion of a Business Combination. The Company generates non-operating income in the form of interest income on marketable securities held in the Trust Account (as defined below). The Company’s sponsor is Anzu SPAC GP I LLC, a Delaware limited liability company (the “Sponsor”). Financing On March 4, 2021, the Company consummated the IPO of 42,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units, the “public shares”) and, on April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option. Each Unit consists of one share of the Company’s Class A common stock, par value $0.0001 per share, and one-third of one warrant (the “Public Warrants”) of the Company, with each whole warrant entitling the holder thereof to purchase one whole share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. The Units were sold at a price of $10.00 per unit, generating aggregate gross proceeds to the Company of $425,000,000 (see Note 4 and Note 8). Simultaneously with the closing of the IPO, the Company completed the private sale (the “Private Placement”) of 12,400,000 warrants (the “Private Placement Warrants”) to the Sponsor and, on April 14, 2021, simultaneously with the closing of the underwriters’ over-allotment option, the Company issued an additional 100,000 Private Placement Warrants to the Sponsor. The Private Placement Warrants were sold at a price of $1.00 per Private Placement Warrant, generating aggregate gross proceeds of $12,500,000. Transaction costs of the IPO prior to the underwriters’ partial exercise of their over-allotment option amounted to $23,731,835, consisting of $8,400,000 of underwriting commissions, $14,700,000 of deferred underwriters’ commissions and $631,835 of other offering costs. Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021 amounted to $280,500, consisting of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. Trust Account Following the closing of the IPO on March 4, 2021, $420,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a U.S.-based trust account (the “Trust Account”). Following the closing of the underwriters’ over-allotment option on April 14, 2021, an additional $5,000,000 ($10.00 per Unit) from the net proceeds of the sale of the additional Units and Private Placement Warrants was placed in the Trust Account. The funds in the Trust Account are invested in a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended. The Company will not be permitted to withdraw any of the principal or interest held in the Trust Account except for the withdrawal of interest to pay taxes, if any. The funds held in the Trust Account will not otherwise be released from the Trust Account until the earliest of (1) the Company’s completion of a Business Combination; (2) the redemption of any public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the public shares if the Company does not complete a Business Combination within 24 months from the closing of the IPO or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; and (3) the redemption of the Company’s public shares if the Company has not completed a Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, subject to applicable law. Based on current interest rates, the Company expects that interest earned on the Trust Account will be sufficient to pay taxes. Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds from the IPO, although substantially all of the net proceeds from the IPO are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a Target Business. As used herein, “Target Business” means one or more target businesses that together have an aggregate fair market value equal to at least 80% of the value of the assets held in the Trust Account (excluding taxes payable on the interest earned on the Trust Account) at the time of the signing of a definitive agreement in connection with a Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of a Business Combination, either (i) in connection with a stockholder meeting called to approve such Business Combination or (ii) by means of a tender offer. The public stockholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account, calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount to be distributed to the public stockholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. As a result, shares of common stock were recorded at their redemption amount and classified as temporary equity upon the completion of the IPO, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). The decision as to whether the Company will seek stockholder approval of a Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, in its sole discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval unless a vote is required by law or stock exchange listing requirements. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the shares of common stock voted are voted in favor of a Business Combination. However, in no event will the Company redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001 upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption of its public shares of common stock and the related Business Combination, and instead may search for an alternate Business Combination. The Company has until September 30, 2023 or such earlier date as determined by the Company’s board of directors (or such longer period as provided in an amendment to the Company’s amended and restated certificate of incorporation approved by the Company’s stockholders (an “Extension Period”)) to complete its initial Business Combination. If the Company does not complete a Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if it fails to complete its initial Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period. The initial stockholders (the Sponsor and the three directors that hold Founder Shares (as defined in Note 6) have entered into a letter agreement with the Company, pursuant to which they have waived their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete its initial Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period. However, if the initial stockholders acquire public shares, they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if the Company fails to complete its initial Business Combination within the allotted time frame. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than $10.00 per public share initially held in the Trust Account. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per public share or (2) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to have all third parties, including, but not limited to, all vendors, service providers (other than its independent registered public accounting firm), prospective target businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claims of any kind in or to any monies held in the Trust Account. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements. On March 10, 2023 Silicon Valley Bank became insolvent. State regulators closed the bank and the Federal Deposit Insurance Corporation (“FDIC”) was appointed as its receiver. The Company held deposits with this bank. As a result of the actions by the FDIC, the Company’s insured and uninsured deposits have been restored. Going Concern As of December 31, 2022 and 2021, the Company had $107,773 and $149,845 in its operating bank accounts, respectively, and working capital deficits of $(7,089,334) and $(1,815,006), respectively. Prior to the completion of the Initial Business Combination, the Company’s liquidity needs had been satisfied through a contribution of $25,000 from Sponsor to cover for certain formation and offering costs in exchange for the issuance of the Founder Shares, the loan of up to $300,000 from the Sponsor pursuant to the Note (see Note 6), and the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 6). As of December 31, 2022 and 2021, there were amounts of $1,500,000 and $0 outstanding under the Working Capital Loans, respectively. The Company may need to raise additional funds through loans from its Sponsor and/or third parties in order to meet the expenditures required for operating its business. If the Company’s estimate of the costs of undertaking in-depth due diligence and negotiating the initial business combination is less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial business combination. The Sponsor is not under any obligation to advance funds to, or to invest in, the Company. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. If a Business Combination is not consummated by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period, there will be a mandatory liquidation and subsequent dissolution of the Company. Mandatory liquidation and liquidity condition raise substantial doubt about the Company’s ability to continue as a going concern through one year from the date of these financial statements if a Business Combination is not consummated. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. Our management plans to complete a Business Combination prior to the mandatory liquidation date and expects to receive financing to meet its obligations through the time of liquidation; however no financing is currently committed. The financial statements do not include any adjustment that might be necessary if we are unable to continue as a going concern.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of June 30, 2023 and the results of operations and cash flows for the periods presented. Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of results that may be expected for the full year or any other period. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2022, as filed with the SEC on April 3, 2023. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liabilities. Other significant accounting estimates include the forward purchase derivative and the convertible working capital loan. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2023 and December 31, 2022. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities and are recognized at fair value. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Gains and losses resulting from the change in fair value of these securities are included in interest earned on investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the FDIC coverage limit of $250,000. The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2023 and December 31, 2022, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. There was no Class A common stock issued or outstanding as of June 30, 2023 and December 31, 2022, classified as permanent equity. The Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to temporary stockholders’ equity upon the completion of the IPO, except those associated with Public Warrants which were expensed. Accordingly, as of June 30, 2023 and December 31, 2022, offering costs in the aggregate of $24,012,335 (consisting of $8,500,000 of underwriting commissions, $14,875,000 of deferred underwriters’ commission and $637,335 other offering costs) have been incurred. In September 2022, the Company reversed $4,462,500 of deferred underwriting fees, as the underwriters resigned from their role in the Business Combination and thereby waived their entitlement to these commissions (see Note 6). Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021, amounted to $280,500 , consisting mainly of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. The Company allocates the offering costs between its common stock and Public Warrants using relative fair value method, with the offering costs allocated to the Public Warrants expensed immediately. Accordingly, as of June 30, 2023 and December 31, 2022, offering costs in the aggregate of $782,812 have been charged to the Company’s unaudited condensed statements of operations (consisting of $762,300 of underwriting discounts and $20,512 of other offering costs). Offering costs associated with the Class A common stock have been charged to temporary equity. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature except for the derivative warrant liabilities and forward purchase agreement asset (see Note 9). Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company’s public warrant liability is based on quoted prices in active markets as of the measurement date and is classified as Level 1. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company accounts for its warrants issued in connection with its IPO as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statements of operations. The fair value of warrants issued by the Company in connection with the IPO and Private Placement has been estimated using binomial lattice model at the date of issuance. As of June 30, 2023 and December 31, 2022, the Company’s public warrants were measured based on quoted prices in active markets, and the private placement warrants are categorized as a Level 2 following the public price. FASB ASC 470-20, “Debt with Conversion and Other Options”, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate IPO proceeds from the Units between common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then common stock. The Company accounts for its forward purchase agreements (collectively, the “Forward Purchase Agreements” or “FPAs”) issued as derivative FPA assets in accordance with ASC 815-40. Accordingly, the Company recognizes the FPA instruments as assets at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited statements of operations. The fair value of the FPAs has been estimated using observable inputs at the date of issuance. As of December 31, 2022, the Company’s FPAs are categorized as a Level 3. The FPA expired on April 17, 2023 and replace by the instrument explained below. The Company accounts for its prepaid forward derivative (“PFD”) issued as a liability in accordance with ASC 815-40. Accordingly, the Company recognizes the PFD instrument as liability at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the PFD has been estimated using observable inputs at the date of issuance. As of June 30, 2023 PFD is categorized as a Level 3. Net Income (loss) per Share of Common Stock The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the year, excluding shares of common stock shares subject to forfeiture. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. The Company’s statements of operations include a presentation of income per share for shares of common stock subject to possible redemption in a manner similar to the two-class method of income per share. Consistent with ASC Topic 480-10-S99-3A, accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates its fair value. The calculation of diluted income (loss) per common stock does not consider the effect of the warrants issued since the exercise of the warrants are contingent upon the occurrence of future events. However, the diluted earnings per share calculation includes the shares subject to forfeiture from the first day of the interim period in which the contingency on such shares was resolved. A reconciliation of net income (loss) per common stock is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Three Months Ended ​ ​ For the Six Months Ended ​ For the Six Months Ended ​ June 30, 2023 June 30, 2022 June 30, 2023 June 30, 2022 ​ Class A Class B Class A Class B Class A Class B Class A Class B Allocation of net income (loss) $ (328,630) ​ $ (809,615) ​ $ 18,026,419 ​ $ 10,625,000 ​ $ (264,590) $ (155,953) $ 12,441,680 $ 3,110,420 Weighted average shares outstanding ​ 4,312,774 ​ ​ 10,625,000 ​ ​ 42,500,000 ​ ​ 10,625,000 ​ ​ 18,026,419 ​ 10,625,000 ​ 42,500,000 ​ 10,625,000 Basic and diluted net income (loss) per share ​ $ (0.08) ​ $ (0.08) ​ $ 0.06 ​ $ 0.06 ​ ​ $ (0.01) ​ $ (0.01) ​ $ 0.29 ​ $ 0.29 ​ Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The tax provision for the six months ended June 30, 2023 and 2022 is $962,768 and $108,315 , respectively. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company’s effective tax rate was 177% and 0.01% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the six months ended June 30, 2023 and 2022, due to changes in fair value of warrants, FPA, and the valuation allowance on the deferred tax assets. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign stockholder corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to distribute to redeeming stockholders or to complete a Business Combination and could adversely affect the Company’s ability to complete a Business Combination. Working Capital Loan – Related Party When the Company issues convertible debt, it first evaluates the balance sheet classification of the convertible instrument in its entirety to determine whether the instrument should be classified as a liability under ASC 480 and second whether the conversion feature should be accounted for separately from the host instrument. A conversion feature of a convertible debt instrument or certain convertible preferred stock would be separated from the convertible instrument and classified as a derivative liability if the conversion feature, were it a stand-alone instrument, meets the definition of an “embedded derivative” as defined in ASC 815. Generally, characteristics that require derivative treatment include, among others, when the conversion feature is not indexed to the Company’s equity, as defined in ASC 815-40, or when it must be settled either in cash or by issuing stock that is readily convertible to cash. When a conversion feature meets the definition of an embedded derivative, it would be separated from the host instrument and classified as a derivative liability carried on the balance sheet at fair value, with any changes in its fair value recognized currently in the condensed statement of operations. The Working Capital Loan has a conversion feature that allows for converting the loan into warrants and is carried at fair value. The fair value of the balance outstanding on the convertible loan was $1,500,000 and $1,500,000 as of June 30, 2023 and December 31, 2022, respectively. During Q2 of 2023 the Company entered into a promissory note with the Sponsor which allowed up to $1,190,000 and accrues no interest. There was $1,190,000 outstanding on this loan as of June 30, 2023 and $0 outstanding as of December 31, 2022. In total the Company had $2,690,000 and $1,500,000 was outstanding on related party loans as of June 30, 2023 and December 31, 2022, respectively. Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”). 2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.	Note 3 — Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities and are recognized at fair value. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Gains and losses resulting from the change in fair value of these securities are included in interest earned on investments held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Concentration of Credit Risk The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2022 and 2021, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to stockholders’ equity upon the completion of the IPO. Accordingly, as of December 31, 2022, offering costs in the aggregate of $24,012,335 (consisting of $8,500,000 of underwriting commissions, $14,875,000 of deferred underwriters’ commission and $637,335 other offering costs) had been incurred. Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021, amounted to $280,500 consisting mainly of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. The Company allocates the offering costs between its common stock and Public Warrants using relative fair value method, with the offering costs allocated to the Public Warrants expensed immediately. Accordingly, as of December 31, 2022, offering costs in the aggregate of $782,812 have been charged to the Company’s statement of operations (consisting of $762,300 of underwriting discounts and $20,512 of other offering costs). Offering costs associated with the Class A common stock have been charged to stockholders’ deficit. As of December 31, 2022, deferred offering costs of $94,992 have been incurred. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature except for the derivative warrant liabilities and forward purchase agreement asset (see Note 10). Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company’s public warrant liability is based on quoted prices in active markets as of the measurement date and is classified as Level 1. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company accounts for its warrants issued in connection with its IPO as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of warrants issued by the Company in connection with the IPO and Private Placement has been estimated using binomial lattice model at the date of issuance. As of December 31, 2022, the Company’s public warrants were measured based on quoted prices in active markets, and the private placement warrants are categorized as a Level 2 following the public price. FASB ASC 470-20, “Debt with Conversion and Other Options”, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate IPO proceeds from the Units between common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then common stock. The Company accounts for its forward purchase agreements (collectively, the “Forward Purchase Agreements” or “FPAs”) issued as derivative FPA assets in accordance with ASC 815-40. Accordingly, the Company recognizes the FPA instruments as assets at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the FPAs has been estimated using observable inputs at the date of issuance. As of December 31, 2022 and 2021, the Company’s FPAs are categorized as a Level 3. Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock outstanding during the year, excluding common stock shares subject to forfeiture. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. The Company’s statements of operations include a presentation of income per share for shares of common stock subject to possible redemption in a manner similar to the two-class method of income per share. Consistent with ASC Topic 480-10-S99-3A, accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates its fair value. The calculation of diluted income per common stock does not consider the effect of the warrants issued since the exercise of the warrants are contingent upon the occurrence of future events. However, the diluted earnings per share calculation includes the shares subject to forfeiture from the first day of the interim period in which the contingency on such shares was resolved. A reconciliation of net income (loss) per common stock is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2022 ​ ​ Class A Class B Allocation of net income ​ $ 15,386,968 ​ $ 3,846,742 Weighted average shares outstanding, basic and diluted ​ 42,500,000 ​ 10,625,000 Basic and diluted net income per share ​ $ 0.36 ​ $ 0.36 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2021 ​ Class A Class B Allocation of net loss $ (193,470) $ (58,163) Weighted average shares outstanding, basic and diluted ​ 35,224,658 ​ 10,589,629 Basic and diluted net loss per share ​ $ (0.01) ​ $ (0.01) ​ Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The tax provision for the years ended December 31, 2022 and 2021 has been disclosed under Note 12, as well as the deferred tax assets as of December 31, 2022 and 2021. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Initial Public Offering
Initial Public Offering	Note 3 - Initial Public Offering On March 4, 2021, the Company consummated the IPO of 42,000,000 Units. Each Unit consists of one share of the Company’s Class A common stock, par value $0.0001 per share, and one -third of one warrant of the Company, with each whole warrant entitling the holder thereof to purchase one whole share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. The underwriters had a 45-day option to purchase up to an additional 6,300,000 Units to cover over-allotments. On April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option. In September 2022, the Company wrote off a liability of $4,462,500 of deferred underwriting fees, as the underwriters resigned from their role in any potential future Business Combination and thereby waived their entitlement to these fees (see Note 6).	Note 4 — Initial Public Offering On March 4, 2021, the Company consummated the IPO of 42,000,000 Units. Each Unit consists of one share of the Company’s Class A common stock, par value $0.0001 per share, and one -third of one warrant of the Company, with each whole warrant entitling the holder thereof to purchase one whole share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. The underwriters had a 45 -day option to purchase up to an additional 6,300,000 Units to cover over-allotments. On April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option.

Private Placement

Private Placement	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Private Placement
Private Placement	Note 4 - Private Placement Simultaneously with the closing of the IPO on March 4, 2021, the Company completed the private sale of an aggregate of 12,400,000 Private Placement Warrants to the Sponsor and, on April 14, 2021, simultaneously with the closing of the underwriters’ over-allotment option, the Company issued an additional 100,000 Private Placement Warrants to the Sponsor. The Private Placement Warrants were sold at a price of $1.00 per Private Placement Warrant, generating aggregate gross proceeds of $12,500,000 . A portion of the proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the IPO held in the Trust Account. Each Private Placement Warrant is exercisable for one share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. If the Company does not complete a Business Combination by September 30, 2023, or during any Extension Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable, or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis and are non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.	Note 5 — Private Placement Simultaneously with the closing of the IPO on March 4, 2021, the Company completed the private sale of an aggregate of 12,400,000 Private Placement Warrants to the Sponsor and, on April 14, 2021, simultaneously with the closing of the underwriters’ over-allotment option, the Company issued an additional 100,000 Private Placement Warrants to the Sponsor. The Private Placement Warrants were sold at a price of $1.00 per Private Placement Warrant, generating aggregate gross proceeds of $12,500,000. A portion of the proceeds from the sale of the Private Placement Warrants was added to the net proceeds from the IPO held in the Trust Account. Each Private Placement Warrant is exercisable for one share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. If the Company does not complete a Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable, or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis and are non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Related Party Transactions

Related Party Transactions	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Related Party Transactions
Related Party Transactions	Note 5 - Related Party Transactions Founder Shares On December 30, 2020, the Sponsor purchased 7,187,500 shares (the “Founder Shares”) of the Company’s Class B common stock for an aggregate purchase price of $25,000 . On February 19, 2021, the Company effected a stock dividend of 2,875,000 Founder Shares to the Sponsor, resulting in the Company’s initial stockholders holding an aggregate of 10,062,500 Founder Shares. On March 1, 2021, the Company effected a stock dividend of 2,012,500 Founder Shares to the Sponsor, resulting in the Company’s initial stockholders holding an aggregate of 12,075,000 Founder Shares. The Founder Shares included an aggregate of up to 1,575,000 shares that were subject to forfeiture depending on the extent that the underwriters’ over-allotment option was exercised, so that the number of Founder Shares would equal 20% of the Company’s issued and outstanding common stock after the IPO. On April 14, 2021, the Sponsor forfeited 1,450,000 Founder Shares following the expiration of the unexercised portion of underwriters’ over-allotment option. As a result, the 10,625,000 Founder Shares issued and outstanding as of June 30, 2023 and December 31, 2022 are not subject to forfeiture. The Sponsor and the Company’s officers, directors, and former directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares or Class A common stock received upon conversion thereof until the earlier of (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination (x) if the last reported sale of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, rights issuances, consolidations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30 - trading day period commencing at least 150 days after a Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company’s public stockholders having the right to exchange their shares of common stock for cash, securities or other property. Promissory Note — Related Party On December 30, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000 . The Promissory Note was non-interest bearing and was payable on the earlier of (i) March 31, 2021 or (ii) the completion of the IPO. The Company had no borrowings under the Promissory Note at June 30, 2023 or December 31, 2022. The facility is no longer available. Working Capital Loans — Related Party On March 29, 2022, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Sponsor may provide up to $1,500,000 to the Company as a Working Capital Loan. The Working Capital Loan does not bear interest and is repayable in full upon on the earlier of (i) March 29, 2023 or (ii) the consummation of the Company’s initial Business Combination. Upon the consummation of a Business Combination, the Sponsor shall have the option, but not the obligation, to convert the principal balance of the Working Capital Loan, in whole or in part, into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loan but no proceeds held in the Trust Account would be used to repay the Working Capital Loan. The Working Capital Loan is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Working Capital Loan and all other sums payable with regard to the Working Capital Loan becoming immediately due and payable. On March 21, 2023, the Company issued an additional unsecured promissory note (the “2023 Promissory Note”) to the Sponsor, pursuant to which the Sponsor may provide up to $1,190,000 to the Company as a working capital loan (the “2023 Working Capital Loan”). The 2023 Working Capital Loan does not bear interest and is repayable in full upon on the earlier of (i) December 31, 2023 or (ii) the consummation of a Business Combination. The 2023 Working Capital Loan is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the 2023 Working Capital Loan and all other sums payable with regard to the 2023 Working Capital Loan becoming immediately due and payable. As of April 3, 2023, $734,300 was outstanding under the 2023 Promissory Note. As of June 30, 2023 and December 31, 2022, there were amounts of $2,690,000 and $1,500,000 outstanding under the Working Capital Loan, respectively. The Working Capital Loan is recorded at fair value of $2,690,000 and $1,500,000 as of June 30, 2023 and December 31, 2022, respectively. Administrative Service Fee The Company has agreed, commencing on March 1, 2021, to pay an affiliate of the Company’s Sponsor a fixed amount of $40,521 per month for office space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. The Company has incurred costs of $121,563 and $243,126 for the three and six months ended June 30, 2023, respectively. The Company has incurred costs of $121,563 and $243,126 for the three and six months ended June 30, 2022, respectively. As of June 30, 2023 and December 31, 2022, there were amounts of $244,175 and $0 accrued on the condensed balance sheets, respectively. Diligence Services The Company has agreed to pay or reimburse Anzu Partners LLC, an affiliate of the Sponsor for certain fees and out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as performing due diligence on suitable business combination opportunities. There were amounts of $ 873,290 and $ 958,429 accrued for such fees and expenses as of June 30, 2023 and December 31, 2022, respectively. The Company incurred $ 54,971 and $142,411 of such fees and expenses for the three months ended June 30, 2023 and 2022, respectively. The Company incurred $201,549 and $385,706 of such fees and expenses for the six months ended June 30, 2023 and 2022, respectively. On June 30, 2023, Anzu Partners LLC waived $286,688 of such accrued fees and expenses.	Note 6 — Related Party Transactions Founder Shares On December 30, 2020, the Sponsor purchased 7,187,500 shares (the “Founder Shares”) of the Company’s Class B common stock for an aggregate purchase price of $25,000 . On February 19, 2021, the Company effected a stock dividend of 2,875,000 Founder Shares to the Sponsor, resulting in the Company’s initial stockholders holding an aggregate of 10,062,500 Founder Shares. On March 1, 2021, the Company effected a stock dividend of 2,012,500 Founder Shares to the Sponsor, resulting in the Company’s initial stockholders holding an aggregate of 12,075,000 Founder Shares. The Founder Shares included an aggregate of up to 1,575,000 shares that were subject to forfeiture depending on the extent that the underwriters’ over-allotment option was exercised, so that the number of Founder Shares would equal 20% of the Company’s issued and outstanding common stock after the IPO. On April 14, 2021, the Sponsor forfeited 1,450,000 Founder Shares following the expiration of the unexercised portion of underwriters’ over-allotment option. As a result, the 10,625,000 Founder Shares issued and outstanding as of December 31, 2022, are not subject to forfeiture. The Sponsor and the Company’s officers and directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares or Class A common stock received upon conversion thereof until the earlier of (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, rights issuances, consolidations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30 - trading day period commencing at least 150 days after a Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company’s public stockholders having the right to exchange their shares of common stock for cash, securities or other property. Promissory Note — Related Party On December 30, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and was payable on the earlier of (i) March 31, 2022 or (ii) the completion of the IPO. The Company had no borrowings under the promissory note at December 31, 2022 or 2021. The facility is no longer available. Working Capital Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021, the Company had amounts of $1,500,000 and $0 under the Working Capital Loans, respectively. On March 29, 2022, the Company issued an unsecured promissory note to the Sponsor (the “2022 Promissory Note”), pursuant to which the Sponsor may provide up to $1,500,000 to the Company as a Working Capital Loan (the “2022 Working Capital Loan”). The 2022 Working Capital Loan does not bear interest and is repayable in full upon on the earlier of (i) March 29, 2023 or (ii) the consummation of the Company’s initial Business Combination. Upon the consummation of a Business Combination, the Sponsor shall have the option, but not the obligation, to convert the principal balance of the 2022 Working Capital Loan, in whole or in part, into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the 2022 Working Capital Loan but no proceeds held in the Trust Account would be used to repay the 2022 Working Capital Loan. The 2022 Working Capital Loan is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the 2022 Working Capital Loan and all other sums payable with regard to the 2022 Working Capital Loan becoming immediately due and payable. As of December 31, 2022 and 2021, the Company had amounts of $1,500,000 and $0 under the 2022 Working Capital Loan, respectively. The 2022 Working Capital Loan is recorded at fair value of $1,500,000. Administrative Service Fee The Company has agreed, commencing on March 1, 2021, to pay an affiliate of the Company’s Sponsor a fixed amount of $40,521 per month for office space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. There was no accrual for administrative service fees as of December 31, 2022 or 2021. The Company has incurred costs due to a related party of $486,252 and $405,210 for the years ended December 31, 2022 and 2021, respectively, and all amounts were paid in the period incurred. Diligence Services The Company has agreed to pay or reimburse an affiliate of the Sponsor for certain fees and out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as performing due diligence on suitable business combination opportunities. As of December 31, 2022 and 2021, there were amounts of $958,429 and $334,731, respectively, accrued for such fees and expenses. The Company paid an affiliate of the Sponsor $0 and $417,185 for such fees and expenses during the years ended December 31, 2022 and 2021, respectively. The Company incurred $623,698 and $751,916 of such fees and expenses for the years ended December 31, 2022 and 2021, respectively.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Commitments and Contingencies.
Commitments and Contingencies	Note 6 - Commitments and Contingencies Registration and Stockholder Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Company’s Class A common stock). The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggyback” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters had a 45-day option from the date of the IPO to purchase up to an additional 6,300,000 Units to cover over-allotments, if any. On April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option. On March 4, 2021 and April 14, 2021, the underwriters were paid a fixed underwriting discount of $8,400,000 and $100,000 , respectively. In addition, the underwriters are entitled to a deferred discount of $0.35 per Unit, or $14,875,000 in the aggregate. The deferred discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. In September 2022, the Company reversed a liability of $4,462,500 of deferred underwriting fees, as some underwriters resigned from their role in any potential future Business Combination and thereby waived their entitlement to these fees. Forward Purchase Agreements On December 6, 2021, the Company entered into Forward Purchase Agreements with certain institutional investors and anchored by Arena Capital Advisors, LLC and Fir Tree Partners (collectively, the “Forward Purchasers”), pursuant to which the Forward Purchasers have agreed, subject to certain conditions, to purchase the following: ● up to an aggregate of $80,000,000 of unsecured convertible notes of the Company (“Convertible Notes”) immediately prior to the closing of the Company’s Business Combination. The terms of the Convertible Notes, including the terms on which the Convertible Notes will convert into shares of the Company’s Class A common stock, will be negotiated by the Company and the Forward Purchasers, each acting in its sole discretion, prior to the issuance of the Convertible Notes. The aggregate total of up to $80,000,000 from the issuance of the Convertible Notes would be received by the Company upon the closing of the Company’s Business Combination; and ● up to an aggregate of 4,000,000 forward purchase securities of the Company (the “Forward Purchase Securities”) for $10.00 per Forward Purchase Security, or an aggregate total of up to $40,000,000 , immediately prior to the Business Combination Closing. Each Forward Purchase Security would consist of one share of Class A common stock issued and sold by the Company and one -nineth of one warrant transferred by the Sponsor for no value, with each whole redeemable warrant exercisable to purchase one share of Class A common stock for $11.50 per share. The aggregate total of up to $40,000,000 from the issuance of the Forward Purchase Securities would be received by the Company upon the closing of the Company’s Business Combination. The shares of Class A common stock included in the Forward Purchase Securities would have the same terms as the Company’s publicly traded shares of Class A common stock. The warrants included in the Forward Purchase Securities would have the same terms as the private placement warrants held by the Sponsor and would be subject to the terms of the Warrant Agreement, dated March 1, 2021, entered into between the Company and American Stock Transfer & Trust Company, as Warrant Agent, in connection with the Company’s initial public offering (the “Warrant Agreement”). In addition, under the Forward Purchase Agreements, if the Company determines to raise capital by the private placement of equity securities in connection with the closing of the Company’s Business Combination (the “New Equity Securities”), the Company shall first make an offer to the Forward Purchasers to purchase the securities then offered on the same terms as such New Equity Securities, in an aggregate amount of up to $120,000,000 . Any commitment by any Forward Purchaser under any of the Forward Purchase Agreements to purchase New Equity Securities is subject to and conditioned upon the acceptance of the Company’s offer by such Forward Purchaser, following the Company’s notification to such Forward Purchaser of its intention to offer the New Equity Securities. Pursuant to the Forward Purchase Agreements, the Forward Purchasers will be entitled to registration rights with respect to shares of Class A common stock underlying the Convertible Notes, the shares of Class A common stock and warrants included in the Forward Purchase Securities, and the New Equity Securities. This Forward Purchase Agreement Expired in the second quarter of 2023 and a new Forward Purchase Agreement was entered into as described below. In addition, on April 17, 2023, prior to entering into the Business Combination Agreement, Anzu, Envoy (for purposes of the Forward Purchase Agreement (as defined below), New Envoy, following the Business Combination, together with Anzu prior to the Business Combination, as the case may be, are referred to in this section as the “Counterparty”), and Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”) and Meteora Select Trading Opportunities Master, LP (“MSTO” and, together with MSOF and MCP, collectively the “Seller”) entered into an agreement (as amended by Amendment No. 1 to the Forward Purchase Agreement, dated as of May 25, 2023, the “Forward Purchase Agreement”) for an OTC Equity Prepaid Forward Transaction (the “Forward Purchase Transaction”). Pursuant to the terms of the Forward Purchase Agreement, Seller intends, but is not obligated, to purchase through a broker in the open market, following the period for making redemption elections and prior to the Closing, shares of Anzu Class A Common Stock from holders of Anzu Class A Common Stock (other than Anzu or affiliates of Anzu) including from holders who have previously elected to redeem their Anzu Class A Common Stock (such purchased shares of Anzu Class A Common Stock, the “FPA Shares”) pursuant to the redemption rights set forth in the Current Charter in connection with the Business Combination (such holders, “Redeeming Holders”). Purchases by the Seller, if any, will be made after the redemption deadline in connection with the Business Combination at a price no higher than the redemption price to be paid to holders who elect to redeem their Anzu Class A Common Stock in connection with the Business Combination. Excluding the shares of Anzu Class A Common Stock transferred to Seller as the Share Consideration (as defined below), the aggregate total number of FPA Shares (the “Number of FPA Shares”) will in no event be more than 4,300,000 FPA Shares (the “Maximum Number of FPA Shares”). The Number of FPA Shares is subject to reduction as described under “Optional Early Termination” in the Forward Purchase Agreement. Seller also may transfer any FPA Shares as needed to beneficially own no more than 9.9% of the total number of shares of Anzu Class A Common Stock outstanding on a post-combination basis. The Seller in its sole discretion may request warrants of the Counterparty exercisable for shares of Anzu Class A Common Stock in an amount equal to (i) the Maximum Number of FPA Shares less (ii) the Number of Shares specified in the supplement of the Forward Purchase Agreement (the “Pricing Date Notice”). Seller has agreed to waive any redemption rights in connection with the Business Combination with respect to the FPA Shares. Such waiver may reduce the number of shares of Anzu Class A Common Stock redeemed in connection with the Business Combination, which could alter the perception of the potential strength of the Business Combination. Seller has further agreed not to vote any of the FPA Shares in favor of the Business Combination Proposal. Further, concurrently with the Business Combination Agreement, Envoy entered into a convertible promissory note (the “Envoy Bridge Note”) pursuant to which it will borrow $10,000,000 from GAT Funding, LLC (“GAT,” or the “Envoy Bridge Note Holder”), which is an entity owned by Glen A. Taylor, a member of the Envoy Board and a holder of more than 5% of the Envoy Common Stock, and the holder of all of the outstanding shares of Envoy Preferred Stock, prior to the Closing. Contingent upon, and effective concurrently with, the PIPE Closing, New Envoy will issue shares of Series A Preferred Stock to GAT in exchange for the Envoy Bridge Note. GAT will have certain customary registration rights, including rights with respect to the filing of a shelf registration statement, underwritten offering rights and piggyback rights, pursuant to the A&R Registration Rights Agreement (as described below) with respect to any shares of New Envoy Class A Common Stock issuable upon conversion of the Series A Preferred Stock. As of June 30, 2023 and December 31, 2022, there is nothing outstanding on the Convertible Notes and no action has been taken on the Forward Purchase Securities other than the initial contract agreement.	Note 7 — Commitments and Contingencies Registration and Stockholder Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Company’s Class A common stock). The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters had a 45 -day option from the date of the IPO to purchase up to an additional 6,300,000 Units to cover over-allotments, if any. On April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option. On March 4, 2021 and April 14, 2021, the underwriters were paid a fixed underwriting discount of $8,400,000 and $100,000, respectively. In addition, the underwriters are entitled to a deferred discount of $0.35 per Unit, or $14,875,000 in the aggregate. During the year ended December 31, 2022, the Company wrote off a liability of $4,462,500 of deferred underwriting fees, through the statement of operations, as some underwriters resigned from their role in any potential future Business Combination and thereby waived their entitlement to these fees. The deferred discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Forward Purchase Agreements On December 6, 2021, the Company entered into Forward Purchase Agreements with certain institutional investors and anchored by Arena Capital Advisors, LLC and Fir Tree Partners (collectively, the “Forward Purchasers”), pursuant to which the Forward Purchasers have agreed, subject to certain conditions, to purchase the following: ● up to an aggregate of $80,000,000 of unsecured convertible notes of the Company (“Convertible Notes”) immediately prior to the closing of the Company’s Business Combination. The terms of the Convertible Notes, including the terms on which the Convertible Notes will convert into shares of the Company’s Class A common stock, will be negotiated by the Company and the Forward Purchasers, each acting in its sole discretion, prior to the issuance of the Convertible Notes. The aggregate total of up to $80,000,000 from the issuance of the Convertible Notes would be received by the Company upon the closing of the Company’s Business Combination. ● up to an aggregate of 4,000,000 forward purchase securities of the Company (the “Forward Purchase Securities”) for $10.00 per Forward Purchase Security, or an aggregate total of up to $40,000,000 , immediately prior to the Business Combination Closing. Each Forward Purchase Security would consist of one share of Class A common stock issued and sold by the Company and one -sixth of one warrant transferred by the Sponsor for no value, with each whole redeemable warrant exercisable to purchase one share of Class A common stock for $11.50 per share. The aggregate total of up to $40,000,000 from the issuance of the Forward Purchase Securities would be received by the Company upon the closing of the Company’s Business Combination. The shares of Class A common stock included in the Forward Purchase Securities would have the same terms as the Company’s publicly traded shares of Class A common stock. The warrants included in the Forward Purchase Securities would have the same terms as the private placement warrants held by the Sponsor and would be subject to the terms of the Warrant Agreement, dated March 1, 2021, entered into between the Company and American Stock Transfer & Trust Company, as Warrant Agent, in connection with the Company’s initial public offering (the “Warrant Agreement”). In addition, under the Forward Purchase Agreements, if the Company determines to raise capital by the private placement of equity securities in connection with the closing of the Company’s Business Combination (the “New Equity Securities”), the Company shall first make an offer to the Forward Purchasers to purchase the securities then offered on the same terms as such New Equity Securities, in an aggregate amount of up to $120,000,000. Any commitment by any Forward Purchaser under any of the Forward Purchase Agreements to purchase New Equity Securities is subject to and conditioned upon the acceptance of the Company’s offer by such Forward Purchaser, following the Company’s notification to such Forward Purchaser of its intention to offer the New Equity Securities. Pursuant to the Forward Purchase Agreements, the Forward Purchasers will be entitled to registration rights with respect to shares of Class A common stock underlying the Convertible Notes, the shares of Class A common stock and warrants included in the Forward Purchase Securities, and the New Equity Securities. As of December 31, 2022, there is nothing outstanding on the Convertible Notes and no action has been taken on the Forward Purchase Securities other than the initial contract agreement.

Class A Common Stock Subject to

Class A Common Stock Subject to Possible Redemption	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Class A Common Stock Subject to Possible Redemption
Class A Common Stock Subject to Possible Redemption	Note 7 - Class A Common Stock Subject to Possible Redemption The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 400,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 4,312,774 and 42,500,000 shares of Class A common stock outstanding, respectively, all of which were subject to possible redemption. As of June 30, 2023, these shares were valued at $10.34 , due to the stockholder rights to the trust proceeds, for a total of $44,595,404 . As of December 31, 2022, these shares were valued at $10.11 per share, for a total of $429,747,193 . At June 30, 2023 and December 31, 2022, the Class A common stock reflected in the unaudited condensed balance sheets is reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 425,000,000 Less: ​ ​ ​ Proceeds allocated to Public Warrants ​ ​ (14,026,667) Class A common stock issuance costs ​ ​ (23,229,523) Plus: ​ ​ ​ Accretion of carrying value to redemption value ​ ​ 37,691,146 Waiver of Class A shares issuance costs ​ ​ 4,312,237 Class A common stock subject to possible redemption at December 31, 2022 ​ ​ 429,747,193 Redemption of Class A common stock ​ ​ (387,606,834) Accretion of carrying value to redemption value ​ ​ 2,025,746 Class A common stock subject to possible redemption at March 31, 2023 ​ ​ 44,166,105 Accretion of carrying value to redemption value ​ ​ 429,299 Class A common stock subject to possible redemption at June 30, 2023 ​ $ 44,595,404 ​	Note 8 — Class A Common Stock Subject to Possible Redemption The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of December 31, 2022 and 2021, there were 42,500,000 shares of Class A common stock outstanding, all of which were subject to possible redemption. As of December 31, 2022, these shares were valued at $10.11 , due to the stockholder rights to the trust proceeds, for a total of $429,747,193 . As of December 31, 2021, these shares were valued at the IPO price of $ 10.00 per share for a total of $425,000,000 . At December 31,2022 and 2021, the Class A common stock reflected in the balance sheets is reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 425,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (14,026,667) Class A common stock issuance costs ​ (23,229,523) Plus: ​ Accretion of carrying value to redemption value ​ 37,256,190 Class A common stock subject to possible redemption at December 31, 2021 ​ ​ 425,000,000 Waiver of Class A shares issuance costs ​ ​ 4,312,237 Accretion of carrying value to redemption value ​ ​ 434,956 Class A common stock subject to possible redemption at December 31, 2022 ​ $ 429,747,193 ​

Stockholders' Deficit

Stockholders' Deficit	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Stockholders' Deficit
Stockholders' Deficit	Note 8 - Stockholders’ Deficit Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock, with a par value of $0.0001 per share. The Company’s board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The board of directors is able to, without stockholder approval, issue shares of preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects. At June 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding . Class A Common Stock — The Company is authorized to issue 400,000,000 shares of Class A common stock, with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 4,312,774 and 42,500,000 shares of Class A common stock issued and outstanding , respectively, which are all subject to possible redemption and are presented as temporary equity. Class B Common Stock — The Company is authorized to issue 40,000,000 shares of Class B common stock, with a par value of $0.0001 per share. Holders of shares of Class B common stock are entitled to one vote for each share. At June 30, 2023 and December 31, 2022, there were 10,625,000 shares of Class B common stock issued and outstanding . Only holders of the Class B common stock have the right to vote on the election of directors prior to a Business Combination. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as otherwise required by law. The Class B common stock will automatically convert into Class A common stock at the time of the completion of a Business Combination, or earlier at the option of the holder, on a one -for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the IPO and related to the closing of a Business Combination, the ratio at which Founder Shares will convert into Class A common stock will be adjusted (subject to waiver by holders of a majority of the Class B common stock) so that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the common stock issued and outstanding upon completion of the IPO plus the number of shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination, excluding any shares of Class A common stock or equity-linked securities issued, or to be issued, to any seller in a Business Combination.	Note 9 — Stockholders’ Deficit Preferred Stock Class A Common Stock there were 42,500,000 shares of Class A common stock issued and outstanding, which are all subject to possible redemption and are presented as temporary equity. Class B Common Stock Only holders of the Class B common stock have the right to vote on the election of directors prior to a Business Combination. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as otherwise required by law. The Class B common stock will automatically convert into Class A common stock at the time of the completion of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the IPO and related to the closing of a Business Combination, the ratio at which Founder Shares will convert into Class A common stock will be adjusted (subject to waiver by holders of a majority of the Class B common stock) so that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the common stock issued and outstanding upon completion of the IPO plus the number of shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination, excluding any shares of Class A common stock or equity-linked securities issued, or to be issued, to any seller in a Business Combination.

Fair Value Measurements

Fair Value Measurements	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Fair Value Measurements
Fair Value Measurements	Note 9 – Fair Value Measurements Level 1 assets include investments in money market funds that invest solely in U.S. government securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of Public Warrants was transferred from a Level 3 measurement to a Level 1 measurement, when the Public Warrants were separately listed and traded in an active market in April 2021. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 fair value measurement as of July 2021, as the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. There were no transfers to/from Levels 1, 2, and 3 during the three and six months ended June 30 , 2023 or 2022. The initial fair value of the Public and Private Placement Warrants, issued concurrently and in connection with the Initial Public Offering, has been estimated using a binomial lattice model. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrants’ listed price in an active market was used as the fair value. The estimated fair value of the Warrants, prior to the Public Warrants being traded in an active market, is determined using Level 3 inputs. Inherent in a binomial lattice model are assumptions related to the Unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The Unit price is based on the publicly traded price of the Units as of the measurement date. The Company estimated the volatility for the Warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the Warrants. The term to expiration was calculated as the contractual term of the Warrants, assuming one year to a Business Combination from the Initial Public Offering date. Finally, the Company does not anticipate paying a dividend. The asset for the FPAs was valued using the time-discounted spread of the fixed purchase price of the Company’s units pursuant to the FPAs over the public trading price of the Company’s Units and is considered to be a Level 3 fair value measurement. The valuation is then adjusted to reduce the value of the FPAs for the value of warrants. The model utilizes key inputs including risk-free interest rates based on U.S. Treasury rates. The liability for the PFD was estimated using a Monte Carlo simulation model, which is a Level 3 fair value measurement. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. In accounting for the working capital loan, the Company bifurcated a derivative liability representing the conversion option, with a fair value of $ 2,690,000 at issuance. To measure the fair value of the derivative liability, the Company compared the calculated value of the working capital loan with the indicated value of the host instrument, defined as the straight-debt component of the working capital loan. The difference between the value of the straight-debt host instrument and the fair value of the working capital loan resulted in the value of the derivative liability. The value of the straight-debt host instrument was estimated using a Monte Carlo simulation model, which is a Level 3 fair value measurement. The following tables present information about the Company’s assets and liabilities that are measured on a recurring basis as of June 30, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Significant Significant ​ ​ Prices in ​ Other ​ Other ​ ​ Active Markets ​ Observable ​ Unobservable ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 44,645,404 ​ $ — ​ $ — Forward Purchase Agreement ​ ​ — ​ ​ — ​ ​ — Fair Value at June 30, 2023 (unaudited) ​ $ 44,645,404 ​ $ — ​ $ — Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ Working capital loan – related party ​ $ — ​ $ — ​ $ 2,690,000 Public Warrant liability ​ ​ 708,333 ​ ​ — ​ ​ — Private Warrant liability ​ ​ — ​ ​ 625,000 ​ ​ — Prepaid forward derivative ​ ​ — ​ ​ — ​ ​ 144,770 Fair Value at June 30, 2023 (unaudited) ​ $ 708,333 ​ $ 625,000 ​ $ 2,834,770 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Significant Significant ​ ​ Prices in ​ Other ​ Other ​ ​ Active Markets ​ Observable ​ Unobservable ​ ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 430,047,193 ​ $ — ​ $ — Forward Purchase Agreement ​ ​ — ​ ​ — ​ ​ 353,731 Fair Value at December 31, 2022 ​ $ 430,047,193 ​ $ — ​ $ 353,731 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ Working capital loan – related party ​ $ — ​ $ — ​ $ 1,500,000 Public Warrant liability ​ ​ 566,667 ​ ​ — ​ ​ — Private Warrant liability ​ ​ — ​ ​ 500,000 ​ ​ — Fair Value at December 31, 2022 ​ $ 566,667 ​ $ 500,000 ​ $ 1,500,000 ​ The following tables provide the roll forward for the Level 3 investments for the six months ended June 30, 2023: ​ ​ ​ ​ ​ FPA assets at December 31, 2022 ​ $ 353,731 Change in fair value of FPA ​ 681,533 FPA assets at March 31, 2023 (unaudited) ​ ​ 1,035,264 Expiration of FPA asset April 17, 2023 ​ ​ (1,035,264) New FPA – liability April 17, 2023 ​ ​ (144,770) FPA liability at June 30, 2023 (unaudited) ​ $ (144,770) ​ ​ ​ ​ Working capital loan at December 31, 2022 ​ $ 1,500,000 Issuance of loan ​ ​ 734,300 Working capital loan at March 31, 2023 (unaudited) ​ ​ 2,234,300 Issuance of loan ​ ​ 455,700 Working capital loan at June 30, 2023 (unaudited) ​ $ 2,690,000 ​ ​ ​ ​ ​ FPA assets at December 31, 2021 $ 1,002,789 Change in fair value of FPA ​ (649,058) FPA assets at December 31, 2022 ​ $ 353,731 ​ ​ ​ Working capital loan at December 31, 2021 ​ $ — Issuance of loan ​ ​ 1,500,000 Change in fair value of working capital loan ​ ​ — Working capital loan at December 31, 2022 ​ $ 1,500,000 ​ The following table presents the quantitative information regarding Level 3 fair value measurements of the Forward Purchase Agreements: ​ ​ ​ ​ ​ ​ ​ December 31, 2022 Unit Price ​ $ 10.00 ​ Remaining Term (in years) ​ ​ 0.16 ​ Risk-Free Rate ​ ​ 4.18 % ​ The following table presents the quantitative information regarding Level 3 fair value measurements of the Prepaid Forward Derivative Agreements: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2023 April 17, 2023 Unit Price ​ $ 10.24 ​ $ 10.07 ​ Remaining Term (in years) ​ 1.25 ​ 1.46 ​ Risk-Free Rate ​ 5.13 % 4.42 % ​ The following table presents the quantitative information regarding Level 3 fair value measurements of the working capital loan: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2023 December 31, 2022 Principal Outstanding ​ $ 1,500,000 ​ $ 1,500,000 Expected Remaining Term (in years) ​ 0.25 ​ ​ 0.25 ​ Volatility ​ 37.4 ​ ​ 43.5 % Risk-Free Rate ​ 4.03 ​ ​ 3.91 % ​	Note 10 — Fair Value Measurements Level 1 assets include investments in money market funds that invest solely in U.S. government securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of Public Warrants was transferred from a Level 3 measurement to a Level 1 measurement, when the Public Warrants were separately listed and traded in an active market in April 2021. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 fair value measurement as of July 2021, as the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. There were no transfers to/from Levels 1, 2, and 3 during the year ended December 31, 2022. There were $14,000,000 in transfers from Level 3 to Level 1 and $8,000,000 in transfers from Level 3 to Level 2 for the year ended December 31, 2021. The initial fair value of the Public and Private Placement Warrants, issued concurrently and in connection with the Initial Public Offering, has been estimated using a binomial lattice model. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrants’ listed price in an active market was used as the fair value for both the Public and Private Placement Warrants. The estimated fair value of the Warrants, prior to the Public Warrants being traded in an active market, is determined using Level 3 inputs. Inherent in a binomial lattice model are assumptions related to the Unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The Unit price is based on the publicly traded price of the Units as of the measurement date. The Company estimated the volatility for the Warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the Warrants. The term to expiration was calculated as the contractual term of the Warrants, assuming one year to a Business Combination from the Initial Public Offering date. Finally, the Company does not anticipate paying a dividend. In accounting for the working capital loan, the Company bifurcated a derivative liability representing the conversion option, with a fair value of $1,500,000 at issuance. To measure the fair value of the derivative liability, the Company compared the calculated value of the working capital loan with the indicated value of the host instrument, defined as the straight-debt component of the working capital loan. The difference between the value of the straight-debt host instrument and the fair value of the working capital loan resulted in the value of the derivative liability. The value of the straight-debt host instrument was estimated using a Monte Carlo simulation model, which is a Level 3 fair value measurement. The asset for the FPAs was valued using the time-discounted spread of the fixed purchase price of the Company’s units pursuant to the FPAs over the public trading price of the Company’s Units and is considered to be a Level 3 fair value measurement. The valuation is then adjusted to reduce the value of the FPAs for the value of warrants. The model utilizes key inputs including risk free interest rates based on U.S. Treasury rates. The following tables present information about the Company’s assets that are measured on a recurring basis as of December 31, 2022 and 2021 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ Significant ​ ​ in Active ​ Other ​ Other ​ Markets Observable Unobservable December 31, 2022 (Level 1) (Level 2) (Level 3) Assets: ​ ​ ​ ​ Investments held in Trust Account $ 430,047,193 $ — $ — Forward Purchase Agreements ​ ​ — ​ ​ — ​ ​ 353,731 Fair value at December 31, 2022 $ 430,047,193 $ — $ 353,731 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ Public Warrant liability $ 566,667 $ — $ — Private Warrant liability ​ ​ — ​ ​ 500,000 ​ ​ — Working Capital Loans – related party ​ ​ — ​ ​ — ​ ​ 1,500,000 Fair Value at December 31, 2022 $ 566,667 $ 500,000 $ 1,500,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ Significant ​ ​ in Active ​ Other ​ Other ​ ​ Markets ​ Observable ​ Unobservable December 31, 2021 (Level 1) (Level 2) (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 425,037,665 $ — ​ $ — Forward Purchase Agreements ​ ​ — ​ — ​ ​ 1,002,789 Fair value at December 31, 2021 ​ $ 425,037,665 $ — ​ $ 1,002,789 Liabilities: ​ ​ Public Warrant liability ​ $ 11,190,235 $ — ​ $ — Private Warrant liability ​ ​ — ​ 9,873,737 ​ ​ — Fair value at December 31, 2021 ​ $ 11,190,235 $ 9,873,737 ​ $ — ​ The following tables provide the roll forward for the Level 3 investments as of December 31, 2022: ​ ​ ​ ​ ​ FPA assets at December 31, 2021 $ 1,002,789 Change in fair value of FPAs ​ (649,058) FPA assets at December 31, 2022 ​ $ 353,731 Working Capital Loans at December 31, 2021 ​ $ — Issuance of loan ​ 1,500,000 Change in fair value of working capital loan ​ — Working Capital Loans at December 31, 2022 ​ $ 1,500,000 ​ The following tables provides the roll forward for the Level 3 investments as of December 31, 2021: ​ ​ ​ ​ ​ Level 3 Warrant liabilities at March 4, 2021 $ 26,260,000 Change in fair value of warrant liabilities ​ (4,363,000) Transfers from Level 3 to Level 1 investments ​ (14,000,000) Warrants issued on April 12, 2021 ​ ​ 103,000 Transfers from Level 3 to Level 2 investments ​ ​ (8,000,000) Level 3 Warrant liabilities at December 31, 2021 ​ $ — Issuance of FPA assets at December 6, 2021 ​ $ 770,000 Change in fair value of FPAs ​ ​ 232,789 Level 3 investments (at asset position) at December 31, 2021 ​ $ 1,002,789 ​ The following table presents the quantitative information regarding Level 3 fair value measurements of the Forward Purchase Agreements: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 December 31, 2021 Unit Price ​ $ 10.00 ​ $ 10.00 ​ Remaining Term (in years) ​ ​ 0.16 ​ 0.50 ​ Risk-Free Rate ​ ​ 4.18 % 0.19 % ​ The following table presents the quantitative information regarding Level 3 fair value measurements of the Working Capital Loan: ​ ​ ​ ​ ​ ​ ​ December 31, 2022 Principal Outstanding ​ $ 1,500,000 Expected Remaining Term (in years) ​ 0.16 ​ Volatility ​ 43.5 % Risk-Free Rate ​ 3.91 % ​ The change in fair value of the warrant liabilities is summarized as follows: ​ ​ ​ ​ ​ Warrant liabilities at December 31, 2021 $ 21,063,972 Change in fair value of warrant liabilities ​ (19,997,305) Warrant liabilities at December 31, 2022 ​ $ 1,066,667 Warrant liabilities at March 4, 2021 ​ $ 26,260,000 Warrants issued on April 12, 2021 ​ 269,667 Change in fair value of warrant liabilities ​ (5,465,695) Warrant liabilities at December 31, 2021 ​ $ 21,063,972 ​

Warrant Liabilities

Warrant Liabilities	6 Months Ended
	Jun. 30, 2023
Warrant Liabilities
Warrant Liabilities	Note 10 - Warrant Liabilities Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the IPO. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination by March 4, 2023, or during any Extension Period, and the Company liquidates the funds held in the Trust Account, holders of the warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the completion of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of shares of the Company’s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described below under “Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $18.00 ” and “Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $10.00 ” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under “Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $10.00 ” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration or a valid exemption from registration is available. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A common stock issuable upon exercise of the Public Warrants. The Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of a Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Class A common stock is, at the time of any exercise of a Public Warrant, not listed on a national securities exchange such that they do not satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $18.00 . Once the Public Warrants become exercisable, the Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per Public Warrant; ● upon not less than 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the last reported sale price of shares of the Class A common stock for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant). Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $10.00 . Once the Public Warrants become exercisable, the Company may redeem the Public Warrants: ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Class A common stock; ● if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and ● if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants. If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. The warrant agreement contains an alternative issuance provision that if less than 70% of the consideration receivable by the holders of shares of the Company’s Class A common stock in the Business Combination is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within 30 days following the public disclosure of the consummation of such Business Combination, the warrant exercise price will be reduced by an amount equal to the difference (but in no event less than zero) of (i) the warrant exercise price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a warrant immediately prior to the consummation of the Business Combination based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets. “Per Share Consideration” means (i) if the consideration paid to holders of shares of the Company’s Class A common stock consists exclusively of cash, the amount of such cash per share of Class A common stock, and (ii) in all other cases, the volume weighted average price of the Company’s Class A common stock as reported during the ten -trading day period ending on the trading day prior to the effective date of the Business Combination. The Company has outstanding an aggregate of 26,666,666 warrants, including 14,166,666 public warrants and 12,500,000 private warrants as of both June 30, 2023 and December 31, 2022, to purchase shares of the Company’s Class A common stock, which were issued in connection with the IPO and the Private Placement (including 266,666 warrants issued in connection with the consummation of the underwriters’ partial exercise of their over-allotment option) (see Notes 3 and 4). The Company believes that the adjustments to the exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under ASC 815–40, and thus the warrants are not eligible for an exception from derivative accounting. The accounting treatment of derivative financial instruments requires that the Company records a derivative liability upon the closing of IPO. Accordingly, the Company has classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the binomial lattice model. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statements of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification. The estimated fair value of the public warrant liability is based on quoted prices in active markets as of the measurement date. The estimated fair value of the private warrant liability is determined using public price.

Subsequent Events

Subsequent Events	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Subsequent Events
Subsequent Events	Note 11 - Subsequent Events The Company evaluated subsequent events and transactions that occurred after the condensed balance sheets date through the date that the unaudited condensed financial statements were issued. Based on this review, the Company did not identify any subsequent events except for those stated below that would have required adjustment or disclosure in the unaudited condensed financial statements.	Note 13 - Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date through April 3, 2023, the date that the financial statements were issued. Based on this review, the Company did not identify any subsequent events besides what is disclosed below that would have required adjustment or disclosure in the financial statements. In February 2023, the remaining underwriter resigned from its role in the Company’s potential business combination with Envoy Medical Corporation (the “Proposed Business Combination”) and thereby waived its entitlement to $10,412,500 in deferred underwriting fees solely with respect to the Proposed Business Combination. On February 28, 2023, the Company reconvened its special meeting of stockholders, which was originally scheduled for February 9, 2023, adjourned until February 21, 2023 and further adjourned until February 28, 2023 (the “Special Meeting”). At the Special Meeting, the Company’s stockholders approved a proposal to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company has to consummate a Business Combination from March 4, 2023 to September 30, 2023 or such earlier date as determined by the Company’s board of directors (the “Extension”). Following the approval of the Extension, the Company waived its right under the amended and restated certificate of incorporation to withdraw up to $100,000 of interest from the Trust Account to pay dissolution expenses in the event of the Company’s liquidation. In connection with the Special Meeting, stockholders holding 38,187,226 shares of the Company’s Class A common stock exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $387.6 million (approximately $10.15 per share of Class A common stock) was removed from the Trust Account to pay such holders and approximately $45.1 million remained in the Trust Account. Following the redemptions, the Company has 4,312,774 shares of Class A common stock outstanding. On March 21, 2023, the Company and the Sponsor amended the 2022 Promissory Note to extend the maturity date of the 2022 Working Capital Loan to the earlier of (i) December 31, 2023 or (ii) the consummation of a Business Combination. On March 21, 2023, the Company issued an additional unsecured promissory note (the “2023 Promissory Note”) to the Sponsor, pursuant to which the Sponsor may provide up to $1,190,000 to the Company as a working capital loan (the “2023 Working Capital Loan”). The 2023 Working Capital Loan does not bear interest and is repayable in full upon on the earlier of (i) December 31, 2023 or (ii) the consummation of a Business Combination. The 2023 Working Capital Loan is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the 2023 Working Capital Loan and all other sums payable with regard to the 2023 Working Capital Loan becoming immediately due and payable. As of April 3, 2023, $734,300 was outstanding under the 2023 Promissory Note.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of June 30, 2023 and the results of operations and cash flows for the periods presented. Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of results that may be expected for the full year or any other period. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2022, as filed with the SEC on April 3, 2023.	Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”).
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liabilities. Other significant accounting estimates include the forward purchase derivative and the convertible working capital loan. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2023 and December 31, 2022.	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities and are recognized at fair value. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Gains and losses resulting from the change in fair value of these securities are included in interest earned on investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities and are recognized at fair value. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Gains and losses resulting from the change in fair value of these securities are included in interest earned on investments held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the FDIC coverage limit of $250,000. The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.	Concentration of Credit Risk The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2023 and December 31, 2022, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. There was no Class A common stock issued or outstanding as of June 30, 2023 and December 31, 2022, classified as permanent equity. The Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2022 and 2021, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to temporary stockholders’ equity upon the completion of the IPO, except those associated with Public Warrants which were expensed. Accordingly, as of June 30, 2023 and December 31, 2022, offering costs in the aggregate of $24,012,335 (consisting of $8,500,000 of underwriting commissions, $14,875,000 of deferred underwriters’ commission and $637,335 other offering costs) have been incurred. In September 2022, the Company reversed $4,462,500 of deferred underwriting fees, as the underwriters resigned from their role in the Business Combination and thereby waived their entitlement to these commissions (see Note 6). Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021, amounted to $280,500 , consisting mainly of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. The Company allocates the offering costs between its common stock and Public Warrants using relative fair value method, with the offering costs allocated to the Public Warrants expensed immediately. Accordingly, as of June 30, 2023 and December 31, 2022, offering costs in the aggregate of $782,812 have been charged to the Company’s unaudited condensed statements of operations (consisting of $762,300 of underwriting discounts and $20,512 of other offering costs). Offering costs associated with the Class A common stock have been charged to temporary equity.	Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to stockholders’ equity upon the completion of the IPO. Accordingly, as of December 31, 2022, offering costs in the aggregate of $24,012,335 (consisting of $8,500,000 of underwriting commissions, $14,875,000 of deferred underwriters’ commission and $637,335 other offering costs) had been incurred. Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021, amounted to $280,500 consisting mainly of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. The Company allocates the offering costs between its common stock and Public Warrants using relative fair value method, with the offering costs allocated to the Public Warrants expensed immediately. Accordingly, as of December 31, 2022, offering costs in the aggregate of $782,812 have been charged to the Company’s statement of operations (consisting of $762,300 of underwriting discounts and $20,512 of other offering costs). Offering costs associated with the Class A common stock have been charged to stockholders’ deficit. As of December 31, 2022, deferred offering costs of $94,992 have been incurred.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature except for the derivative warrant liabilities and forward purchase agreement asset (see Note 9).	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature except for the derivative warrant liabilities and forward purchase agreement asset (see Note 10).
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company’s public warrant liability is based on quoted prices in active markets as of the measurement date and is classified as Level 1.	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company’s public warrant liability is based on quoted prices in active markets as of the measurement date and is classified as Level 1.
Derivative Financial Instruments	Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company accounts for its warrants issued in connection with its IPO as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statements of operations. The fair value of warrants issued by the Company in connection with the IPO and Private Placement has been estimated using binomial lattice model at the date of issuance. As of June 30, 2023 and December 31, 2022, the Company’s public warrants were measured based on quoted prices in active markets, and the private placement warrants are categorized as a Level 2 following the public price. FASB ASC 470-20, “Debt with Conversion and Other Options”, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate IPO proceeds from the Units between common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then common stock. The Company accounts for its forward purchase agreements (collectively, the “Forward Purchase Agreements” or “FPAs”) issued as derivative FPA assets in accordance with ASC 815-40. Accordingly, the Company recognizes the FPA instruments as assets at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited statements of operations. The fair value of the FPAs has been estimated using observable inputs at the date of issuance. As of December 31, 2022, the Company’s FPAs are categorized as a Level 3. The FPA expired on April 17, 2023 and replace by the instrument explained below. The Company accounts for its prepaid forward derivative (“PFD”) issued as a liability in accordance with ASC 815-40. Accordingly, the Company recognizes the PFD instrument as liability at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the PFD has been estimated using observable inputs at the date of issuance. As of June 30, 2023 PFD is categorized as a Level 3.	Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company accounts for its warrants issued in connection with its IPO as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of warrants issued by the Company in connection with the IPO and Private Placement has been estimated using binomial lattice model at the date of issuance. As of December 31, 2022, the Company’s public warrants were measured based on quoted prices in active markets, and the private placement warrants are categorized as a Level 2 following the public price. FASB ASC 470-20, “Debt with Conversion and Other Options”, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate IPO proceeds from the Units between common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then common stock. The Company accounts for its forward purchase agreements (collectively, the “Forward Purchase Agreements” or “FPAs”) issued as derivative FPA assets in accordance with ASC 815-40. Accordingly, the Company recognizes the FPA instruments as assets at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the FPAs has been estimated using observable inputs at the date of issuance. As of December 31, 2022 and 2021, the Company’s FPAs are categorized as a Level 3.
Net Income (loss) per Share of Common Stock	Net Income (loss) per Share of Common Stock The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the year, excluding shares of common stock shares subject to forfeiture. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. The Company’s statements of operations include a presentation of income per share for shares of common stock subject to possible redemption in a manner similar to the two-class method of income per share. Consistent with ASC Topic 480-10-S99-3A, accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates its fair value. The calculation of diluted income (loss) per common stock does not consider the effect of the warrants issued since the exercise of the warrants are contingent upon the occurrence of future events. However, the diluted earnings per share calculation includes the shares subject to forfeiture from the first day of the interim period in which the contingency on such shares was resolved. A reconciliation of net income (loss) per common stock is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Three Months Ended ​ ​ For the Six Months Ended ​ For the Six Months Ended ​ June 30, 2023 June 30, 2022 June 30, 2023 June 30, 2022 ​ Class A Class B Class A Class B Class A Class B Class A Class B Allocation of net income (loss) $ (328,630) ​ $ (809,615) ​ $ 18,026,419 ​ $ 10,625,000 ​ $ (264,590) $ (155,953) $ 12,441,680 $ 3,110,420 Weighted average shares outstanding ​ 4,312,774 ​ ​ 10,625,000 ​ ​ 42,500,000 ​ ​ 10,625,000 ​ ​ 18,026,419 ​ 10,625,000 ​ 42,500,000 ​ 10,625,000 Basic and diluted net income (loss) per share ​ $ (0.08) ​ $ (0.08) ​ $ 0.06 ​ $ 0.06 ​ ​ $ (0.01) ​ $ (0.01) ​ $ 0.29 ​ $ 0.29	Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock outstanding during the year, excluding common stock shares subject to forfeiture. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. The Company’s statements of operations include a presentation of income per share for shares of common stock subject to possible redemption in a manner similar to the two-class method of income per share. Consistent with ASC Topic 480-10-S99-3A, accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates its fair value. The calculation of diluted income per common stock does not consider the effect of the warrants issued since the exercise of the warrants are contingent upon the occurrence of future events. However, the diluted earnings per share calculation includes the shares subject to forfeiture from the first day of the interim period in which the contingency on such shares was resolved. A reconciliation of net income (loss) per common stock is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2022 ​ ​ Class A Class B Allocation of net income ​ $ 15,386,968 ​ $ 3,846,742 Weighted average shares outstanding, basic and diluted ​ 42,500,000 ​ 10,625,000 Basic and diluted net income per share ​ $ 0.36 ​ $ 0.36 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2021 ​ Class A Class B Allocation of net loss $ (193,470) $ (58,163) Weighted average shares outstanding, basic and diluted ​ 35,224,658 ​ 10,589,629 Basic and diluted net loss per share ​ $ (0.01) ​ $ (0.01)
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The tax provision for the six months ended June 30, 2023 and 2022 is $962,768 and $108,315 , respectively. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company’s effective tax rate was 177% and 0.01% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the six months ended June 30, 2023 and 2022, due to changes in fair value of warrants, FPA, and the valuation allowance on the deferred tax assets. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign stockholder corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to distribute to redeeming stockholders or to complete a Business Combination and could adversely affect the Company’s ability to complete a Business Combination.	Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The tax provision for the years ended December 31, 2022 and 2021 has been disclosed under Note 12, as well as the deferred tax assets as of December 31, 2022 and 2021. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Working Capital Loan - Related Party	Working Capital Loan – Related Party When the Company issues convertible debt, it first evaluates the balance sheet classification of the convertible instrument in its entirety to determine whether the instrument should be classified as a liability under ASC 480 and second whether the conversion feature should be accounted for separately from the host instrument. A conversion feature of a convertible debt instrument or certain convertible preferred stock would be separated from the convertible instrument and classified as a derivative liability if the conversion feature, were it a stand-alone instrument, meets the definition of an “embedded derivative” as defined in ASC 815. Generally, characteristics that require derivative treatment include, among others, when the conversion feature is not indexed to the Company’s equity, as defined in ASC 815-40, or when it must be settled either in cash or by issuing stock that is readily convertible to cash. When a conversion feature meets the definition of an embedded derivative, it would be separated from the host instrument and classified as a derivative liability carried on the balance sheet at fair value, with any changes in its fair value recognized currently in the condensed statement of operations. The Working Capital Loan has a conversion feature that allows for converting the loan into warrants and is carried at fair value. The fair value of the balance outstanding on the convertible loan was $1,500,000 and $1,500,000 as of June 30, 2023 and December 31, 2022, respectively. During Q2 of 2023 the Company entered into a promissory note with the Sponsor which allowed up to $1,190,000 and accrues no interest. There was $1,190,000 outstanding on this loan as of June 30, 2023 and $0 outstanding as of December 31, 2022. In total the Company had $2,690,000 and $1,500,000 was outstanding on related party loans as of June 30, 2023 and December 31, 2022, respectively.
Recent Accounting Standards	Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”). 2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.	Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies
Schedule of reconciliation of net income (loss) per common stock	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Three Months Ended ​ ​ For the Six Months Ended ​ For the Six Months Ended ​ June 30, 2023 June 30, 2022 June 30, 2023 June 30, 2022 ​ Class A Class B Class A Class B Class A Class B Class A Class B Allocation of net income (loss) $ (328,630) ​ $ (809,615) ​ $ 18,026,419 ​ $ 10,625,000 ​ $ (264,590) $ (155,953) $ 12,441,680 $ 3,110,420 Weighted average shares outstanding ​ 4,312,774 ​ ​ 10,625,000 ​ ​ 42,500,000 ​ ​ 10,625,000 ​ ​ 18,026,419 ​ 10,625,000 ​ 42,500,000 ​ 10,625,000 Basic and diluted net income (loss) per share ​ $ (0.08) ​ $ (0.08) ​ $ 0.06 ​ $ 0.06 ​ ​ $ (0.01) ​ $ (0.01) ​ $ 0.29 ​ $ 0.29	​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2022 ​ ​ Class A Class B Allocation of net income ​ $ 15,386,968 ​ $ 3,846,742 Weighted average shares outstanding, basic and diluted ​ 42,500,000 ​ 10,625,000 Basic and diluted net income per share ​ $ 0.36 ​ $ 0.36 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2021 ​ Class A Class B Allocation of net loss $ (193,470) $ (58,163) Weighted average shares outstanding, basic and diluted ​ 35,224,658 ​ 10,589,629 Basic and diluted net loss per share ​ $ (0.01) ​ $ (0.01)

Class A Common Stock Subject _2

Class A Common Stock Subject to Possible Redemption (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Class A Common Stock Subject to Possible Redemption
Schedule of Class A common stock reflected in the unaudited condensed balance sheets	​ ​ ​ ​ ​ Gross proceeds $ 425,000,000 Less: ​ ​ ​ Proceeds allocated to Public Warrants ​ ​ (14,026,667) Class A common stock issuance costs ​ ​ (23,229,523) Plus: ​ ​ ​ Accretion of carrying value to redemption value ​ ​ 37,691,146 Waiver of Class A shares issuance costs ​ ​ 4,312,237 Class A common stock subject to possible redemption at December 31, 2022 ​ ​ 429,747,193 Redemption of Class A common stock ​ ​ (387,606,834) Accretion of carrying value to redemption value ​ ​ 2,025,746 Class A common stock subject to possible redemption at March 31, 2023 ​ ​ 44,166,105 Accretion of carrying value to redemption value ​ ​ 429,299 Class A common stock subject to possible redemption at June 30, 2023 ​ $ 44,595,404	​ ​ ​ ​ ​ Gross proceeds $ 425,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (14,026,667) Class A common stock issuance costs ​ (23,229,523) Plus: ​ Accretion of carrying value to redemption value ​ 37,256,190 Class A common stock subject to possible redemption at December 31, 2021 ​ ​ 425,000,000 Waiver of Class A shares issuance costs ​ ​ 4,312,237 Accretion of carrying value to redemption value ​ ​ 434,956 Class A common stock subject to possible redemption at December 31, 2022 ​ $ 429,747,193

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Fair Value Measurements
Schedule of assets and liabilities that are measured on a recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Significant Significant ​ ​ Prices in ​ Other ​ Other ​ ​ Active Markets ​ Observable ​ Unobservable ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 44,645,404 ​ $ — ​ $ — Forward Purchase Agreement ​ ​ — ​ ​ — ​ ​ — Fair Value at June 30, 2023 (unaudited) ​ $ 44,645,404 ​ $ — ​ $ — Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ Working capital loan – related party ​ $ — ​ $ — ​ $ 2,690,000 Public Warrant liability ​ ​ 708,333 ​ ​ — ​ ​ — Private Warrant liability ​ ​ — ​ ​ 625,000 ​ ​ — Prepaid forward derivative ​ ​ — ​ ​ — ​ ​ 144,770 Fair Value at June 30, 2023 (unaudited) ​ $ 708,333 ​ $ 625,000 ​ $ 2,834,770 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Significant Significant ​ ​ Prices in ​ Other ​ Other ​ ​ Active Markets ​ Observable ​ Unobservable ​ ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 430,047,193 ​ $ — ​ $ — Forward Purchase Agreement ​ ​ — ​ ​ — ​ ​ 353,731 Fair Value at December 31, 2022 ​ $ 430,047,193 ​ $ — ​ $ 353,731 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ Working capital loan – related party ​ $ — ​ $ — ​ $ 1,500,000 Public Warrant liability ​ ​ 566,667 ​ ​ — ​ ​ — Private Warrant liability ​ ​ — ​ ​ 500,000 ​ ​ — Fair Value at December 31, 2022 ​ $ 566,667 ​ $ 500,000 ​ $ 1,500,000 ​	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ Significant ​ ​ in Active ​ Other ​ Other ​ Markets Observable Unobservable December 31, 2022 (Level 1) (Level 2) (Level 3) Assets: ​ ​ ​ ​ Investments held in Trust Account $ 430,047,193 $ — $ — Forward Purchase Agreements ​ ​ — ​ ​ — ​ ​ 353,731 Fair value at December 31, 2022 $ 430,047,193 $ — $ 353,731 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ Public Warrant liability $ 566,667 $ — $ — Private Warrant liability ​ ​ — ​ ​ 500,000 ​ ​ — Working Capital Loans – related party ​ ​ — ​ ​ — ​ ​ 1,500,000 Fair Value at December 31, 2022 $ 566,667 $ 500,000 $ 1,500,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ Significant ​ ​ in Active ​ Other ​ Other ​ ​ Markets ​ Observable ​ Unobservable December 31, 2021 (Level 1) (Level 2) (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 425,037,665 $ — ​ $ — Forward Purchase Agreements ​ ​ — ​ — ​ ​ 1,002,789 Fair value at December 31, 2021 ​ $ 425,037,665 $ — ​ $ 1,002,789 Liabilities: ​ ​ Public Warrant liability ​ $ 11,190,235 $ — ​ $ — Private Warrant liability ​ ​ — ​ 9,873,737 ​ ​ — Fair value at December 31, 2021 ​ $ 11,190,235 $ 9,873,737 ​ $ —
Schedule of roll forward for the Level 3 investments	​ ​ ​ ​ ​ FPA assets at December 31, 2022 ​ $ 353,731 Change in fair value of FPA ​ 681,533 FPA assets at March 31, 2023 (unaudited) ​ ​ 1,035,264 Expiration of FPA asset April 17, 2023 ​ ​ (1,035,264) New FPA – liability April 17, 2023 ​ ​ (144,770) FPA liability at June 30, 2023 (unaudited) ​ $ (144,770) ​ ​ ​ ​ Working capital loan at December 31, 2022 ​ $ 1,500,000 Issuance of loan ​ ​ 734,300 Working capital loan at March 31, 2023 (unaudited) ​ ​ 2,234,300 Issuance of loan ​ ​ 455,700 Working capital loan at June 30, 2023 (unaudited) ​ $ 2,690,000 ​ ​ ​ ​ ​ FPA assets at December 31, 2021 $ 1,002,789 Change in fair value of FPA ​ (649,058) FPA assets at December 31, 2022 ​ $ 353,731 ​ ​ ​ Working capital loan at December 31, 2021 ​ $ — Issuance of loan ​ ​ 1,500,000 Change in fair value of working capital loan ​ ​ — Working capital loan at December 31, 2022 ​ $ 1,500,000 ​	​ ​ ​ ​ ​ FPA assets at December 31, 2021 $ 1,002,789 Change in fair value of FPAs ​ (649,058) FPA assets at December 31, 2022 ​ $ 353,731 Working Capital Loans at December 31, 2021 ​ $ — Issuance of loan ​ 1,500,000 Change in fair value of working capital loan ​ — Working Capital Loans at December 31, 2022 ​ $ 1,500,000 ​ ​ ​ ​ ​ Level 3 Warrant liabilities at March 4, 2021 $ 26,260,000 Change in fair value of warrant liabilities ​ (4,363,000) Transfers from Level 3 to Level 1 investments ​ (14,000,000) Warrants issued on April 12, 2021 ​ ​ 103,000 Transfers from Level 3 to Level 2 investments ​ ​ (8,000,000) Level 3 Warrant liabilities at December 31, 2021 ​ $ — Issuance of FPA assets at December 6, 2021 ​ $ 770,000 Change in fair value of FPAs ​ ​ 232,789 Level 3 investments (at asset position) at December 31, 2021 ​ $ 1,002,789
Schedule of warrant liabilities		​ ​ ​ ​ ​ Warrant liabilities at December 31, 2021 $ 21,063,972 Change in fair value of warrant liabilities ​ (19,997,305) Warrant liabilities at December 31, 2022 ​ $ 1,066,667 Warrant liabilities at March 4, 2021 ​ $ 26,260,000 Warrants issued on April 12, 2021 ​ 269,667 Change in fair value of warrant liabilities ​ (5,465,695) Warrant liabilities at December 31, 2021 ​ $ 21,063,972
Forward Purchase Agreement
Fair Value Measurements
Schedule of quantitative information regarding Level 3 fair value measurements	​ ​ ​ ​ ​ ​ ​ December 31, 2022 Unit Price ​ $ 10.00 ​ Remaining Term (in years) ​ ​ 0.16 ​ Risk-Free Rate ​ ​ 4.18 %	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 December 31, 2021 Unit Price ​ $ 10.00 ​ $ 10.00 ​ Remaining Term (in years) ​ ​ 0.16 ​ 0.50 ​ Risk-Free Rate ​ ​ 4.18 % 0.19 %
Prepaid Forward Derivative Agreements
Fair Value Measurements
Schedule of quantitative information regarding Level 3 fair value measurements	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2023 April 17, 2023 Unit Price ​ $ 10.24 ​ $ 10.07 ​ Remaining Term (in years) ​ 1.25 ​ 1.46 ​ Risk-Free Rate ​ 5.13 % 4.42 %
Working capital loan - related party
Fair Value Measurements
Schedule of quantitative information regarding Level 3 fair value measurements	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2023 December 31, 2022 Principal Outstanding ​ $ 1,500,000 ​ $ 1,500,000 Expected Remaining Term (in years) ​ 0.25 ​ ​ 0.25 ​ Volatility ​ 37.4 ​ ​ 43.5 % Risk-Free Rate ​ 4.03 ​ ​ 3.91 %	​ ​ ​ ​ ​ ​ ​ December 31, 2022 Principal Outstanding ​ $ 1,500,000 Expected Remaining Term (in years) ​ 0.16 ​ Volatility ​ 43.5 % Risk-Free Rate ​ 3.91 %

Organization and Business Ope_2

Organization and Business Operations (Details)						6 Months Ended	12 Months Ended
	Apr. 17, 2023 USD ($) $ / shares shares	Feb. 28, 2023 USD ($) $ / shares shares	Apr. 14, 2021 USD ($) $ / shares shares	Mar. 04, 2021 USD ($) $ / shares shares	Dec. 28, 2020 item	Jun. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) item $ / shares shares	Dec. 31, 2021 USD ($) $ / shares	Mar. 29, 2022 USD ($)	Oct. 31, 2020 USD ($)
Organization and Business Operations
Condition for future business combination number of businesses minimum | item					1
Number of shares in a unit | shares				1
Transaction costs						$ 24,012,335	$ 24,012,335			$ 23,731,835
Underwriting commissions						8,500,000	8,500,000			8,400,000
Deferred underwriters' commissions						14,875,000	14,875,000			14,700,000
Other offering costs						$ 637,335	$ 637,335			$ 631,835
Percentage of redemption required if business combination is not completed by specified date						100%	100%
Duration of business combination period						24 months
Threshold business combination fair market value as percent of Trust assets						80%	80%
Redemption of shares calculated based on business days prior to consummation of business combination (in days)						2 days
Minimum net tangible assets of the target						$ 5,000,001	$ 5,000,001
Redemption period upon closure						10 days	10 days
Maximum allowed dissolution expenses						$ 100,000	$ 100,000
Right to withdraw interest from the trust account waived		$ 100,000
Amount remained in the trust account						44,645,404	430,047,193	$ 425,037,665
Cash held in operating bank accounts						132,773	107,773	149,845
Working capital deficit						8,949,755	7,089,334	(1,815,006)
Proceeds received from related party to cover certain expense payments in exchange for shares issued						25,000	25,000
Maximum borrowing capacity of related party promissory note	$ 10,000,000					300,000	300,000
Borrowings outstanding						$ 2,690,000	$ 1,500,000
Private Warrant
Organization and Business Operations
Additional units sold of shares | shares			100,000
Number of warrants to purchase shares issued | shares				12,400,000			12,400,000
Public Warrant
Organization and Business Operations
Exercise price of warrants | $ / shares						$ 10	$ 10
Transaction costs						$ 782,812	$ 782,812
Underwriting commissions						762,300	762,300
Other offering costs						$ 20,512	$ 20,512
Initial Public Offering
Organization and Business Operations
Condition for future business combination number of businesses minimum | item							1
Number of units issued | shares				42,000,000
Number of shares in a unit | shares							1
Common stock, par value (in dollars per share) | $ / shares				$ 0.0001
Number of shares issuable per warrant | shares				0.33
Number of warrants in a unit | shares				1
Exercise price of warrants | $ / shares							$ 11.50
Price per share | $ / shares			$ 10	$ 10			$ 10
Proceeds from issuance initial public offering, gross				$ 425,000,000			$ 425,000,000
Transaction costs				23,731,835
Underwriting commissions				8,400,000			8,500,000
Deferred underwriters' commissions				14,700,000			14,875,000
Other offering costs				631,835			637,335
Payments for investment of cash in Trust Account				$ 420,000,000
Additional units sold of value			$ 5,000,000
Initial Public Offering | Public Warrant
Organization and Business Operations
Underwriting commissions							762,300
Other offering costs							$ 20,512
Private Placement | Private Warrant
Organization and Business Operations
Additional units sold of shares | shares			100,000
Number of shares issuable per warrant | shares			1
Price per warrant | $ / shares			$ 1			$ 1	$ 1
Exercise price of warrants | $ / shares			$ 11.50
Number of warrants to purchase shares issued | shares				12,400,000
Proceeds from issuance of warrants			$ 12,500,000			$ 12,500,000	$ 12,500,000
Over-allotment option
Organization and Business Operations
Number of units issued | shares			500,000	6,300,000
Additional units sold of shares | shares			500,000
Price per share | $ / shares			$ 10
Transaction costs			$ 280,500
Underwriting commissions			100,000
Deferred underwriters' commissions			175,000
Other offering costs			5,500
Additional units sold of value			$ 5,000,000
Over-allotment option | Private Warrant
Organization and Business Operations
Number of warrants to purchase shares issued | shares			100,000
Working capital loan - related party
Organization and Business Operations
Price per warrant | $ / shares						$ 1
Maximum borrowing capacity of related party promissory note									$ 1,500,000
Borrowings outstanding						$ 2,690,000	$ 1,500,000	$ 0
Class A common stock
Organization and Business Operations
Common stock, par value (in dollars per share) | $ / shares	$ 0.01					$ 0.0001	$ 0.0001	$ 0.0001
Number of shares issued | shares	15,000,000
Shares redeemed during period | shares		38,187,226
Amount removed from the trust account for redemption of shares		$ 387,600,000
Redemption value per share | $ / shares		$ 10.15
Amount remained in the trust account		$ 44,300,000
Common shares, shares outstanding | shares		4,312,774				0	0
Class A common stock | Initial Public Offering
Organization and Business Operations
Additional units sold of shares | shares			500,000
Number of shares in a unit | shares				1			1
Common stock, par value (in dollars per share) | $ / shares				$ 0.0001
Number of shares issuable per warrant | shares				1
Price per warrant | $ / shares							$ 0.0001
Exercise price of warrants | $ / shares				$ 11.50
Class A common stock | Initial Public Offering | Public Warrant
Organization and Business Operations
Number of shares issuable per warrant | shares				0.33
Number of warrants in a unit | shares				0.33

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Sep. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Mar. 21, 2023	Feb. 28, 2023	Apr. 14, 2021	Mar. 04, 2021	Oct. 31, 2020
Summary of Significant Accounting Policies
Cash equivalents		$ 0		$ 0		$ 0	$ 0
Transaction costs		24,012,335		24,012,335		24,012,335						$ 23,731,835
Underwriting commissions or discounts		8,500,000		8,500,000		8,500,000						8,400,000
Deferred underwriters' commissions		14,875,000		14,875,000		14,875,000						14,700,000
Other offering costs		637,335		637,335		637,335						$ 631,835
Deferred offering costs						94,992
Forgiveness of deferred underwriting fees	$ 4,462,500					4,462,500
Income tax expense		(121,245)	$ (108,315)	$ (962,768)	$ (108,315)	$ (1,501,714)
Effective tax rate				177%	0.01%	7.24%	0%
Statutory tax rate				21%	21%
Unrecognized tax benefits accrued for interest and penalties		0		$ 0		$ 0	$ 0
Working capital loan - related party		2,690,000		2,690,000		1,500,000
Promissory note | Sponsor
Summary of Significant Accounting Policies
Working capital loan		1,190,000		1,190,000				$ 1,190,000
Working capital loan - related party		1,190,000		1,190,000		0
Convertible loan
Summary of Significant Accounting Policies
Borrowings recorded at fair value		$ 1,500,000		$ 1,500,000		$ 1,500,000
Class A common stock
Summary of Significant Accounting Policies
Common shares, shares issued		0		0		0
Common shares, shares outstanding		0		0		0			4,312,774
Public Warrant
Summary of Significant Accounting Policies
Transaction costs		$ 782,812		$ 782,812		$ 782,812
Underwriting commissions or discounts		762,300		762,300		762,300
Other offering costs		$ 20,512		$ 20,512		20,512
Initial Public Offering
Summary of Significant Accounting Policies
Transaction costs											$ 23,731,835
Underwriting commissions or discounts						8,500,000					8,400,000
Deferred underwriters' commissions						14,875,000					14,700,000
Other offering costs						637,335					$ 631,835
Initial Public Offering | Public Warrant
Summary of Significant Accounting Policies
Underwriting commissions or discounts						762,300
Other offering costs						$ 20,512
Over-allotment option
Summary of Significant Accounting Policies
Transaction costs										$ 280,500
Underwriting commissions or discounts										100,000
Deferred underwriters' commissions										175,000
Other offering costs										$ 5,500
Forgiveness of deferred underwriting fees	$ 4,462,500

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Reconciliation of net income (loss) per common stock (Details) - USD ($)	3 Months Ended			6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Class A common stock
Summary of Significant Accounting Policies
Allocation of net income (loss)	$ (328,630)		$ 18,026,419	$ (264,590)	$ 12,441,680		$ 15,386,968	$ (193,470)
Weighted average shares outstanding, basic	4,312,774		42,500,000	18,026,419	42,500,000		42,500,000	35,224,658
Weighted average shares outstanding, diluted	4,312,774		42,500,000	18,026,419	42,500,000		42,500,000	35,224,658
Basic net income (loss) per share	$ (0.08)	$ 0.03	$ 0.06	$ (0.01)	$ 0.29	$ 0.32	$ 0.36	$ (0.01)
Diluted net income (loss) per share	$ (0.08)	0.03	$ 0.06	$ (0.01)	$ 0.29	0.32	$ 0.36	$ (0.01)
Class B common stock
Summary of Significant Accounting Policies
Allocation of net income (loss)	$ (809,615)		$ 10,625,000	$ (155,953)	$ 3,110,420		$ 3,846,742	$ (58,163)
Weighted average shares outstanding, basic	10,625,000		10,625,000	10,625,000	10,625,000		10,625,000	10,589,629
Weighted average shares outstanding, diluted	10,625,000		10,625,000	10,625,000	10,625,000		10,625,000	10,589,629
Basic net income (loss) per share	$ (0.08)	0.03	$ 0.06	$ (0.01)	$ 0.29	0.32	$ 0.36	$ (0.01)
Diluted net income (loss) per share	$ (0.08)	$ 0.03	$ 0.06	$ (0.01)	$ 0.29	$ 0.32	$ 0.36	$ (0.01)

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)			1 Months Ended	12 Months Ended
	Apr. 14, 2021	Mar. 04, 2021	Sep. 30, 2022	Dec. 31, 2022	Jun. 30, 2023	Apr. 17, 2023	Dec. 31, 2021
Initial Public Offering
Number of shares in a unit		1
Forgiveness of deferred underwriting fees			$ 4,462,500	$ 4,462,500
Class A common stock
Initial Public Offering
Common stock, par value (in dollars per share)				$ 0.0001	$ 0.0001	$ 0.01	$ 0.0001
Initial Public Offering
Initial Public Offering
Number of units issued		42,000,000
Number of shares in a unit				1
Common stock, par value (in dollars per share)		$ 0.0001
Number of shares issuable per warrant		0.33
Number of warrants in a unit		1
Exercise price of warrants				$ 11.50
Initial Public Offering | Class A common stock
Initial Public Offering
Number of shares in a unit		1		1
Common stock, par value (in dollars per share)		$ 0.0001
Number of shares issuable per warrant		1
Exercise price of warrants		$ 11.50
Over-allotment option
Initial Public Offering
Number of units issued	500,000	6,300,000
Underwriters options period		45 days
Forgiveness of deferred underwriting fees			$ 4,462,500

Private Placement (Details)

Private Placement (Details) - Private Warrant - USD ($)		6 Months Ended	12 Months Ended
	Apr. 14, 2021	Jun. 30, 2023	Dec. 31, 2022	Mar. 04, 2021
Private Placement
Number of warrants to purchase shares issued			12,400,000	12,400,000
Over-allotment option
Private Placement
Number of warrants to purchase shares issued	100,000
Private Placement
Private Placement
Number of warrants to purchase shares issued				12,400,000
Price of warrants	$ 1	$ 1	$ 1
Aggregate gross proceeds	$ 12,500,000	$ 12,500,000	$ 12,500,000
Number of shares issuable per warrant	1
Exercise price of warrant	$ 11.50
Threshold period for not to transfer assign or sell any shares or warrants after completion of initial business combination	30 days

Related Party Transactions - Fo

Related Party Transactions - Founder Shares (Details) - Class B common stock					12 Months Ended
	Apr. 14, 2021 shares	Mar. 01, 2021 shares	Feb. 19, 2021 shares	Dec. 30, 2020 USD ($) D $ / shares shares	Dec. 31, 2022 shares	Jun. 30, 2023 shares	Dec. 31, 2021 shares
Related Party Transactions
Aggregate number of shares owned			10,062,500
Common shares, shares issued					10,625,000	10,625,000	10,625,000
Common shares, shares outstanding					10,625,000	10,625,000	10,625,000
Sponsor
Related Party Transactions
Stock dividend		2,012,500	2,875,000
Aggregate number of shares owned		12,075,000
Shares subject to forfeiture		1,575,000
Founder Shares | Sponsor
Related Party Transactions
Number of shares issued				7,187,500
Aggregate purchase price | $				$ 25,000
Stock dividend		2,012,500	2,875,000
Aggregate number of shares owned		12,075,000	10,062,500
Shares subject to forfeiture				1,575,000
Maximum number of shares subject to forfeiture		1,575,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders		20%		20%
Number of shares forfeited	1,450,000
Common shares, shares issued					10,625,000	10,625,000
Common shares, shares outstanding					10,625,000	10,625,000
Restrictions on transfer period of time after completion of business combination				1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares				$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D				20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D				30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences				150 days	150 days

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 01, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Apr. 17, 2023	Apr. 03, 2023	Mar. 21, 2023	Mar. 29, 2022	Dec. 30, 2020
Related Party Transactions
Maximum borrowing capacity of related party promissory note		$ 300,000		$ 300,000		$ 300,000		$ 10,000,000
Borrowings outstanding		2,690,000		2,690,000		1,500,000
Working capital loan - related party		2,690,000		2,690,000		1,500,000
Outstanding promissory note									$ 734,300
Waiver of accrued fees and expense				286,688
Working capital loans warrant
Related Party Transactions
Outstanding balance of related party note						1,500,000	$ 0
Maximum Loans Convertible into Warrants						$ 1,500,000
Price per warrant						$ 1
Repayment of promissory note - related party						$ 0
Promissory Note - Related Party
Related Party Transactions
Maximum borrowing capacity of related party promissory note												$ 300,000
Outstanding balance of related party note		0		0		0	0
Administrative Service Fee
Related Party Transactions
Expenses per month	$ 40,521
Fees and expenses incurred		121,563	$ 121,563	243,126	$ 243,126
Administrative service fee, accrued		244,175		244,175		0
Administrative Support Agreement
Related Party Transactions
Expenses per month	$ 40,521
Fees and expenses incurred						486,252	405,210
Diligence Services
Related Party Transactions
Fees and expenses incurred		54,971	$ 142,411	201,549	$ 385,706	623,698	751,916
Amount accrued for service		873,290		873,290		958,429	334,731
Payments for service						0	417,185
2022 Working Capital Loan
Related Party Transactions
Maximum borrowing capacity of related party promissory note											$ 1,500,000
Proceeds held in the Trust Account that would be used to repay loan						0
Borrowings outstanding		2,690,000		2,690,000		1,500,000	0
Working capital loan - related party		2,690,000		2,690,000		1,500,000	$ 0
Borrowings recorded at fair value		2,690,000		2,690,000		1,500,000
2022 Working Capital Loan | Working capital loans warrant
Related Party Transactions
Price per warrant											$ 1
Sponsor | Unsecured promissory note
Related Party Transactions
Borrowings outstanding		1,190,000		1,190,000		0
Working capital loan - related party		1,190,000		1,190,000		$ 0
Working capital loan		$ 1,190,000		$ 1,190,000						$ 1,190,000

Commitments and Contingencies (

Commitments and Contingencies (Details)					1 Months Ended	6 Months Ended	12 Months Ended
	Apr. 17, 2023 USD ($) shares	Dec. 06, 2021 USD ($) $ / shares shares	Apr. 14, 2021 USD ($) $ / shares shares	Mar. 04, 2021 USD ($) shares	Sep. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) item $ / shares	Dec. 31, 2022 USD ($) item $ / shares shares	Dec. 31, 2021 USD ($)
Commitments and Contingencies
Maximum number of demands for registration of securities | item						3	3
Underwriting discount			$ 100,000	$ 8,400,000
Deferred discount per Unit | $ / shares						$ 0.35	$ 0.35
Aggregate deferred underwriting fee payable							$ 14,875,000
Deferred discount						$ 14,875,000
Deferred underwriting liability written off					$ 4,462,500		4,462,500
Issuance of forward purchase agreements								$ 770,000
Shares issued during period for services | shares	4,300,000
Maximum percentage of beneficiary shares owned	9.90%
Maximum borrowing capacity of related party promissory note	$ 10,000,000					300,000	$ 300,000
Maximum percentage of outstanding preferred stock	5%
Class A common stock
Commitments and Contingencies
Number of shares issued | shares	15,000,000
Forward Purchase Agreements | Maximum
Commitments and Contingencies
Number of shares issued | shares							120,000,000
Aggregate purchase price						$ 120,000,000
Forward Purchase Agreements | Unsecured convertible notes
Commitments and Contingencies
Aggregate unsecured convertible notes		$ 80,000,000
Aggregate proceeds from issuance of convertible notes		80,000,000
Forward Purchase Agreements | Unsecured convertible notes | Maximum
Commitments and Contingencies
Aggregate unsecured convertible notes		80,000,000
Aggregate proceeds from issuance of convertible notes		$ 80,000,000
Over-allotment option
Commitments and Contingencies
Underwriters options period				45 days
Number of units issued | shares			500,000	6,300,000
Deferred underwriting liability written off					$ 4,462,500
Price per share | $ / shares			$ 10
Forward Purchase Securities | Forward Purchase Agreements
Commitments and Contingencies
Price per share | $ / shares		$ 10
Number of shares in a forward purchase securities | shares		1
Number of warrants in a forward purchase securities | shares		1
Number of shares issuable per warrant | shares		1
Exercise price of warrants | $ / shares		$ 11.50
Forward Purchase Securities | Forward Purchase Agreements | Class A common stock
Commitments and Contingencies
Number of shares in a forward purchase securities | shares		1
Number of warrants in a forward purchase securities | shares		1
Forward Purchase Securities | Forward Purchase Agreements | Maximum
Commitments and Contingencies
Number of shares issued | shares		4,000,000
Aggregate purchase price		$ 40,000,000
Issuance of forward purchase agreements		$ 40,000,000

Class A Common Stock Subject _3

Class A Common Stock Subject to Possible Redemption (Details) - USD ($)	3 Months Ended		6 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Class A Common Stock Subject to Possible Redemption
Gross proceeds				$ 425,000,000	$ 425,000,000
Proceeds allocated to Public Warrants				(14,026,667)	(14,026,667)
Class A common stock issuance costs				(23,229,523)	(23,229,523)
Accretion of carrying value to redemption value	$ 429,299	$ 2,025,746		37,691,146	37,256,190
Waiver of Class A shares issuance costs				4,312,237
Redemption of Class A common stock		(387,606,834)	$ (387,606,836)
Class A common stock subject to possible redemption	$ 44,595,404	$ 44,166,105	$ 44,595,404	$ 429,747,193	$ 425,000,000

Class A Common Stock Subject _4

Class A Common Stock Subject to Possible Redemption - Additional Information (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2023 USD ($) Vote $ / shares shares	Dec. 31, 2022 USD ($) Vote $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Class A Common Stock Subject to Possible Redemption
Class A common stock subject to possible redemption, shares authorized | shares		400,000,000
Class A common stock subject to possible redemption, par value (in dollars per share) | $ / shares		$ 0.0001
Class A common stock subject to possible redemption, votes per share | Vote	1	1
Class A common stock subject to possible redemption, shares outstanding | shares		42,500,000	42,500,000
Class A common stock subject to possible redemption, price per share | $ / shares		$ 10.11	$ 10
Trust proceeds | $		$ 425,000,000	$ 425,000,000
Class A common stock subject to possible redemption
Class A Common Stock Subject to Possible Redemption
Class A common stock subject to possible redemption, shares authorized | shares	400,000,000	400,000,000
Class A common stock subject to possible redemption, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Class A common stock subject to possible redemption, shares outstanding | shares	4,312,774	42,500,000	42,500,000
Class A common stock subject to possible redemption, price per share | $ / shares	$ 10.34	$ 10.11	$ 10
Trust proceeds | $	$ 44,595,404	$ 429,747,193

Stockholders' Deficit - Preferr

Stockholders' Deficit - Preferred Stock (Details) - $ / shares	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Stockholders' Deficit
Preferred stock, shares authorized	1,000,000	1,000,000	1,000,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0

Stockholders' Deficit - Common

Stockholders' Deficit - Common Stock (Details)		6 Months Ended	12 Months Ended
	Apr. 14, 2021 shares	Jun. 30, 2023 Vote $ / shares shares	Dec. 31, 2022 Vote $ / shares shares	Apr. 17, 2023 $ / shares	Feb. 28, 2023 shares	Dec. 31, 2021 $ / shares shares
Stockholders' Equity (Deficit)
Class A common stock subject to possible redemption, shares outstanding			42,500,000			42,500,000
Class A common stock
Stockholders' Equity (Deficit)
Common stock, shares authorized		400,000,000	400,000,000			400,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001	$ 0.01		$ 0.0001
Common stock, votes per share | Vote		1	1
Common stock, shares issued		0	0
Common stock, shares outstanding		0	0		4,312,774
Class A common stock subject to possible redemption
Stockholders' Equity (Deficit)
Class A common stock subject to possible redemption, shares issued		4,312,774	42,500,000			42,500,000
Class A common stock subject to possible redemption, shares outstanding		4,312,774	42,500,000			42,500,000
Class B common stock
Stockholders' Equity (Deficit)
Common stock, shares authorized		40,000,000	40,000,000			40,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001			$ 0.0001
Common stock, votes per share | Vote		1	1
Common stock, shares issued		10,625,000	10,625,000			10,625,000
Common stock, shares outstanding		10,625,000	10,625,000			10,625,000
Conversion ratio		1	1
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)		20%	20%
Number of shares for which forfeiture condition has expired (in shares)	1,450,000

Fair Value Measurement - Additi

Fair Value Measurement - Additional information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Fair Value Measurements
Transfers from/to levels	$ 0	$ 0	$ 0	$ 0
Working capital loan
Fair Value Measurements
Borrowings recorded at fair value	$ 2,690,000		$ 2,690,000

Fair Value Measurements - Asset

Fair Value Measurements - Assets and liabilities that are measured on a recurring basis (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Assets:
Investments held in Trust Account	$ 44,645,404	$ 430,047,193	$ 425,037,665
Recurring | Level 1
Assets:
Investments held in Trust Account	44,645,404	430,047,193	425,037,665
Assets Fair value	44,645,404	430,047,193	425,037,665
Liabilities:
Fair value measurements	708,333	566,667	11,190,235
Recurring | Level 2
Liabilities:
Fair value measurements	625,000	500,000	9,873,737
Recurring | Level 3
Assets:
Forward Purchase Agreement		353,731	1,002,789
Assets Fair value		353,731	1,002,789
Liabilities:
Fair value measurements	2,834,770	1,500,000
Prepaid forward derivative	144,770
Recurring | Public Warrant | Level 1
Liabilities:
Fair value measurements	708,333	566,667	11,190,235
Recurring | Private Warrant | Level 2
Liabilities:
Fair value measurements	625,000	500,000	$ 9,873,737
Recurring | Working capital loan - related party | Level 3
Liabilities:
Fair value measurements	$ 2,690,000	$ 1,500,000

Fair Value Measurements - Roll

Fair Value Measurements - Roll forward for the Level 3 investments (Details) - USD ($)	1 Months Ended	3 Months Ended		10 Months Ended	12 Months Ended
	Dec. 31, 2021	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2021	Dec. 31, 2022
Fair Value Measurements
FPA liability at June 30, 2023 (unaudited)		$ 144,770
Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List Not Disclosed Flag					true
Warrant
Fair Value Measurements
New FPA - liability April 17, 2023				$ (269,667)
Working capital loan at beginning balance			$ 1,066,667	26,260,000	$ 21,063,972
Working capital loan at ending of balance	$ 21,063,972			21,063,972	1,066,667
Level 3
Fair Value Measurements
FPA assets at the beginning balance		1,035,264	353,731		1,002,789
Change in fair value of FPA	232,789		681,533		(649,058)
Expiration of FPA asset April 17, 2023		(1,035,264)
New FPA - liability April 17, 2023		(144,770)
FPA liability at June 30, 2023 (unaudited)		(144,770)
FPA assets at the ending balance	1,002,789		1,035,264	1,002,789	353,731
Working capital loan at beginning balance		2,234,300	1,500,000
Issuance of loan		455,700	734,300		1,500,000
Working capital loan at ending of balance		$ 2,690,000	$ 2,234,300		$ 1,500,000
Transfers from Level 3 to Level 1 investments				14,000,000
Warrants issued on April 12, 2021 (unaudited)				103,000
Transfer from Level 3 to Level 2 investments				(8,000,000)
Level 3 Warrant liabilities at December 31, 2021	$ 1,002,789			1,002,789
Level 3 | Warrant
Fair Value Measurements
Working capital loan at beginning balance				$ 26,260,000

Fair Value Measurements - Quant

Fair Value Measurements - Quantitative information regarding Level 3 fair value measurements of the working capital loan (Details) - Level 3	Jun. 30, 2023 USD ($) Y $ / shares	Apr. 17, 2023 Y $ / shares	Dec. 31, 2022 USD ($) Y $ / shares
Working capital loan
Fair Value Measurements
Principal Outstanding | $	$ 1,500,000		$ 1,500,000
Unit Price | Forward Purchase Agreement
Fair Value Measurements
Measurement input of Forward Purchase | $ / shares			10
Unit Price | Prepaid Forward Derivative Agreements
Fair Value Measurements
Measurement input of Forward Purchase | $ / shares	10.24	10.07
Expected Remaining Term (in years) | Forward Purchase Agreement
Fair Value Measurements
Measurement input of Forward Purchase			0.16
Expected Remaining Term (in years) | Prepaid Forward Derivative Agreements
Fair Value Measurements
Measurement input of Forward Purchase	1.25	1.46
Expected Remaining Term (in years) | Working capital loan
Fair Value Measurements
Measurement input of Forward Purchase	0.25		0.25
Volatility | Working capital loan
Fair Value Measurements
Measurement input of Forward Purchase	0.374		0.435
Risk-Free Rate | Forward Purchase Agreement
Fair Value Measurements
Measurement input of Forward Purchase			0.0418
Risk-Free Rate | Prepaid Forward Derivative Agreements
Fair Value Measurements
Measurement input of Forward Purchase	0.0513	0.0442
Risk-Free Rate | Working capital loan
Fair Value Measurements
Measurement input of Forward Purchase	0.0403		0.0391

Warrant Liabilities (Details)

Warrant Liabilities (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2023 $ / shares shares	Dec. 31, 2022 $ / shares shares	Dec. 31, 2021 shares	Apr. 14, 2021 $ / shares
Warrant Liabilities
Warrants outstanding | shares	26,666,666	26,666,666	0
Public warrants expire		5 years
Repurchase of equity percentage		60
Trading days		10 days
Series of individually immaterial business acquisitions
Warrant Liabilities
Issue price		$ 9.20
Business combination		$ 9.20
Class A common stock
Warrant Liabilities
Threshold percentage of consideration receivable by the holders of shares in business combination as alternative issuance provision contained in warrant agreement	70%
Threshold period for registered holder of the warrant to exercise warrant, following the public disclosure of the consummation of such Business Combination	30 days
Threshold trading days for calculating volume-weighted average price	10 days
Class A common stock		20 days
Redemption price per share		$ 10
Warrant
Warrant Liabilities
Public warrants exercisable period		30 days
Public Warrant
Warrant Liabilities
Public Warrants exercisable term after the completion of a business combination	30 days
Public Warrants exercisable term from the closing of the initial public offering	12 months
Public Warrants expiration term	5 years
Threshold period for filling registration statement after business combination	15 days
Maximum threshold period for registration statement to become effective after business combination	60 days
Warrants outstanding | shares	14,166,666	14,166,666
Public Warrant | Redemption of warrants when the price per share of the Company's Class A common stock equals or exceeds $18.00
Warrant Liabilities
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115%
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18
Price per share	18
Redemption price per public warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Threshold trading days for redemption of public warrants	20 days
Threshold consecutive trading days for redemption of public warrants	30 days
Public Warrant | Redemption of warrants when the price per share of the Company's Class A common stock equals or exceeds $10.00
Warrant Liabilities
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	180%
Stock price trigger for redemption of public warrants (in dollars per share)	$ 10
Price per share	10
Redemption price per public warrant (in dollars per share)	$ 0.10
Minimum threshold written notice period for redemption of public warrants	30 days
Public Warrant | Class A common stock
Warrant Liabilities
Share price	$ 9.20
Percentage of gross proceeds on total equity proceeds	60%
Threshold trading days for calculating market value	20 days
Private warrants
Warrant Liabilities
Warrants outstanding | shares	12,500,000	12,500,000
Over-allotment option
Warrant Liabilities
Price per share				$ 10
Warrants outstanding | shares	266,666	266,666

Balance Sheets

Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 132,773	$ 107,773	$ 149,845
Prepaid expenses	264,924	112,649	713,322
Total current assets	397,697	220,422	863,167
Investments held in Trust Account	44,645,404	430,047,193	425,037,665
Forward Purchase Agreement Assets		353,731	1,002,789
Total Assets	45,043,101	430,621,346	426,903,621
Current liabilities:
Accounts payable	1,431,573	1,177,546	618,742
Accrued expenses	5,123,818	3,945,680	2,059,431
Working capital loan - related party	2,690,000	1,500,000
Income taxes payable	102,061	686,530
Total current liabilities	9,347,452	7,309,756	2,678,173
Deferred underwriting fee payable	10,412,500	10,412,500	14,875,000
Derivative warrant liabilities	1,333,334	1,066,667	21,063,972
Total liabilities	21,238,056	18,788,923	38,617,145
Commitments and Contingencies
Class A common stock subject to possible redemption, $0.0001 par value; 400,000,000 shares authorized; 4,312,774 and 42,500,000 shares issued and outstanding as of June 30, 2023 and December 31, 2022 valued at $10.34 and $10.11 redemption value, respectively	44,595,404	429,747,193	425,000,000
Stockholders' deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of December 31, 2022 and 2021
Accumulated deficit	(20,791,422)	(17,915,833)	(36,714,587)
Total stockholders' deficit	(20,790,359)	(17,914,770)	(36,713,524)
Total Liabilities, Class A Common Stock Subject to Possible Redemption, and Stockholders' Deficit	45,043,101	430,621,346	426,903,621
Class A common stock
Stockholders' deficit
Common stock		0	0
Class A common stock subject to possible redemption
Current liabilities:
Class A common stock subject to possible redemption, $0.0001 par value; 400,000,000 shares authorized; 4,312,774 and 42,500,000 shares issued and outstanding as of June 30, 2023 and December 31, 2022 valued at $10.34 and $10.11 redemption value, respectively	44,595,404	429,747,193	425,000,000
Class B common stock
Stockholders' deficit
Common stock	$ 1,063	$ 1,063	$ 1,063

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Apr. 17, 2023	Feb. 28, 2023	Dec. 31, 2022	Dec. 31, 2021
Class A common stock subject to possible redemption, par value (in dollars per share)				$ 0.0001
Class A common stock subject to possible redemption, shares outstanding				42,500,000	42,500,000
Class A common stock subject to possible redemption, price per share				$ 10.11	$ 10
Preferred stock, par value (in dollars per share)	$ 0.0001			$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000			1,000,000	1,000,000
Preferred stock, shares issued	0			0	0
Preferred stock, shares outstanding	0			0	0
Class A common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.01		$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000			400,000,000	400,000,000
Common stock, shares issued	0			0
Common stock, shares outstanding	0		4,312,774	0
Class A common stock subject to possible redemption
Class A common stock subject to possible redemption, par value (in dollars per share)	$ 0.0001			$ 0.0001	$ 0.0001
Class A common stock subject to possible redemption, shares issued	4,312,774			42,500,000	42,500,000
Class A common stock subject to possible redemption, shares outstanding	4,312,774			42,500,000	42,500,000
Class A common stock subject to possible redemption, price per share	$ 10.34			$ 10.11	$ 10
Class A common stock not subject to possible redemption
Common stock, shares issued	0			0	0
Common stock, shares outstanding	0			0	0
Class B common stock
Common stock, par value (in dollars per share)	$ 0.0001			$ 0.0001	$ 0.0001
Common stock, shares authorized	40,000,000			40,000,000	40,000,000
Common stock, shares issued	10,625,000			10,625,000	10,625,000
Common stock, shares outstanding	10,625,000			10,625,000	10,625,000

Statements of Operations

Statements of Operations	12 Months Ended
	Dec. 31, 2021 USD ($) $ / shares shares
Operating expenses:
Formation and operating costs	$ (5,204,970)
Loss from operations	(5,204,970)
Other income (expense):
Interest earned on investments held in Trust Account	37,665
Offering costs allocated to warrant liabilities	(782,812)
Change in fair value of Forward Purchase Agreements	232,789
Change in fair value of warrant liabilities	5,465,695
Income (loss) before income tax expense	(251,633)
Net income (loss)	$ (251,633)
Class A common stock
Other income (expense):
Weighted average shares outstanding, basic (in shares) | shares	35,224,658
Weighted average shares outstanding, diluted (in shares) | shares	35,224,658
Basic net income (loss) per share of common stock | $ / shares	$ (0.01)
Diluted net income (loss) per share of common stock | $ / shares	$ (0.01)
Class B common stock
Other income (expense):
Weighted average shares outstanding, basic (in shares) | shares	10,589,629
Weighted average shares outstanding, diluted (in shares) | shares	10,589,629
Basic net income (loss) per share of common stock | $ / shares	$ (0.01)
Diluted net income (loss) per share of common stock | $ / shares	$ (0.01)

Statements of Changes in Stockh

Statements of Changes in Stockholders' Deficit - USD ($)	Common stock Class B common stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2020	$ 1,208	$ 23,792	$ (701)	$ 24,299
Balance at the beginning (in shares) at Dec. 31, 2020	12,075,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)			(251,633)	(251,633)
Forfeiture of Founder Shares	$ (145)	145
Forfeiture of Founder Shares (in shares)	(1,450,000)
Accretion for Class A common stock to redemption amount		(23,937)	(37,232,253)	(37,256,190)
Issuance of Forward Purchase Agreements			770,000	770,000
Balance at the end at Dec. 31, 2021	$ 1,063	0	(36,714,587)	(36,713,524)
Balance at the end (in shares) at Dec. 31, 2021	10,625,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)			12,461,381	12,461,381
Balance at the end at Mar. 31, 2022	$ 1,063		(24,253,206)	(24,252,143)
Balance at the end (in shares) at Mar. 31, 2022	10,625,000
Balance at the beginning at Dec. 31, 2021	$ 1,063	0	(36,714,587)	(36,713,524)
Balance at the beginning (in shares) at Dec. 31, 2021	10,625,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)				15,552,100
Balance at the end at Jun. 30, 2022	$ 1,063		(21,453,304)	(21,452,241)
Balance at the end (in shares) at Jun. 30, 2022	10,625,000
Balance at the beginning at Dec. 31, 2021	$ 1,063	0	(36,714,587)	(36,713,524)
Balance at the beginning (in shares) at Dec. 31, 2021	10,625,000
Increase (Decrease) in Stockholders' Deficit
Increase in redemption value of Class A common stock subject to redemption		0	(434,956)	(434,956)
Net income (loss)		0	19,233,710	19,233,710
Balance at the end at Dec. 31, 2022	$ 1,063	0	(17,915,833)	(17,914,770)
Balance at the end (in shares) at Dec. 31, 2022	10,625,000
Balance at the beginning at Mar. 31, 2022	$ 1,063		(24,253,206)	(24,252,143)
Balance at the beginning (in shares) at Mar. 31, 2022	10,625,000
Increase (Decrease) in Stockholders' Deficit
Increase in redemption value of Class A common stock subject to redemption			(290,817)	(290,817)
Net income (loss)			3,090,719	3,090,719
Balance at the end at Jun. 30, 2022	$ 1,063		(21,453,304)	(21,452,241)
Balance at the end (in shares) at Jun. 30, 2022	10,625,000
Balance at the beginning at Dec. 31, 2022	$ 1,063	0	(17,915,833)	(17,914,770)
Balance at the beginning (in shares) at Dec. 31, 2022	10,625,000
Increase (Decrease) in Stockholders' Deficit
Increase in redemption value of Class A common stock subject to redemption			(2,025,746)	(2,025,746)
Net income (loss)			717,701	717,701
Balance at the end at Mar. 31, 2023	$ 1,063		(19,223,878)	(19,222,815)
Balance at the end (in shares) at Mar. 31, 2023	10,625,000
Balance at the beginning at Dec. 31, 2022	$ 1,063	$ 0	(17,915,833)	(17,914,770)
Balance at the beginning (in shares) at Dec. 31, 2022	10,625,000
Increase (Decrease) in Stockholders' Deficit
Net income (loss)				(420,544)
Balance at the end at Jun. 30, 2023	$ 1,063		(20,791,422)	(20,790,359)
Balance at the end (in shares) at Jun. 30, 2023	10,625,000
Balance at the beginning at Mar. 31, 2023	$ 1,063		(19,223,878)	(19,222,815)
Balance at the beginning (in shares) at Mar. 31, 2023	10,625,000
Increase (Decrease) in Stockholders' Deficit
Increase in redemption value of Class A common stock subject to redemption			(429,299)	(429,299)
Net income (loss)			(1,138,245)	(1,138,245)
Balance at the end at Jun. 30, 2023	$ 1,063		$ (20,791,422)	$ (20,790,359)
Balance at the end (in shares) at Jun. 30, 2023	10,625,000

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flow from operating activities:
Net income (loss)	$ 19,233,710	$ (251,633)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Amortization of prepaid expenses	704,857	499,699
Change in fair value of warrant liabilities	(19,997,306)	(5,465,695)
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities	(150,262)
Change in fair value of Forward Purchase Agreements	649,058	(232,789)
Offering costs allocated to warrant liabilities		782,812
Interest earned on investments held in Trust Account	6,125,038	37,665
Changes in operating assets and liabilities:
Prepaid expenses	(104,184)	(1,213,021)
Accounts payable	558,804	618,040
Accrued expenses	1,886,249	2,059,431
Income taxes payable	686,530
Net cash used in operating activities	(2,657,582)	(3,240,821)
Cash flows from investing activities:
Withdrawal from (investment of) fundes in Trust Account	1,115,510	(425,000,000)
Net cash provided by investing activities	1,115,510	(425,000,000)
Cash flows from financing activities:
Proceeds from sale of Units, gross		425,000,000
Proceeds from sale of Private Placement Warrants		12,500,000
Payment of offering costs		(9,134,334)
Proceeds from note payable - related party	1,500,000
Net cash provided by (used in) financing activities	1,500,000	428,365,666
Net change in cash	(42,072)	124,845
Cash at beginning of the period	149,845	25,000
Cash at end of the period	107,773	149,845
Supplemental disclosure of non-cash financing activities:
Deferred underwriting commissions		14,875,000
Deferred offering costs included in accounts payable		(94,992)
Deferred offering costs associated with proposed public offering		94,992
Accretion of Class A common stock to redemption amount	$ (434,956)	(37,256,190)
Initial classification of Forward Purchase Agreements		$ (770,000)

Organization and Business Ope_3

Organization and Business Operations	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Organization and Business Operations
Organization and Business Operations	Note 1 - Organization and Business Operations Organization and General Anzu Special Acquisition Corp I (the “Company”) is a blank check company incorporated as a Delaware corporation on December 28, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). Since completing the Company’s initial public offering (the “IPO” or the “Initial Public Offering”), the Company has reviewed, and continues to review, a number of opportunities to enter into a Business Combination with an operating business, but the Company is not able to determine at this time whether it will complete a Business Combination with any of the target businesses that the Company has reviewed or with any other target business. The Company intends to effectuate a Business Combination using cash from the proceeds of the IPO and the sale of the Private Placement Warrants (as defined below), the Company’s capital stock, debt, or a combination of cash, stock and debt. As of June 30, 2023, the Company had not commenced any operations. All activity through June 30, 2023 relates to the Company’s formation and the IPO described below, and, subsequent to the IPO, identifying a target company for a Business Combination. The Company does not expect to generate any operating revenues until after the completion of a Business Combination. The Company generates non-operating income in the form of interest income on proceeds from the IPO held in the Trust Account (as defined below). The Company’s sponsor is Anzu SPAC GP I LLC, a Delaware limited liability company (the “Sponsor”). Financing On March 4, 2021, the Company consummated the IPO of 42,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units, the “public shares”) and, on April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option. Each Unit consists of one share of the Company’s Class A common stock, par value $0.0001 per share, and one -third of one warrant (the “Public Warrants”) of the Company, with each whole warrant entitling the holder thereof to purchase one whole share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. The Units were sold at a price of $10.00 per unit, generating aggregate gross proceeds to the Company of $425,000,000 (see Note 3 and Note 7). Simultaneously with the closing of the IPO, the Company completed the private sale (the “Private Placement”) of 12,400,000 warrants (the “Private Placement Warrants”) to the Sponsor and, on April 14, 2021, simultaneously with the closing of the underwriters’ over-allotment option, the Company issued an additional 100,000 Private Placement Warrants to the Sponsor. The Private Placement Warrants were sold at a price of $1.00 per Private Placement Warrant, generating aggregate gross proceeds of $12,500,000 . Transaction costs of the IPO prior to the underwriters’ partial exercise of their over-allotment option amounted to $23,731,835 , consisting of $8,400,000 of underwriting commissions, $14,700,000 of deferred underwriters’ commissions and $631,835 of other offering costs. Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021 amounted to $280,500 , consisting of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. Trust Account Following the closing of the IPO on March 4, 2021, $420,000,000 ( $10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a U.S. based trust account (the “Trust Account”). Following the closing of the underwriters’ over-allotment option on April 14, 2021, an additional $5,000,000 ( $10.00 per Unit) from the net proceeds of the sale of the additional Units and Private Placement Warrants was placed in the Trust Account. The funds in the Trust Account are invested in a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended. The Company will not be permitted to withdraw any of the principal or interest held in the Trust Account except for the withdrawal of interest to pay taxes, if any. The funds held in the Trust Account will not otherwise be released from the Trust Account until the earliest of (1) the Company’s completion of a Business Combination; (2) the redemption of any public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the public shares if the Company does not complete a Business Combination within 24 months from the closing of the IPO or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; and (3) the redemption of the Company’s public shares if the Company has not completed a Business Combination by September 30, 2023 or during any Extension Period (as defined below), subject to applicable law. Based on current interest rates, the Company expects that interest earned on the Trust Account will be sufficient to pay taxes. Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds from the IPO, although substantially all of the net proceeds from the IPO are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a Target Business. As used herein, “Target Business” means one or more target businesses that together have an aggregate fair market value equal to at least 80% of the value of the assets held in the Trust Account (excluding taxes payable on the interest earned on the Trust Account) at the time of the signing of a definitive agreement in connection with a Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of a Business Combination, either (i) in connection with a stockholder meeting called to approve such Business Combination or (ii) by means of a tender offer. The public stockholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account, calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount to be distributed to the public stockholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. As a result, shares of common stock were recorded at their redemption amount and classified as temporary equity upon the completion of the IPO, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). The decision as to whether the Company will seek stockholder approval of a Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, in its sole discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval unless a vote is required by law or stock exchange listing requirements. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the shares of common stock voted are voted in favor of a Business Combination. However, in no event will the Company redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001 upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption of its public shares of common stock and the related Business Combination, and instead may search for an alternate Business Combination. The Company has until September 30, 2023 or such earlier date as determined by the Company’s board of directors (or such longer period as provided in an amendment to the Company’s amended and restated certificate of incorporation approved by the Company’s stockholders (an “Extension Period”)) to complete its initial Business Combination. If the Company does not complete a Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if it fails to complete its initial Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period. The initial stockholders (the Sponsor and the three directors that hold Founder Shares (as defined in Note 5) have entered into a letter agreement with the Company, pursuant to which they have waived their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete its initial Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period. However, if the initial stockholders acquire public shares, they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if the Company fails to complete its initial Business Combination within the allotted time frame. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than $10.00 per public share initially held in the Trust Account. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per public share or (2) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to have all third parties, including, but not limited to, all vendors, service providers (other than its independent registered public accounting firm), prospective target businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claims of any kind in or to any monies held in the Trust Account. On February 28, 2023, the Company reconvened its special meeting of stockholders, which was originally scheduled for February 9, 2023, adjourned until February 21, 2023 and further adjourned until February 28, 2023 (the “Special Meeting”). At the Special Meeting, the Company’s stockholders approved a proposal to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company has to consummate a Business Combination from March 4, 2023 to September 30, 2023 or such earlier date as determined by the Company’s board of directors (the “Extension”). Following the approval of the Extension, the Company waived its right under the amended and restated certificate of incorporation to withdraw up to $100,000 of interest from the Trust Account to pay dissolution expenses in the event of the Company’s liquidation. In connection with the Special Meeting, on March 7, 2023 stockholders holding 38,187,226 shares of the Company’s Class A common stock exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $387.6 million (approximately $10.15 per share of Class A common stock) was removed from the Trust Account to pay such holders and approximately $44.3 million remained in the Trust Account. Following the redemptions, the Company has 4,312,774 shares of Class A common stock outstanding. On March 21, 2023, the Company and the Sponsor amended the 2022 Promissory Note to extend the maturity date of the 2022 Working Capital Loan to the earlier of (i) December 31, 2023 or (ii) the consummation of a Business Combination. On April 17, 2023, the Company entered into a business combination agreement (the “Business Combination Agreement”) with Envoy Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”), and Envoy Medical Corporation, a Minnesota Corporation (“Envoy”), a U.S.-based medical device company that has developed and is in early clinical testing of an implanted device that already received “Breakthrough Device Designation” from the Food and Drug Administration. The transactions contemplated by the Business Combination Agreement are referred to herein as the “Proposed Business Combination.” Pursuant to the terms of the Business Combination Agreement, Merger Sub will merge with and into Envoy, the separate corporate existence of Merger Sub will cease and Envoy will be the surviving corporation and wholly owned, privately-held subsidiary of the Company (the “Merger”). The Company will change its name to “Envoy Medical, Inc.”, which will continue as the surviving public corporation after the closing of the Proposed Business Combination (the “Closing”). As a result of the Merger, among other things, (a) each share of Envoy common stock, par value $0.01 per share (the “Envoy common stock”), issued and outstanding (including Envoy common stock issued upon the exercise or conversion of Envoy warrants, Envoy convertible notes or Envoy preferred stock) shall be canceled and converted into the right to receive a number of shares of Class A common stock equal to the exchange ratio (as calculated pursuant to the Business Combination Agreement), amounting to aggregate closing Merger consideration of 15 million shares of Class A Common Stock (subject to adjustment as provided in the Business Combination Agreement); (b) each outstanding option to purchase shares of Envoy common stock will be cancelled in exchange for nominal consideration; (c) immediately prior to the effective time of the Merger, each outstanding Envoy warrant will automatically, depending on the applicable exercise price, be canceled or exercised on a net exercise basis and converted into shares of Envoy common stock in accordance with its terms; and (d) immediately prior to the effective time of the Merger, each outstanding Envoy convertible note will automatically be converted into shares of Envoy common stock in accordance with its terms. Risks and Uncertainties In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these unaudited condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements. On March 10, 2023, Silicon Valley Bank became insolvent. State regulators closed the bank, and the Federal Deposit Insurance Corporation (“FDIC”) was appointed as its receiver. The Company held deposits with this bank. As a result of the actions by the FDIC, the Company’s insured and uninsured deposits have been restored. Going Concern As of June 30, 2023 and December 31, 2022, the Company had $132,773 and $107,773 in its operating bank accounts, respectively, and working capital deficits of $8,949,755 and $7,089,334 , respectively. Prior to the completion of the Initial Business Combination, the Company’s liquidity needs had been satisfied through a contribution of $25,000 from Sponsor to cover certain formation and offering costs in exchange for the issuance of the Founder Shares (as defined in Note 5), the loan of up to $300,000 from the Sponsor pursuant to the Note (see Note 5), and the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). As of June 30, 2023 and December 31, 2022, there were amounts of $2,690,000 and $1,500,000 outstanding under the Working Capital Loans, respectively. The Company may need to raise additional funds through loans from its Sponsor and/or third parties in order to meet the expenditures required for operating its business. If the Company’s estimate of the costs of undertaking in-depth due diligence and negotiating the initial business combination is less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial business combination. The Sponsor is not under any obligation to advance funds to, or to invest in, the Company. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. If a Business Combination is not consummated by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period, there will be a mandatory liquidation and subsequent dissolution of the Company. Mandatory liquidation and liquidity condition raise substantial doubt about the Company’s ability to continue as a going concern through one year from the date of these financial statements if a Business Combination is not consummated. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s management plans to complete a Business Combination prior to the mandatory liquidation date and expects to receive financing to meet its obligations through the time of liquidation; however, no financing is currently committed. The unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.	Note 1 — Organization and Business Operations Organization and General Anzu Special Acquisition Corp I (the “Company”) is a blank check company incorporated as a Delaware corporation on December 28, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). While the Company may pursue a Business Combination target in any industry, the Company currently intends to concentrate its efforts in identifying high-quality businesses with transformative technologies. Since completing the Company’s initial public offering (the “IPO” or the “Initial Public Offering”), the Company has reviewed, and continues to review, a number of opportunities to enter into a Business Combination with an operating business, but the Company is not able to determine at this time whether it will complete a Business Combination with any of the target businesses that the Company has reviewed or with any other target business. The Company intends to effectuate a Business Combination using cash from the proceeds of the IPO and the sale of the Private Placement Warrants (as defined below), the Company’s capital stock, debt, or a combination of cash, stock and debt. As of December 31, 2022, the Company had not commenced any operations. All activity through December 31, 2022 relates to the Company’s formation and the IPO described below, and, subsequent to the IPO, identifying a target company for a Business Combination. The Company does not expect to generate any operating revenues until after the completion of a Business Combination. The Company generates non-operating income in the form of interest income on marketable securities held in the Trust Account (as defined below). The Company’s sponsor is Anzu SPAC GP I LLC, a Delaware limited liability company (the “Sponsor”). Financing On March 4, 2021, the Company consummated the IPO of 42,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units, the “public shares”) and, on April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option. Each Unit consists of one share of the Company’s Class A common stock, par value $0.0001 per share, and one-third of one warrant (the “Public Warrants”) of the Company, with each whole warrant entitling the holder thereof to purchase one whole share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. The Units were sold at a price of $10.00 per unit, generating aggregate gross proceeds to the Company of $425,000,000 (see Note 4 and Note 8). Simultaneously with the closing of the IPO, the Company completed the private sale (the “Private Placement”) of 12,400,000 warrants (the “Private Placement Warrants”) to the Sponsor and, on April 14, 2021, simultaneously with the closing of the underwriters’ over-allotment option, the Company issued an additional 100,000 Private Placement Warrants to the Sponsor. The Private Placement Warrants were sold at a price of $1.00 per Private Placement Warrant, generating aggregate gross proceeds of $12,500,000. Transaction costs of the IPO prior to the underwriters’ partial exercise of their over-allotment option amounted to $23,731,835, consisting of $8,400,000 of underwriting commissions, $14,700,000 of deferred underwriters’ commissions and $631,835 of other offering costs. Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021 amounted to $280,500, consisting of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. Trust Account Following the closing of the IPO on March 4, 2021, $420,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a U.S.-based trust account (the “Trust Account”). Following the closing of the underwriters’ over-allotment option on April 14, 2021, an additional $5,000,000 ($10.00 per Unit) from the net proceeds of the sale of the additional Units and Private Placement Warrants was placed in the Trust Account. The funds in the Trust Account are invested in a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended. The Company will not be permitted to withdraw any of the principal or interest held in the Trust Account except for the withdrawal of interest to pay taxes, if any. The funds held in the Trust Account will not otherwise be released from the Trust Account until the earliest of (1) the Company’s completion of a Business Combination; (2) the redemption of any public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the public shares if the Company does not complete a Business Combination within 24 months from the closing of the IPO or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; and (3) the redemption of the Company’s public shares if the Company has not completed a Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, subject to applicable law. Based on current interest rates, the Company expects that interest earned on the Trust Account will be sufficient to pay taxes. Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds from the IPO, although substantially all of the net proceeds from the IPO are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a Target Business. As used herein, “Target Business” means one or more target businesses that together have an aggregate fair market value equal to at least 80% of the value of the assets held in the Trust Account (excluding taxes payable on the interest earned on the Trust Account) at the time of the signing of a definitive agreement in connection with a Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of a Business Combination, either (i) in connection with a stockholder meeting called to approve such Business Combination or (ii) by means of a tender offer. The public stockholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account, calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The per-share amount to be distributed to the public stockholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. As a result, shares of common stock were recorded at their redemption amount and classified as temporary equity upon the completion of the IPO, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). The decision as to whether the Company will seek stockholder approval of a Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, in its sole discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval unless a vote is required by law or stock exchange listing requirements. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the shares of common stock voted are voted in favor of a Business Combination. However, in no event will the Company redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001 upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption of its public shares of common stock and the related Business Combination, and instead may search for an alternate Business Combination. The Company has until September 30, 2023 or such earlier date as determined by the Company’s board of directors (or such longer period as provided in an amendment to the Company’s amended and restated certificate of incorporation approved by the Company’s stockholders (an “Extension Period”)) to complete its initial Business Combination. If the Company does not complete a Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if it fails to complete its initial Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period. The initial stockholders (the Sponsor and the three directors that hold Founder Shares (as defined in Note 6) have entered into a letter agreement with the Company, pursuant to which they have waived their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete its initial Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period. However, if the initial stockholders acquire public shares, they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if the Company fails to complete its initial Business Combination within the allotted time frame. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than $10.00 per public share initially held in the Trust Account. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per public share or (2) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to have all third parties, including, but not limited to, all vendors, service providers (other than its independent registered public accounting firm), prospective target businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claims of any kind in or to any monies held in the Trust Account. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements. On March 10, 2023 Silicon Valley Bank became insolvent. State regulators closed the bank and the Federal Deposit Insurance Corporation (“FDIC”) was appointed as its receiver. The Company held deposits with this bank. As a result of the actions by the FDIC, the Company’s insured and uninsured deposits have been restored. Going Concern As of December 31, 2022 and 2021, the Company had $107,773 and $149,845 in its operating bank accounts, respectively, and working capital deficits of $(7,089,334) and $(1,815,006), respectively. Prior to the completion of the Initial Business Combination, the Company’s liquidity needs had been satisfied through a contribution of $25,000 from Sponsor to cover for certain formation and offering costs in exchange for the issuance of the Founder Shares, the loan of up to $300,000 from the Sponsor pursuant to the Note (see Note 6), and the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 6). As of December 31, 2022 and 2021, there were amounts of $1,500,000 and $0 outstanding under the Working Capital Loans, respectively. The Company may need to raise additional funds through loans from its Sponsor and/or third parties in order to meet the expenditures required for operating its business. If the Company’s estimate of the costs of undertaking in-depth due diligence and negotiating the initial business combination is less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial business combination. The Sponsor is not under any obligation to advance funds to, or to invest in, the Company. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. If a Business Combination is not consummated by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period, there will be a mandatory liquidation and subsequent dissolution of the Company. Mandatory liquidation and liquidity condition raise substantial doubt about the Company’s ability to continue as a going concern through one year from the date of these financial statements if a Business Combination is not consummated. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. Our management plans to complete a Business Combination prior to the mandatory liquidation date and expects to receive financing to meet its obligations through the time of liquidation; however no financing is currently committed. The financial statements do not include any adjustment that might be necessary if we are unable to continue as a going concern.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	12 Months Ended
	Dec. 31, 2022
Restatement of Previously Issued Financial Statements
Restatement of Previously Issued Financial Statements	Note 2 — Restatement of Previously Issued Financial Statements The Company had recognized a liability upon closing of its initial public offering in March 2021 for a portion of the underwriters’ commissions which was contingently payable upon closing of a future business combination, with the offsetting entry resulting in an initial discount to the securities sold in the initial public offering. One of the underwriters waived all claims to this deferred commission in September 2022. The Company recognized the waiver as an extinguishment, with a resulting non-operating gain recognized in its statement of operations for the three and nine months ended September 30, 2022. Upon subsequent review and analysis, management concluded that the Company should have recognized the extinguishment of the contingent liability as a credit to stockholders’ deficit. Therefore, the Company’s management and the Audit Committee of the Company’s Board of Directors (the “Audit Committee”) concluded that the Company’s previously issued unaudited condensed financial statements as of September 30, 2022 should no longer be relied upon and that it is appropriate to restate. As such, the Company will restate its financial statements filed November 14, 2022 (the “Original Filing”) in this Form 10-K. Impact of the Restatement The impact of the restatement on the statements of operations, statements of changes in stockholders’ deficit and statements of cash flows for the affected period is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. Statement of Operations ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ Three months ended September 30, 2022 Reported filed ​ Adjustment ​ Restated Deferred offering cost forgiveness ​ $ 4,462,500 ​ $ (4,312,237) ​ $ 150,263 Net Income ​ $ 5,690,350 ​ $ (4,312,237) ​ $ 1,378,113 Basic and diluted net income per common stock, Class A ​ $ 0.11 ​ $ (0.08) ​ $ 0.03 Basic net income per common stock, Class B ​ $ 0.11 ​ $ (0.08) ​ $ 0.03 Diluted net income per common stock, Class B ​ $ 0.11 ​ $ (0.08) ​ $ 0.03 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ ​ ​ Nine months ended September 30, 2022 Reported filed Adjustment Restated Deferred offering cost forgiveness ​ $ 4,462,500 ​ $ (4,312,237) ​ $ 150,263 Net Income ​ $ 21,242,449 ​ $ (4,312,237) ​ $ 16,930,212 Basic and diluted net income per common stock, Class A ​ $ 0.40 ​ $ (0.08) ​ $ 0.32 Basic net income per common stock, Class B ​ $ 0.40 ​ $ (0.08) ​ $ 0.32 Diluted net income per common stock, Class B ​ $ 0.40 ​ $ (0.08) ​ $ 0.32 ​ Changes in stockholders’ deficit ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ Three months ended September 30, 2022 Reported filed ​ Adjustment ​ Restated Net Income $ 5,690,350 $ (4,312,237) $ 1,378,113 Deemed dividend – increase in redemption value of Class A common stock subject to redemption $ (1,589,302) ​ $ 4,312,237 ​ $ 2,722,935 ​ Cash Flow Statement for the nine months ended September 30, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ ​ Reported filed ​ Adjustment ​ Restated Net Income ​ $ 21,242,449 ​ $ (4,312,237) ​ $ 16,930,212 Gain on forgiveness of deferred offering costs ​ $ 4,462,500 ​ $ (4,312,237) ​ $ 150,263 Supplemental Disclosure of noncash activities ​ ​ ​ Extinguishment of deferred underwriting commissions allocated to public shares ​ $ — ​ $ 4,312,237 ​ $ 4,312,237 ​

Summary of Significant Accoun_6

Summary of Significant Accounting Policies	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of June 30, 2023 and the results of operations and cash flows for the periods presented. Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of results that may be expected for the full year or any other period. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2022, as filed with the SEC on April 3, 2023. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liabilities. Other significant accounting estimates include the forward purchase derivative and the convertible working capital loan. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2023 and December 31, 2022. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities and are recognized at fair value. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Gains and losses resulting from the change in fair value of these securities are included in interest earned on investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the FDIC coverage limit of $250,000. The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2023 and December 31, 2022, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. There was no Class A common stock issued or outstanding as of June 30, 2023 and December 31, 2022, classified as permanent equity. The Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to temporary stockholders’ equity upon the completion of the IPO, except those associated with Public Warrants which were expensed. Accordingly, as of June 30, 2023 and December 31, 2022, offering costs in the aggregate of $24,012,335 (consisting of $8,500,000 of underwriting commissions, $14,875,000 of deferred underwriters’ commission and $637,335 other offering costs) have been incurred. In September 2022, the Company reversed $4,462,500 of deferred underwriting fees, as the underwriters resigned from their role in the Business Combination and thereby waived their entitlement to these commissions (see Note 6). Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021, amounted to $280,500 , consisting mainly of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. The Company allocates the offering costs between its common stock and Public Warrants using relative fair value method, with the offering costs allocated to the Public Warrants expensed immediately. Accordingly, as of June 30, 2023 and December 31, 2022, offering costs in the aggregate of $782,812 have been charged to the Company’s unaudited condensed statements of operations (consisting of $762,300 of underwriting discounts and $20,512 of other offering costs). Offering costs associated with the Class A common stock have been charged to temporary equity. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature except for the derivative warrant liabilities and forward purchase agreement asset (see Note 9). Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company’s public warrant liability is based on quoted prices in active markets as of the measurement date and is classified as Level 1. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company accounts for its warrants issued in connection with its IPO as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statements of operations. The fair value of warrants issued by the Company in connection with the IPO and Private Placement has been estimated using binomial lattice model at the date of issuance. As of June 30, 2023 and December 31, 2022, the Company’s public warrants were measured based on quoted prices in active markets, and the private placement warrants are categorized as a Level 2 following the public price. FASB ASC 470-20, “Debt with Conversion and Other Options”, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate IPO proceeds from the Units between common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then common stock. The Company accounts for its forward purchase agreements (collectively, the “Forward Purchase Agreements” or “FPAs”) issued as derivative FPA assets in accordance with ASC 815-40. Accordingly, the Company recognizes the FPA instruments as assets at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited statements of operations. The fair value of the FPAs has been estimated using observable inputs at the date of issuance. As of December 31, 2022, the Company’s FPAs are categorized as a Level 3. The FPA expired on April 17, 2023 and replace by the instrument explained below. The Company accounts for its prepaid forward derivative (“PFD”) issued as a liability in accordance with ASC 815-40. Accordingly, the Company recognizes the PFD instrument as liability at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the PFD has been estimated using observable inputs at the date of issuance. As of June 30, 2023 PFD is categorized as a Level 3. Net Income (loss) per Share of Common Stock The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the year, excluding shares of common stock shares subject to forfeiture. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. The Company’s statements of operations include a presentation of income per share for shares of common stock subject to possible redemption in a manner similar to the two-class method of income per share. Consistent with ASC Topic 480-10-S99-3A, accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates its fair value. The calculation of diluted income (loss) per common stock does not consider the effect of the warrants issued since the exercise of the warrants are contingent upon the occurrence of future events. However, the diluted earnings per share calculation includes the shares subject to forfeiture from the first day of the interim period in which the contingency on such shares was resolved. A reconciliation of net income (loss) per common stock is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Three Months Ended ​ ​ For the Six Months Ended ​ For the Six Months Ended ​ June 30, 2023 June 30, 2022 June 30, 2023 June 30, 2022 ​ Class A Class B Class A Class B Class A Class B Class A Class B Allocation of net income (loss) $ (328,630) ​ $ (809,615) ​ $ 18,026,419 ​ $ 10,625,000 ​ $ (264,590) $ (155,953) $ 12,441,680 $ 3,110,420 Weighted average shares outstanding ​ 4,312,774 ​ ​ 10,625,000 ​ ​ 42,500,000 ​ ​ 10,625,000 ​ ​ 18,026,419 ​ 10,625,000 ​ 42,500,000 ​ 10,625,000 Basic and diluted net income (loss) per share ​ $ (0.08) ​ $ (0.08) ​ $ 0.06 ​ $ 0.06 ​ ​ $ (0.01) ​ $ (0.01) ​ $ 0.29 ​ $ 0.29 ​ Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The tax provision for the six months ended June 30, 2023 and 2022 is $962,768 and $108,315 , respectively. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company’s effective tax rate was 177% and 0.01% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the six months ended June 30, 2023 and 2022, due to changes in fair value of warrants, FPA, and the valuation allowance on the deferred tax assets. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign stockholder corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to distribute to redeeming stockholders or to complete a Business Combination and could adversely affect the Company’s ability to complete a Business Combination. Working Capital Loan – Related Party When the Company issues convertible debt, it first evaluates the balance sheet classification of the convertible instrument in its entirety to determine whether the instrument should be classified as a liability under ASC 480 and second whether the conversion feature should be accounted for separately from the host instrument. A conversion feature of a convertible debt instrument or certain convertible preferred stock would be separated from the convertible instrument and classified as a derivative liability if the conversion feature, were it a stand-alone instrument, meets the definition of an “embedded derivative” as defined in ASC 815. Generally, characteristics that require derivative treatment include, among others, when the conversion feature is not indexed to the Company’s equity, as defined in ASC 815-40, or when it must be settled either in cash or by issuing stock that is readily convertible to cash. When a conversion feature meets the definition of an embedded derivative, it would be separated from the host instrument and classified as a derivative liability carried on the balance sheet at fair value, with any changes in its fair value recognized currently in the condensed statement of operations. The Working Capital Loan has a conversion feature that allows for converting the loan into warrants and is carried at fair value. The fair value of the balance outstanding on the convertible loan was $1,500,000 and $1,500,000 as of June 30, 2023 and December 31, 2022, respectively. During Q2 of 2023 the Company entered into a promissory note with the Sponsor which allowed up to $1,190,000 and accrues no interest. There was $1,190,000 outstanding on this loan as of June 30, 2023 and $0 outstanding as of December 31, 2022. In total the Company had $2,690,000 and $1,500,000 was outstanding on related party loans as of June 30, 2023 and December 31, 2022, respectively. Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”). 2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.	Note 3 — Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities and are recognized at fair value. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Gains and losses resulting from the change in fair value of these securities are included in interest earned on investments held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Concentration of Credit Risk The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2022 and 2021, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to stockholders’ equity upon the completion of the IPO. Accordingly, as of December 31, 2022, offering costs in the aggregate of $24,012,335 (consisting of $8,500,000 of underwriting commissions, $14,875,000 of deferred underwriters’ commission and $637,335 other offering costs) had been incurred. Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021, amounted to $280,500 consisting mainly of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. The Company allocates the offering costs between its common stock and Public Warrants using relative fair value method, with the offering costs allocated to the Public Warrants expensed immediately. Accordingly, as of December 31, 2022, offering costs in the aggregate of $782,812 have been charged to the Company’s statement of operations (consisting of $762,300 of underwriting discounts and $20,512 of other offering costs). Offering costs associated with the Class A common stock have been charged to stockholders’ deficit. As of December 31, 2022, deferred offering costs of $94,992 have been incurred. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature except for the derivative warrant liabilities and forward purchase agreement asset (see Note 10). Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company’s public warrant liability is based on quoted prices in active markets as of the measurement date and is classified as Level 1. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company accounts for its warrants issued in connection with its IPO as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of warrants issued by the Company in connection with the IPO and Private Placement has been estimated using binomial lattice model at the date of issuance. As of December 31, 2022, the Company’s public warrants were measured based on quoted prices in active markets, and the private placement warrants are categorized as a Level 2 following the public price. FASB ASC 470-20, “Debt with Conversion and Other Options”, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate IPO proceeds from the Units between common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then common stock. The Company accounts for its forward purchase agreements (collectively, the “Forward Purchase Agreements” or “FPAs”) issued as derivative FPA assets in accordance with ASC 815-40. Accordingly, the Company recognizes the FPA instruments as assets at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the FPAs has been estimated using observable inputs at the date of issuance. As of December 31, 2022 and 2021, the Company’s FPAs are categorized as a Level 3. Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock outstanding during the year, excluding common stock shares subject to forfeiture. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. The Company’s statements of operations include a presentation of income per share for shares of common stock subject to possible redemption in a manner similar to the two-class method of income per share. Consistent with ASC Topic 480-10-S99-3A, accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates its fair value. The calculation of diluted income per common stock does not consider the effect of the warrants issued since the exercise of the warrants are contingent upon the occurrence of future events. However, the diluted earnings per share calculation includes the shares subject to forfeiture from the first day of the interim period in which the contingency on such shares was resolved. A reconciliation of net income (loss) per common stock is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2022 ​ ​ Class A Class B Allocation of net income ​ $ 15,386,968 ​ $ 3,846,742 Weighted average shares outstanding, basic and diluted ​ 42,500,000 ​ 10,625,000 Basic and diluted net income per share ​ $ 0.36 ​ $ 0.36 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2021 ​ Class A Class B Allocation of net loss $ (193,470) $ (58,163) Weighted average shares outstanding, basic and diluted ​ 35,224,658 ​ 10,589,629 Basic and diluted net loss per share ​ $ (0.01) ​ $ (0.01) ​ Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The tax provision for the years ended December 31, 2022 and 2021 has been disclosed under Note 12, as well as the deferred tax assets as of December 31, 2022 and 2021. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering_2

Initial Public Offering	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Initial Public Offering
Initial Public Offering	Note 3 - Initial Public Offering On March 4, 2021, the Company consummated the IPO of 42,000,000 Units. Each Unit consists of one share of the Company’s Class A common stock, par value $0.0001 per share, and one -third of one warrant of the Company, with each whole warrant entitling the holder thereof to purchase one whole share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. The underwriters had a 45-day option to purchase up to an additional 6,300,000 Units to cover over-allotments. On April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option. In September 2022, the Company wrote off a liability of $4,462,500 of deferred underwriting fees, as the underwriters resigned from their role in any potential future Business Combination and thereby waived their entitlement to these fees (see Note 6).	Note 4 — Initial Public Offering On March 4, 2021, the Company consummated the IPO of 42,000,000 Units. Each Unit consists of one share of the Company’s Class A common stock, par value $0.0001 per share, and one -third of one warrant of the Company, with each whole warrant entitling the holder thereof to purchase one whole share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. The underwriters had a 45 -day option to purchase up to an additional 6,300,000 Units to cover over-allotments. On April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option.

Private Placement_2

Private Placement	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Private Placement
Private Placement	Note 4 - Private Placement Simultaneously with the closing of the IPO on March 4, 2021, the Company completed the private sale of an aggregate of 12,400,000 Private Placement Warrants to the Sponsor and, on April 14, 2021, simultaneously with the closing of the underwriters’ over-allotment option, the Company issued an additional 100,000 Private Placement Warrants to the Sponsor. The Private Placement Warrants were sold at a price of $1.00 per Private Placement Warrant, generating aggregate gross proceeds of $12,500,000 . A portion of the proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the IPO held in the Trust Account. Each Private Placement Warrant is exercisable for one share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. If the Company does not complete a Business Combination by September 30, 2023, or during any Extension Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable, or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis and are non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.	Note 5 — Private Placement Simultaneously with the closing of the IPO on March 4, 2021, the Company completed the private sale of an aggregate of 12,400,000 Private Placement Warrants to the Sponsor and, on April 14, 2021, simultaneously with the closing of the underwriters’ over-allotment option, the Company issued an additional 100,000 Private Placement Warrants to the Sponsor. The Private Placement Warrants were sold at a price of $1.00 per Private Placement Warrant, generating aggregate gross proceeds of $12,500,000. A portion of the proceeds from the sale of the Private Placement Warrants was added to the net proceeds from the IPO held in the Trust Account. Each Private Placement Warrant is exercisable for one share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. If the Company does not complete a Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable, or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis and are non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Related Party Transactions_2

Related Party Transactions	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Related Party Transactions
Related Party Transactions	Note 5 - Related Party Transactions Founder Shares On December 30, 2020, the Sponsor purchased 7,187,500 shares (the “Founder Shares”) of the Company’s Class B common stock for an aggregate purchase price of $25,000 . On February 19, 2021, the Company effected a stock dividend of 2,875,000 Founder Shares to the Sponsor, resulting in the Company’s initial stockholders holding an aggregate of 10,062,500 Founder Shares. On March 1, 2021, the Company effected a stock dividend of 2,012,500 Founder Shares to the Sponsor, resulting in the Company’s initial stockholders holding an aggregate of 12,075,000 Founder Shares. The Founder Shares included an aggregate of up to 1,575,000 shares that were subject to forfeiture depending on the extent that the underwriters’ over-allotment option was exercised, so that the number of Founder Shares would equal 20% of the Company’s issued and outstanding common stock after the IPO. On April 14, 2021, the Sponsor forfeited 1,450,000 Founder Shares following the expiration of the unexercised portion of underwriters’ over-allotment option. As a result, the 10,625,000 Founder Shares issued and outstanding as of June 30, 2023 and December 31, 2022 are not subject to forfeiture. The Sponsor and the Company’s officers, directors, and former directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares or Class A common stock received upon conversion thereof until the earlier of (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination (x) if the last reported sale of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, rights issuances, consolidations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30 - trading day period commencing at least 150 days after a Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company’s public stockholders having the right to exchange their shares of common stock for cash, securities or other property. Promissory Note — Related Party On December 30, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000 . The Promissory Note was non-interest bearing and was payable on the earlier of (i) March 31, 2021 or (ii) the completion of the IPO. The Company had no borrowings under the Promissory Note at June 30, 2023 or December 31, 2022. The facility is no longer available. Working Capital Loans — Related Party On March 29, 2022, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Sponsor may provide up to $1,500,000 to the Company as a Working Capital Loan. The Working Capital Loan does not bear interest and is repayable in full upon on the earlier of (i) March 29, 2023 or (ii) the consummation of the Company’s initial Business Combination. Upon the consummation of a Business Combination, the Sponsor shall have the option, but not the obligation, to convert the principal balance of the Working Capital Loan, in whole or in part, into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loan but no proceeds held in the Trust Account would be used to repay the Working Capital Loan. The Working Capital Loan is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Working Capital Loan and all other sums payable with regard to the Working Capital Loan becoming immediately due and payable. On March 21, 2023, the Company issued an additional unsecured promissory note (the “2023 Promissory Note”) to the Sponsor, pursuant to which the Sponsor may provide up to $1,190,000 to the Company as a working capital loan (the “2023 Working Capital Loan”). The 2023 Working Capital Loan does not bear interest and is repayable in full upon on the earlier of (i) December 31, 2023 or (ii) the consummation of a Business Combination. The 2023 Working Capital Loan is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the 2023 Working Capital Loan and all other sums payable with regard to the 2023 Working Capital Loan becoming immediately due and payable. As of April 3, 2023, $734,300 was outstanding under the 2023 Promissory Note. As of June 30, 2023 and December 31, 2022, there were amounts of $2,690,000 and $1,500,000 outstanding under the Working Capital Loan, respectively. The Working Capital Loan is recorded at fair value of $2,690,000 and $1,500,000 as of June 30, 2023 and December 31, 2022, respectively. Administrative Service Fee The Company has agreed, commencing on March 1, 2021, to pay an affiliate of the Company’s Sponsor a fixed amount of $40,521 per month for office space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. The Company has incurred costs of $121,563 and $243,126 for the three and six months ended June 30, 2023, respectively. The Company has incurred costs of $121,563 and $243,126 for the three and six months ended June 30, 2022, respectively. As of June 30, 2023 and December 31, 2022, there were amounts of $244,175 and $0 accrued on the condensed balance sheets, respectively. Diligence Services The Company has agreed to pay or reimburse Anzu Partners LLC, an affiliate of the Sponsor for certain fees and out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as performing due diligence on suitable business combination opportunities. There were amounts of $ 873,290 and $ 958,429 accrued for such fees and expenses as of June 30, 2023 and December 31, 2022, respectively. The Company incurred $ 54,971 and $142,411 of such fees and expenses for the three months ended June 30, 2023 and 2022, respectively. The Company incurred $201,549 and $385,706 of such fees and expenses for the six months ended June 30, 2023 and 2022, respectively. On June 30, 2023, Anzu Partners LLC waived $286,688 of such accrued fees and expenses.	Note 6 — Related Party Transactions Founder Shares On December 30, 2020, the Sponsor purchased 7,187,500 shares (the “Founder Shares”) of the Company’s Class B common stock for an aggregate purchase price of $25,000 . On February 19, 2021, the Company effected a stock dividend of 2,875,000 Founder Shares to the Sponsor, resulting in the Company’s initial stockholders holding an aggregate of 10,062,500 Founder Shares. On March 1, 2021, the Company effected a stock dividend of 2,012,500 Founder Shares to the Sponsor, resulting in the Company’s initial stockholders holding an aggregate of 12,075,000 Founder Shares. The Founder Shares included an aggregate of up to 1,575,000 shares that were subject to forfeiture depending on the extent that the underwriters’ over-allotment option was exercised, so that the number of Founder Shares would equal 20% of the Company’s issued and outstanding common stock after the IPO. On April 14, 2021, the Sponsor forfeited 1,450,000 Founder Shares following the expiration of the unexercised portion of underwriters’ over-allotment option. As a result, the 10,625,000 Founder Shares issued and outstanding as of December 31, 2022, are not subject to forfeiture. The Sponsor and the Company’s officers and directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares or Class A common stock received upon conversion thereof until the earlier of (A) one year after the completion of a Business Combination; and (B) subsequent to a Business Combination (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, rights issuances, consolidations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30 - trading day period commencing at least 150 days after a Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company’s public stockholders having the right to exchange their shares of common stock for cash, securities or other property. Promissory Note — Related Party On December 30, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and was payable on the earlier of (i) March 31, 2022 or (ii) the completion of the IPO. The Company had no borrowings under the promissory note at December 31, 2022 or 2021. The facility is no longer available. Working Capital Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021, the Company had amounts of $1,500,000 and $0 under the Working Capital Loans, respectively. On March 29, 2022, the Company issued an unsecured promissory note to the Sponsor (the “2022 Promissory Note”), pursuant to which the Sponsor may provide up to $1,500,000 to the Company as a Working Capital Loan (the “2022 Working Capital Loan”). The 2022 Working Capital Loan does not bear interest and is repayable in full upon on the earlier of (i) March 29, 2023 or (ii) the consummation of the Company’s initial Business Combination. Upon the consummation of a Business Combination, the Sponsor shall have the option, but not the obligation, to convert the principal balance of the 2022 Working Capital Loan, in whole or in part, into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the 2022 Working Capital Loan but no proceeds held in the Trust Account would be used to repay the 2022 Working Capital Loan. The 2022 Working Capital Loan is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the 2022 Working Capital Loan and all other sums payable with regard to the 2022 Working Capital Loan becoming immediately due and payable. As of December 31, 2022 and 2021, the Company had amounts of $1,500,000 and $0 under the 2022 Working Capital Loan, respectively. The 2022 Working Capital Loan is recorded at fair value of $1,500,000. Administrative Service Fee The Company has agreed, commencing on March 1, 2021, to pay an affiliate of the Company’s Sponsor a fixed amount of $40,521 per month for office space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. There was no accrual for administrative service fees as of December 31, 2022 or 2021. The Company has incurred costs due to a related party of $486,252 and $405,210 for the years ended December 31, 2022 and 2021, respectively, and all amounts were paid in the period incurred. Diligence Services The Company has agreed to pay or reimburse an affiliate of the Sponsor for certain fees and out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as performing due diligence on suitable business combination opportunities. As of December 31, 2022 and 2021, there were amounts of $958,429 and $334,731, respectively, accrued for such fees and expenses. The Company paid an affiliate of the Sponsor $0 and $417,185 for such fees and expenses during the years ended December 31, 2022 and 2021, respectively. The Company incurred $623,698 and $751,916 of such fees and expenses for the years ended December 31, 2022 and 2021, respectively.

Commitments and Contingencies_2

Commitments and Contingencies	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Commitments and Contingencies.
Commitments and Contingencies	Note 6 - Commitments and Contingencies Registration and Stockholder Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Company’s Class A common stock). The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggyback” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters had a 45-day option from the date of the IPO to purchase up to an additional 6,300,000 Units to cover over-allotments, if any. On April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option. On March 4, 2021 and April 14, 2021, the underwriters were paid a fixed underwriting discount of $8,400,000 and $100,000 , respectively. In addition, the underwriters are entitled to a deferred discount of $0.35 per Unit, or $14,875,000 in the aggregate. The deferred discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. In September 2022, the Company reversed a liability of $4,462,500 of deferred underwriting fees, as some underwriters resigned from their role in any potential future Business Combination and thereby waived their entitlement to these fees. Forward Purchase Agreements On December 6, 2021, the Company entered into Forward Purchase Agreements with certain institutional investors and anchored by Arena Capital Advisors, LLC and Fir Tree Partners (collectively, the “Forward Purchasers”), pursuant to which the Forward Purchasers have agreed, subject to certain conditions, to purchase the following: ● up to an aggregate of $80,000,000 of unsecured convertible notes of the Company (“Convertible Notes”) immediately prior to the closing of the Company’s Business Combination. The terms of the Convertible Notes, including the terms on which the Convertible Notes will convert into shares of the Company’s Class A common stock, will be negotiated by the Company and the Forward Purchasers, each acting in its sole discretion, prior to the issuance of the Convertible Notes. The aggregate total of up to $80,000,000 from the issuance of the Convertible Notes would be received by the Company upon the closing of the Company’s Business Combination; and ● up to an aggregate of 4,000,000 forward purchase securities of the Company (the “Forward Purchase Securities”) for $10.00 per Forward Purchase Security, or an aggregate total of up to $40,000,000 , immediately prior to the Business Combination Closing. Each Forward Purchase Security would consist of one share of Class A common stock issued and sold by the Company and one -nineth of one warrant transferred by the Sponsor for no value, with each whole redeemable warrant exercisable to purchase one share of Class A common stock for $11.50 per share. The aggregate total of up to $40,000,000 from the issuance of the Forward Purchase Securities would be received by the Company upon the closing of the Company’s Business Combination. The shares of Class A common stock included in the Forward Purchase Securities would have the same terms as the Company’s publicly traded shares of Class A common stock. The warrants included in the Forward Purchase Securities would have the same terms as the private placement warrants held by the Sponsor and would be subject to the terms of the Warrant Agreement, dated March 1, 2021, entered into between the Company and American Stock Transfer & Trust Company, as Warrant Agent, in connection with the Company’s initial public offering (the “Warrant Agreement”). In addition, under the Forward Purchase Agreements, if the Company determines to raise capital by the private placement of equity securities in connection with the closing of the Company’s Business Combination (the “New Equity Securities”), the Company shall first make an offer to the Forward Purchasers to purchase the securities then offered on the same terms as such New Equity Securities, in an aggregate amount of up to $120,000,000 . Any commitment by any Forward Purchaser under any of the Forward Purchase Agreements to purchase New Equity Securities is subject to and conditioned upon the acceptance of the Company’s offer by such Forward Purchaser, following the Company’s notification to such Forward Purchaser of its intention to offer the New Equity Securities. Pursuant to the Forward Purchase Agreements, the Forward Purchasers will be entitled to registration rights with respect to shares of Class A common stock underlying the Convertible Notes, the shares of Class A common stock and warrants included in the Forward Purchase Securities, and the New Equity Securities. This Forward Purchase Agreement Expired in the second quarter of 2023 and a new Forward Purchase Agreement was entered into as described below. In addition, on April 17, 2023, prior to entering into the Business Combination Agreement, Anzu, Envoy (for purposes of the Forward Purchase Agreement (as defined below), New Envoy, following the Business Combination, together with Anzu prior to the Business Combination, as the case may be, are referred to in this section as the “Counterparty”), and Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”) and Meteora Select Trading Opportunities Master, LP (“MSTO” and, together with MSOF and MCP, collectively the “Seller”) entered into an agreement (as amended by Amendment No. 1 to the Forward Purchase Agreement, dated as of May 25, 2023, the “Forward Purchase Agreement”) for an OTC Equity Prepaid Forward Transaction (the “Forward Purchase Transaction”). Pursuant to the terms of the Forward Purchase Agreement, Seller intends, but is not obligated, to purchase through a broker in the open market, following the period for making redemption elections and prior to the Closing, shares of Anzu Class A Common Stock from holders of Anzu Class A Common Stock (other than Anzu or affiliates of Anzu) including from holders who have previously elected to redeem their Anzu Class A Common Stock (such purchased shares of Anzu Class A Common Stock, the “FPA Shares”) pursuant to the redemption rights set forth in the Current Charter in connection with the Business Combination (such holders, “Redeeming Holders”). Purchases by the Seller, if any, will be made after the redemption deadline in connection with the Business Combination at a price no higher than the redemption price to be paid to holders who elect to redeem their Anzu Class A Common Stock in connection with the Business Combination. Excluding the shares of Anzu Class A Common Stock transferred to Seller as the Share Consideration (as defined below), the aggregate total number of FPA Shares (the “Number of FPA Shares”) will in no event be more than 4,300,000 FPA Shares (the “Maximum Number of FPA Shares”). The Number of FPA Shares is subject to reduction as described under “Optional Early Termination” in the Forward Purchase Agreement. Seller also may transfer any FPA Shares as needed to beneficially own no more than 9.9% of the total number of shares of Anzu Class A Common Stock outstanding on a post-combination basis. The Seller in its sole discretion may request warrants of the Counterparty exercisable for shares of Anzu Class A Common Stock in an amount equal to (i) the Maximum Number of FPA Shares less (ii) the Number of Shares specified in the supplement of the Forward Purchase Agreement (the “Pricing Date Notice”). Seller has agreed to waive any redemption rights in connection with the Business Combination with respect to the FPA Shares. Such waiver may reduce the number of shares of Anzu Class A Common Stock redeemed in connection with the Business Combination, which could alter the perception of the potential strength of the Business Combination. Seller has further agreed not to vote any of the FPA Shares in favor of the Business Combination Proposal. Further, concurrently with the Business Combination Agreement, Envoy entered into a convertible promissory note (the “Envoy Bridge Note”) pursuant to which it will borrow $10,000,000 from GAT Funding, LLC (“GAT,” or the “Envoy Bridge Note Holder”), which is an entity owned by Glen A. Taylor, a member of the Envoy Board and a holder of more than 5% of the Envoy Common Stock, and the holder of all of the outstanding shares of Envoy Preferred Stock, prior to the Closing. Contingent upon, and effective concurrently with, the PIPE Closing, New Envoy will issue shares of Series A Preferred Stock to GAT in exchange for the Envoy Bridge Note. GAT will have certain customary registration rights, including rights with respect to the filing of a shelf registration statement, underwritten offering rights and piggyback rights, pursuant to the A&R Registration Rights Agreement (as described below) with respect to any shares of New Envoy Class A Common Stock issuable upon conversion of the Series A Preferred Stock. As of June 30, 2023 and December 31, 2022, there is nothing outstanding on the Convertible Notes and no action has been taken on the Forward Purchase Securities other than the initial contract agreement.	Note 7 — Commitments and Contingencies Registration and Stockholder Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Company’s Class A common stock). The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters had a 45 -day option from the date of the IPO to purchase up to an additional 6,300,000 Units to cover over-allotments, if any. On April 14, 2021, the Company issued an additional 500,000 Units in connection with the underwriters’ partial exercise of their over-allotment option. On March 4, 2021 and April 14, 2021, the underwriters were paid a fixed underwriting discount of $8,400,000 and $100,000, respectively. In addition, the underwriters are entitled to a deferred discount of $0.35 per Unit, or $14,875,000 in the aggregate. During the year ended December 31, 2022, the Company wrote off a liability of $4,462,500 of deferred underwriting fees, through the statement of operations, as some underwriters resigned from their role in any potential future Business Combination and thereby waived their entitlement to these fees. The deferred discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Forward Purchase Agreements On December 6, 2021, the Company entered into Forward Purchase Agreements with certain institutional investors and anchored by Arena Capital Advisors, LLC and Fir Tree Partners (collectively, the “Forward Purchasers”), pursuant to which the Forward Purchasers have agreed, subject to certain conditions, to purchase the following: ● up to an aggregate of $80,000,000 of unsecured convertible notes of the Company (“Convertible Notes”) immediately prior to the closing of the Company’s Business Combination. The terms of the Convertible Notes, including the terms on which the Convertible Notes will convert into shares of the Company’s Class A common stock, will be negotiated by the Company and the Forward Purchasers, each acting in its sole discretion, prior to the issuance of the Convertible Notes. The aggregate total of up to $80,000,000 from the issuance of the Convertible Notes would be received by the Company upon the closing of the Company’s Business Combination. ● up to an aggregate of 4,000,000 forward purchase securities of the Company (the “Forward Purchase Securities”) for $10.00 per Forward Purchase Security, or an aggregate total of up to $40,000,000 , immediately prior to the Business Combination Closing. Each Forward Purchase Security would consist of one share of Class A common stock issued and sold by the Company and one -sixth of one warrant transferred by the Sponsor for no value, with each whole redeemable warrant exercisable to purchase one share of Class A common stock for $11.50 per share. The aggregate total of up to $40,000,000 from the issuance of the Forward Purchase Securities would be received by the Company upon the closing of the Company’s Business Combination. The shares of Class A common stock included in the Forward Purchase Securities would have the same terms as the Company’s publicly traded shares of Class A common stock. The warrants included in the Forward Purchase Securities would have the same terms as the private placement warrants held by the Sponsor and would be subject to the terms of the Warrant Agreement, dated March 1, 2021, entered into between the Company and American Stock Transfer & Trust Company, as Warrant Agent, in connection with the Company’s initial public offering (the “Warrant Agreement”). In addition, under the Forward Purchase Agreements, if the Company determines to raise capital by the private placement of equity securities in connection with the closing of the Company’s Business Combination (the “New Equity Securities”), the Company shall first make an offer to the Forward Purchasers to purchase the securities then offered on the same terms as such New Equity Securities, in an aggregate amount of up to $120,000,000. Any commitment by any Forward Purchaser under any of the Forward Purchase Agreements to purchase New Equity Securities is subject to and conditioned upon the acceptance of the Company’s offer by such Forward Purchaser, following the Company’s notification to such Forward Purchaser of its intention to offer the New Equity Securities. Pursuant to the Forward Purchase Agreements, the Forward Purchasers will be entitled to registration rights with respect to shares of Class A common stock underlying the Convertible Notes, the shares of Class A common stock and warrants included in the Forward Purchase Securities, and the New Equity Securities. As of December 31, 2022, there is nothing outstanding on the Convertible Notes and no action has been taken on the Forward Purchase Securities other than the initial contract agreement.

Class A Common Stock Subject _5

Class A Common Stock Subject to Possible Redemption	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Class A Common Stock Subject to Possible Redemption
Class A Common Stock Subject to Possible Redemption	Note 7 - Class A Common Stock Subject to Possible Redemption The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 400,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 4,312,774 and 42,500,000 shares of Class A common stock outstanding, respectively, all of which were subject to possible redemption. As of June 30, 2023, these shares were valued at $10.34 , due to the stockholder rights to the trust proceeds, for a total of $44,595,404 . As of December 31, 2022, these shares were valued at $10.11 per share, for a total of $429,747,193 . At June 30, 2023 and December 31, 2022, the Class A common stock reflected in the unaudited condensed balance sheets is reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 425,000,000 Less: ​ ​ ​ Proceeds allocated to Public Warrants ​ ​ (14,026,667) Class A common stock issuance costs ​ ​ (23,229,523) Plus: ​ ​ ​ Accretion of carrying value to redemption value ​ ​ 37,691,146 Waiver of Class A shares issuance costs ​ ​ 4,312,237 Class A common stock subject to possible redemption at December 31, 2022 ​ ​ 429,747,193 Redemption of Class A common stock ​ ​ (387,606,834) Accretion of carrying value to redemption value ​ ​ 2,025,746 Class A common stock subject to possible redemption at March 31, 2023 ​ ​ 44,166,105 Accretion of carrying value to redemption value ​ ​ 429,299 Class A common stock subject to possible redemption at June 30, 2023 ​ $ 44,595,404 ​	Note 8 — Class A Common Stock Subject to Possible Redemption The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of December 31, 2022 and 2021, there were 42,500,000 shares of Class A common stock outstanding, all of which were subject to possible redemption. As of December 31, 2022, these shares were valued at $10.11 , due to the stockholder rights to the trust proceeds, for a total of $429,747,193 . As of December 31, 2021, these shares were valued at the IPO price of $ 10.00 per share for a total of $425,000,000 . At December 31,2022 and 2021, the Class A common stock reflected in the balance sheets is reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 425,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (14,026,667) Class A common stock issuance costs ​ (23,229,523) Plus: ​ Accretion of carrying value to redemption value ​ 37,256,190 Class A common stock subject to possible redemption at December 31, 2021 ​ ​ 425,000,000 Waiver of Class A shares issuance costs ​ ​ 4,312,237 Accretion of carrying value to redemption value ​ ​ 434,956 Class A common stock subject to possible redemption at December 31, 2022 ​ $ 429,747,193 ​

Stockholders' Deficit_2

Stockholders' Deficit	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Stockholders' Deficit
Stockholders' Deficit	Note 8 - Stockholders’ Deficit Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock, with a par value of $0.0001 per share. The Company’s board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The board of directors is able to, without stockholder approval, issue shares of preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects. At June 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding . Class A Common Stock — The Company is authorized to issue 400,000,000 shares of Class A common stock, with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 4,312,774 and 42,500,000 shares of Class A common stock issued and outstanding , respectively, which are all subject to possible redemption and are presented as temporary equity. Class B Common Stock — The Company is authorized to issue 40,000,000 shares of Class B common stock, with a par value of $0.0001 per share. Holders of shares of Class B common stock are entitled to one vote for each share. At June 30, 2023 and December 31, 2022, there were 10,625,000 shares of Class B common stock issued and outstanding . Only holders of the Class B common stock have the right to vote on the election of directors prior to a Business Combination. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as otherwise required by law. The Class B common stock will automatically convert into Class A common stock at the time of the completion of a Business Combination, or earlier at the option of the holder, on a one -for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the IPO and related to the closing of a Business Combination, the ratio at which Founder Shares will convert into Class A common stock will be adjusted (subject to waiver by holders of a majority of the Class B common stock) so that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the common stock issued and outstanding upon completion of the IPO plus the number of shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination, excluding any shares of Class A common stock or equity-linked securities issued, or to be issued, to any seller in a Business Combination.	Note 9 — Stockholders’ Deficit Preferred Stock Class A Common Stock there were 42,500,000 shares of Class A common stock issued and outstanding, which are all subject to possible redemption and are presented as temporary equity. Class B Common Stock Only holders of the Class B common stock have the right to vote on the election of directors prior to a Business Combination. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as otherwise required by law. The Class B common stock will automatically convert into Class A common stock at the time of the completion of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the IPO and related to the closing of a Business Combination, the ratio at which Founder Shares will convert into Class A common stock will be adjusted (subject to waiver by holders of a majority of the Class B common stock) so that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the common stock issued and outstanding upon completion of the IPO plus the number of shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination, excluding any shares of Class A common stock or equity-linked securities issued, or to be issued, to any seller in a Business Combination.

Fair Value Measurements_2

Fair Value Measurements	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Fair Value Measurements
Fair Value Measurements	Note 9 – Fair Value Measurements Level 1 assets include investments in money market funds that invest solely in U.S. government securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of Public Warrants was transferred from a Level 3 measurement to a Level 1 measurement, when the Public Warrants were separately listed and traded in an active market in April 2021. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 fair value measurement as of July 2021, as the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. There were no transfers to/from Levels 1, 2, and 3 during the three and six months ended June 30 , 2023 or 2022. The initial fair value of the Public and Private Placement Warrants, issued concurrently and in connection with the Initial Public Offering, has been estimated using a binomial lattice model. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrants’ listed price in an active market was used as the fair value. The estimated fair value of the Warrants, prior to the Public Warrants being traded in an active market, is determined using Level 3 inputs. Inherent in a binomial lattice model are assumptions related to the Unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The Unit price is based on the publicly traded price of the Units as of the measurement date. The Company estimated the volatility for the Warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the Warrants. The term to expiration was calculated as the contractual term of the Warrants, assuming one year to a Business Combination from the Initial Public Offering date. Finally, the Company does not anticipate paying a dividend. The asset for the FPAs was valued using the time-discounted spread of the fixed purchase price of the Company’s units pursuant to the FPAs over the public trading price of the Company’s Units and is considered to be a Level 3 fair value measurement. The valuation is then adjusted to reduce the value of the FPAs for the value of warrants. The model utilizes key inputs including risk-free interest rates based on U.S. Treasury rates. The liability for the PFD was estimated using a Monte Carlo simulation model, which is a Level 3 fair value measurement. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. In accounting for the working capital loan, the Company bifurcated a derivative liability representing the conversion option, with a fair value of $ 2,690,000 at issuance. To measure the fair value of the derivative liability, the Company compared the calculated value of the working capital loan with the indicated value of the host instrument, defined as the straight-debt component of the working capital loan. The difference between the value of the straight-debt host instrument and the fair value of the working capital loan resulted in the value of the derivative liability. The value of the straight-debt host instrument was estimated using a Monte Carlo simulation model, which is a Level 3 fair value measurement. The following tables present information about the Company’s assets and liabilities that are measured on a recurring basis as of June 30, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Significant Significant ​ ​ Prices in ​ Other ​ Other ​ ​ Active Markets ​ Observable ​ Unobservable ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 44,645,404 ​ $ — ​ $ — Forward Purchase Agreement ​ ​ — ​ ​ — ​ ​ — Fair Value at June 30, 2023 (unaudited) ​ $ 44,645,404 ​ $ — ​ $ — Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ Working capital loan – related party ​ $ — ​ $ — ​ $ 2,690,000 Public Warrant liability ​ ​ 708,333 ​ ​ — ​ ​ — Private Warrant liability ​ ​ — ​ ​ 625,000 ​ ​ — Prepaid forward derivative ​ ​ — ​ ​ — ​ ​ 144,770 Fair Value at June 30, 2023 (unaudited) ​ $ 708,333 ​ $ 625,000 ​ $ 2,834,770 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Significant Significant ​ ​ Prices in ​ Other ​ Other ​ ​ Active Markets ​ Observable ​ Unobservable ​ ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 430,047,193 ​ $ — ​ $ — Forward Purchase Agreement ​ ​ — ​ ​ — ​ ​ 353,731 Fair Value at December 31, 2022 ​ $ 430,047,193 ​ $ — ​ $ 353,731 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ Working capital loan – related party ​ $ — ​ $ — ​ $ 1,500,000 Public Warrant liability ​ ​ 566,667 ​ ​ — ​ ​ — Private Warrant liability ​ ​ — ​ ​ 500,000 ​ ​ — Fair Value at December 31, 2022 ​ $ 566,667 ​ $ 500,000 ​ $ 1,500,000 ​ The following tables provide the roll forward for the Level 3 investments for the six months ended June 30, 2023: ​ ​ ​ ​ ​ FPA assets at December 31, 2022 ​ $ 353,731 Change in fair value of FPA ​ 681,533 FPA assets at March 31, 2023 (unaudited) ​ ​ 1,035,264 Expiration of FPA asset April 17, 2023 ​ ​ (1,035,264) New FPA – liability April 17, 2023 ​ ​ (144,770) FPA liability at June 30, 2023 (unaudited) ​ $ (144,770) ​ ​ ​ ​ Working capital loan at December 31, 2022 ​ $ 1,500,000 Issuance of loan ​ ​ 734,300 Working capital loan at March 31, 2023 (unaudited) ​ ​ 2,234,300 Issuance of loan ​ ​ 455,700 Working capital loan at June 30, 2023 (unaudited) ​ $ 2,690,000 ​ ​ ​ ​ ​ FPA assets at December 31, 2021 $ 1,002,789 Change in fair value of FPA ​ (649,058) FPA assets at December 31, 2022 ​ $ 353,731 ​ ​ ​ Working capital loan at December 31, 2021 ​ $ — Issuance of loan ​ ​ 1,500,000 Change in fair value of working capital loan ​ ​ — Working capital loan at December 31, 2022 ​ $ 1,500,000 ​ The following table presents the quantitative information regarding Level 3 fair value measurements of the Forward Purchase Agreements: ​ ​ ​ ​ ​ ​ ​ December 31, 2022 Unit Price ​ $ 10.00 ​ Remaining Term (in years) ​ ​ 0.16 ​ Risk-Free Rate ​ ​ 4.18 % ​ The following table presents the quantitative information regarding Level 3 fair value measurements of the Prepaid Forward Derivative Agreements: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2023 April 17, 2023 Unit Price ​ $ 10.24 ​ $ 10.07 ​ Remaining Term (in years) ​ 1.25 ​ 1.46 ​ Risk-Free Rate ​ 5.13 % 4.42 % ​ The following table presents the quantitative information regarding Level 3 fair value measurements of the working capital loan: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2023 December 31, 2022 Principal Outstanding ​ $ 1,500,000 ​ $ 1,500,000 Expected Remaining Term (in years) ​ 0.25 ​ ​ 0.25 ​ Volatility ​ 37.4 ​ ​ 43.5 % Risk-Free Rate ​ 4.03 ​ ​ 3.91 % ​	Note 10 — Fair Value Measurements Level 1 assets include investments in money market funds that invest solely in U.S. government securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of Public Warrants was transferred from a Level 3 measurement to a Level 1 measurement, when the Public Warrants were separately listed and traded in an active market in April 2021. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 fair value measurement as of July 2021, as the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. There were no transfers to/from Levels 1, 2, and 3 during the year ended December 31, 2022. There were $14,000,000 in transfers from Level 3 to Level 1 and $8,000,000 in transfers from Level 3 to Level 2 for the year ended December 31, 2021. The initial fair value of the Public and Private Placement Warrants, issued concurrently and in connection with the Initial Public Offering, has been estimated using a binomial lattice model. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrants’ listed price in an active market was used as the fair value for both the Public and Private Placement Warrants. The estimated fair value of the Warrants, prior to the Public Warrants being traded in an active market, is determined using Level 3 inputs. Inherent in a binomial lattice model are assumptions related to the Unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The Unit price is based on the publicly traded price of the Units as of the measurement date. The Company estimated the volatility for the Warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the Warrants. The term to expiration was calculated as the contractual term of the Warrants, assuming one year to a Business Combination from the Initial Public Offering date. Finally, the Company does not anticipate paying a dividend. In accounting for the working capital loan, the Company bifurcated a derivative liability representing the conversion option, with a fair value of $1,500,000 at issuance. To measure the fair value of the derivative liability, the Company compared the calculated value of the working capital loan with the indicated value of the host instrument, defined as the straight-debt component of the working capital loan. The difference between the value of the straight-debt host instrument and the fair value of the working capital loan resulted in the value of the derivative liability. The value of the straight-debt host instrument was estimated using a Monte Carlo simulation model, which is a Level 3 fair value measurement. The asset for the FPAs was valued using the time-discounted spread of the fixed purchase price of the Company’s units pursuant to the FPAs over the public trading price of the Company’s Units and is considered to be a Level 3 fair value measurement. The valuation is then adjusted to reduce the value of the FPAs for the value of warrants. The model utilizes key inputs including risk free interest rates based on U.S. Treasury rates. The following tables present information about the Company’s assets that are measured on a recurring basis as of December 31, 2022 and 2021 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ Significant ​ ​ in Active ​ Other ​ Other ​ Markets Observable Unobservable December 31, 2022 (Level 1) (Level 2) (Level 3) Assets: ​ ​ ​ ​ Investments held in Trust Account $ 430,047,193 $ — $ — Forward Purchase Agreements ​ ​ — ​ ​ — ​ ​ 353,731 Fair value at December 31, 2022 $ 430,047,193 $ — $ 353,731 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ Public Warrant liability $ 566,667 $ — $ — Private Warrant liability ​ ​ — ​ ​ 500,000 ​ ​ — Working Capital Loans – related party ​ ​ — ​ ​ — ​ ​ 1,500,000 Fair Value at December 31, 2022 $ 566,667 $ 500,000 $ 1,500,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ Significant ​ ​ in Active ​ Other ​ Other ​ ​ Markets ​ Observable ​ Unobservable December 31, 2021 (Level 1) (Level 2) (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 425,037,665 $ — ​ $ — Forward Purchase Agreements ​ ​ — ​ — ​ ​ 1,002,789 Fair value at December 31, 2021 ​ $ 425,037,665 $ — ​ $ 1,002,789 Liabilities: ​ ​ Public Warrant liability ​ $ 11,190,235 $ — ​ $ — Private Warrant liability ​ ​ — ​ 9,873,737 ​ ​ — Fair value at December 31, 2021 ​ $ 11,190,235 $ 9,873,737 ​ $ — ​ The following tables provide the roll forward for the Level 3 investments as of December 31, 2022: ​ ​ ​ ​ ​ FPA assets at December 31, 2021 $ 1,002,789 Change in fair value of FPAs ​ (649,058) FPA assets at December 31, 2022 ​ $ 353,731 Working Capital Loans at December 31, 2021 ​ $ — Issuance of loan ​ 1,500,000 Change in fair value of working capital loan ​ — Working Capital Loans at December 31, 2022 ​ $ 1,500,000 ​ The following tables provides the roll forward for the Level 3 investments as of December 31, 2021: ​ ​ ​ ​ ​ Level 3 Warrant liabilities at March 4, 2021 $ 26,260,000 Change in fair value of warrant liabilities ​ (4,363,000) Transfers from Level 3 to Level 1 investments ​ (14,000,000) Warrants issued on April 12, 2021 ​ ​ 103,000 Transfers from Level 3 to Level 2 investments ​ ​ (8,000,000) Level 3 Warrant liabilities at December 31, 2021 ​ $ — Issuance of FPA assets at December 6, 2021 ​ $ 770,000 Change in fair value of FPAs ​ ​ 232,789 Level 3 investments (at asset position) at December 31, 2021 ​ $ 1,002,789 ​ The following table presents the quantitative information regarding Level 3 fair value measurements of the Forward Purchase Agreements: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 December 31, 2021 Unit Price ​ $ 10.00 ​ $ 10.00 ​ Remaining Term (in years) ​ ​ 0.16 ​ 0.50 ​ Risk-Free Rate ​ ​ 4.18 % 0.19 % ​ The following table presents the quantitative information regarding Level 3 fair value measurements of the Working Capital Loan: ​ ​ ​ ​ ​ ​ ​ December 31, 2022 Principal Outstanding ​ $ 1,500,000 Expected Remaining Term (in years) ​ 0.16 ​ Volatility ​ 43.5 % Risk-Free Rate ​ 3.91 % ​ The change in fair value of the warrant liabilities is summarized as follows: ​ ​ ​ ​ ​ Warrant liabilities at December 31, 2021 $ 21,063,972 Change in fair value of warrant liabilities ​ (19,997,305) Warrant liabilities at December 31, 2022 ​ $ 1,066,667 Warrant liabilities at March 4, 2021 ​ $ 26,260,000 Warrants issued on April 12, 2021 ​ 269,667 Change in fair value of warrant liabilities ​ (5,465,695) Warrant liabilities at December 31, 2021 ​ $ 21,063,972 ​

Warrant Liabilities_2

Warrant Liabilities	12 Months Ended
	Dec. 31, 2022
Warrant Liabilities
Warrant Liabilities	Note 11 - Warrant Liabilities Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the IPO. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination by September 30, 2023 or such earlier date as determined by the Company’s board of directors, or during any Extension Period, and the Company liquidates the funds held in the Trust Account, holders of the warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the completion of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of shares of the Company’s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described below under “Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $18.00 ” and “Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $10.00 ” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under “Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $10.00 ” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration or a valid exemption from registration is available. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A common stock issuable upon exercise of the Public Warrants. The Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of a Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Class A common stock is, at the time of any exercise of a Public Warrant, not listed on a national securities exchange such that they do not satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $18.00 . ● in whole and not in part; ● at a price of $0.01 per Public Warrant; ● upon not less than 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the last reported sale price of shares of the Class A common stock for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant). Redemption of warrants when the price per share of the Company’s Class A common stock equals or exceeds $10.00 . ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Class A common stock; ● if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and ● if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants. If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. The warrant agreement contains an alternative issuance provision that if less than 70% of the consideration receivable by the holders of shares of the Company’s Class A common stock in the Business Combination is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within 30 days following the public disclosure of the consummation of such Business Combination, the warrant exercise price will be reduced by an amount equal to the difference (but in no event less than zero) of (i) the warrant exercise price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a warrant immediately prior to the consummation of the Business Combination based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets. “Per Share Consideration” means (i) if the consideration paid to holders of shares of the Company’s Class A common stock consists exclusively of cash, the amount of such cash per share of Class A common stock, and (ii) in all other cases, the volume weighted average price of the Company’s Class A common stock as reported during the ten -trading day period ending on the trading day prior to the effective date of the Business Combination. The Company has outstanding an aggregate of 26,666,666 warrants, including 14,166,666 public warrants and 12,500,000 private warrants, and 0 warrants as of December 31, 2022 and 2021, respectively, to purchase shares of the Company’s Class A common stock, which were issued in connection with the IPO and the Private Placement (including 266,666 warrants issued in connection with the consummation of the underwriters’ partial exercise of their over-allotment option) (see Notes 4 and 5). The Company believes that the adjustments to the exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under ASC 815–40, and thus the warrants are not eligible for an exception from derivative accounting. The accounting treatment of derivative financial instruments requires that the Company records a derivative liability upon the closing of IPO. Accordingly, the Company has classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the binomial lattice model. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statements of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification. The estimated fair value of the public warrant liability is based on quoted prices in active markets as of the measurement date. The estimated fair value of the private warrant liability is determined using public price.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2022
Income Taxes
Income Taxes	Note 12 - Income Taxes The Company’s taxable income primarily consists of interest income on the Trust Account, less any franchise taxes. The Company’s formation and operating costs are generally considered start-up costs and are not currently deductible. The income tax provision consists of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, Year Ended December 31, ​ ​ 2022 ​ 2021 Current ​ ​ ​ ​ Federal ​ $ 1,175,834 ​ $ — State ​ ​ 325,880 ​ — Deferred ​ ​ ​ ​ Federal ​ ​ (2,077,550) ​ (1,085,134) State ​ ​ (429,855) ​ — Change in valuation allowance ​ ​ 2,507,405 ​ 1,085,134 Income tax provision ​ $ 1,501,714 ​ $ — ​ The Company’s net deferred tax assets are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, December 31, ​ ​ 2022 ​ 2021 Deferred tax assets: ​ ​ ​ ​ ​ ​ Net operating loss carryover ​ $ — ​ $ 7,910 Start-up/organization costs ​ ​ (2,507,405) ​ ​ (1,093,044) Total deferred tax assets ​ ​ (2,507,405) ​ ​ (1,085,134) Valuation allowance ​ ​ 2,507,405 ​ ​ 1,085,134 Deferred tax asset, net of allowance ​ $ — ​ $ — ​ In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. A reconciliation of the statutory federal income tax rate (benefit) to the Company’s effective tax rate for the years ended December 31, 2022 and 2021 is as follows: ​ ​ ​ ​ ​ ​ ​ Statutory federal income tax rate 21.00 % 21.00 % Cost allocated to warrants ​ 0.00 % 65.33 % Change in deferred offering costs ​ (0.15) % 0.00 % Change in fair value of warrant liabilities ​ (20.25) % (456.14) % Change in fair value of FPAs ​ 0.66 % (19.43) % Change in valuation allowance ​ 6.82 % 389.24 % Other ​ (0.84) % 0.00 % Effective tax rate ​ 7.24 % 0.00 % ​ There were no unrecognized tax benefits as of December 31, 2022 and 2021. No amounts were accrued for the payment of interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has been subject to income tax examinations by major taxing authorities since inception. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Subsequent Events_2

Subsequent Events	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Subsequent Events
Subsequent Events	Note 11 - Subsequent Events The Company evaluated subsequent events and transactions that occurred after the condensed balance sheets date through the date that the unaudited condensed financial statements were issued. Based on this review, the Company did not identify any subsequent events except for those stated below that would have required adjustment or disclosure in the unaudited condensed financial statements.	Note 13 - Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date through April 3, 2023, the date that the financial statements were issued. Based on this review, the Company did not identify any subsequent events besides what is disclosed below that would have required adjustment or disclosure in the financial statements. In February 2023, the remaining underwriter resigned from its role in the Company’s potential business combination with Envoy Medical Corporation (the “Proposed Business Combination”) and thereby waived its entitlement to $10,412,500 in deferred underwriting fees solely with respect to the Proposed Business Combination. On February 28, 2023, the Company reconvened its special meeting of stockholders, which was originally scheduled for February 9, 2023, adjourned until February 21, 2023 and further adjourned until February 28, 2023 (the “Special Meeting”). At the Special Meeting, the Company’s stockholders approved a proposal to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company has to consummate a Business Combination from March 4, 2023 to September 30, 2023 or such earlier date as determined by the Company’s board of directors (the “Extension”). Following the approval of the Extension, the Company waived its right under the amended and restated certificate of incorporation to withdraw up to $100,000 of interest from the Trust Account to pay dissolution expenses in the event of the Company’s liquidation. In connection with the Special Meeting, stockholders holding 38,187,226 shares of the Company’s Class A common stock exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $387.6 million (approximately $10.15 per share of Class A common stock) was removed from the Trust Account to pay such holders and approximately $45.1 million remained in the Trust Account. Following the redemptions, the Company has 4,312,774 shares of Class A common stock outstanding. On March 21, 2023, the Company and the Sponsor amended the 2022 Promissory Note to extend the maturity date of the 2022 Working Capital Loan to the earlier of (i) December 31, 2023 or (ii) the consummation of a Business Combination. On March 21, 2023, the Company issued an additional unsecured promissory note (the “2023 Promissory Note”) to the Sponsor, pursuant to which the Sponsor may provide up to $1,190,000 to the Company as a working capital loan (the “2023 Working Capital Loan”). The 2023 Working Capital Loan does not bear interest and is repayable in full upon on the earlier of (i) December 31, 2023 or (ii) the consummation of a Business Combination. The 2023 Working Capital Loan is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the 2023 Working Capital Loan and all other sums payable with regard to the 2023 Working Capital Loan becoming immediately due and payable. As of April 3, 2023, $734,300 was outstanding under the 2023 Promissory Note.

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Policies)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of June 30, 2023 and the results of operations and cash flows for the periods presented. Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of results that may be expected for the full year or any other period. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2022, as filed with the SEC on April 3, 2023.	Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”).
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is either not an emerging growth company or an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liabilities. Other significant accounting estimates include the forward purchase derivative and the convertible working capital loan. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2023 and December 31, 2022.	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities and are recognized at fair value. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Gains and losses resulting from the change in fair value of these securities are included in interest earned on investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities and are recognized at fair value. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Gains and losses resulting from the change in fair value of these securities are included in interest earned on investments held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the FDIC coverage limit of $250,000. The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.	Concentration of Credit Risk The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2023 and December 31, 2022, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. There was no Class A common stock issued or outstanding as of June 30, 2023 and December 31, 2022, classified as permanent equity. The Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2022 and 2021, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets. The Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to temporary stockholders’ equity upon the completion of the IPO, except those associated with Public Warrants which were expensed. Accordingly, as of June 30, 2023 and December 31, 2022, offering costs in the aggregate of $24,012,335 (consisting of $8,500,000 of underwriting commissions, $14,875,000 of deferred underwriters’ commission and $637,335 other offering costs) have been incurred. In September 2022, the Company reversed $4,462,500 of deferred underwriting fees, as the underwriters resigned from their role in the Business Combination and thereby waived their entitlement to these commissions (see Note 6). Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021, amounted to $280,500 , consisting mainly of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. The Company allocates the offering costs between its common stock and Public Warrants using relative fair value method, with the offering costs allocated to the Public Warrants expensed immediately. Accordingly, as of June 30, 2023 and December 31, 2022, offering costs in the aggregate of $782,812 have been charged to the Company’s unaudited condensed statements of operations (consisting of $762,300 of underwriting discounts and $20,512 of other offering costs). Offering costs associated with the Class A common stock have been charged to temporary equity.	Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to stockholders’ equity upon the completion of the IPO. Accordingly, as of December 31, 2022, offering costs in the aggregate of $24,012,335 (consisting of $8,500,000 of underwriting commissions, $14,875,000 of deferred underwriters’ commission and $637,335 other offering costs) had been incurred. Offering costs associated with the closing of the underwriters’ over-allotment option on April 14, 2021, amounted to $280,500 consisting mainly of $100,000 of underwriting commissions, $175,000 of deferred underwriters’ commissions and $5,500 of other offering costs. The Company allocates the offering costs between its common stock and Public Warrants using relative fair value method, with the offering costs allocated to the Public Warrants expensed immediately. Accordingly, as of December 31, 2022, offering costs in the aggregate of $782,812 have been charged to the Company’s statement of operations (consisting of $762,300 of underwriting discounts and $20,512 of other offering costs). Offering costs associated with the Class A common stock have been charged to stockholders’ deficit. As of December 31, 2022, deferred offering costs of $94,992 have been incurred.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature except for the derivative warrant liabilities and forward purchase agreement asset (see Note 9).	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature except for the derivative warrant liabilities and forward purchase agreement asset (see Note 10).
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company’s public warrant liability is based on quoted prices in active markets as of the measurement date and is classified as Level 1.	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company’s public warrant liability is based on quoted prices in active markets as of the measurement date and is classified as Level 1.
Derivative Financial Instruments	Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company accounts for its warrants issued in connection with its IPO as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statements of operations. The fair value of warrants issued by the Company in connection with the IPO and Private Placement has been estimated using binomial lattice model at the date of issuance. As of June 30, 2023 and December 31, 2022, the Company’s public warrants were measured based on quoted prices in active markets, and the private placement warrants are categorized as a Level 2 following the public price. FASB ASC 470-20, “Debt with Conversion and Other Options”, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate IPO proceeds from the Units between common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then common stock. The Company accounts for its forward purchase agreements (collectively, the “Forward Purchase Agreements” or “FPAs”) issued as derivative FPA assets in accordance with ASC 815-40. Accordingly, the Company recognizes the FPA instruments as assets at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited statements of operations. The fair value of the FPAs has been estimated using observable inputs at the date of issuance. As of December 31, 2022, the Company’s FPAs are categorized as a Level 3. The FPA expired on April 17, 2023 and replace by the instrument explained below. The Company accounts for its prepaid forward derivative (“PFD”) issued as a liability in accordance with ASC 815-40. Accordingly, the Company recognizes the PFD instrument as liability at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the PFD has been estimated using observable inputs at the date of issuance. As of June 30, 2023 PFD is categorized as a Level 3.	Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company accounts for its warrants issued in connection with its IPO as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of warrants issued by the Company in connection with the IPO and Private Placement has been estimated using binomial lattice model at the date of issuance. As of December 31, 2022, the Company’s public warrants were measured based on quoted prices in active markets, and the private placement warrants are categorized as a Level 2 following the public price. FASB ASC 470-20, “Debt with Conversion and Other Options”, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate IPO proceeds from the Units between common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then common stock. The Company accounts for its forward purchase agreements (collectively, the “Forward Purchase Agreements” or “FPAs”) issued as derivative FPA assets in accordance with ASC 815-40. Accordingly, the Company recognizes the FPA instruments as assets at fair value and adjusts the instruments to fair value at each reporting period. The assets are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the FPAs has been estimated using observable inputs at the date of issuance. As of December 31, 2022 and 2021, the Company’s FPAs are categorized as a Level 3.
Net Income (Loss) per Common Share	Net Income (loss) per Share of Common Stock The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the year, excluding shares of common stock shares subject to forfeiture. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. The Company’s statements of operations include a presentation of income per share for shares of common stock subject to possible redemption in a manner similar to the two-class method of income per share. Consistent with ASC Topic 480-10-S99-3A, accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates its fair value. The calculation of diluted income (loss) per common stock does not consider the effect of the warrants issued since the exercise of the warrants are contingent upon the occurrence of future events. However, the diluted earnings per share calculation includes the shares subject to forfeiture from the first day of the interim period in which the contingency on such shares was resolved. A reconciliation of net income (loss) per common stock is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Three Months Ended ​ ​ For the Six Months Ended ​ For the Six Months Ended ​ June 30, 2023 June 30, 2022 June 30, 2023 June 30, 2022 ​ Class A Class B Class A Class B Class A Class B Class A Class B Allocation of net income (loss) $ (328,630) ​ $ (809,615) ​ $ 18,026,419 ​ $ 10,625,000 ​ $ (264,590) $ (155,953) $ 12,441,680 $ 3,110,420 Weighted average shares outstanding ​ 4,312,774 ​ ​ 10,625,000 ​ ​ 42,500,000 ​ ​ 10,625,000 ​ ​ 18,026,419 ​ 10,625,000 ​ 42,500,000 ​ 10,625,000 Basic and diluted net income (loss) per share ​ $ (0.08) ​ $ (0.08) ​ $ 0.06 ​ $ 0.06 ​ ​ $ (0.01) ​ $ (0.01) ​ $ 0.29 ​ $ 0.29	Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock outstanding during the year, excluding common stock shares subject to forfeiture. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. The Company’s statements of operations include a presentation of income per share for shares of common stock subject to possible redemption in a manner similar to the two-class method of income per share. Consistent with ASC Topic 480-10-S99-3A, accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates its fair value. The calculation of diluted income per common stock does not consider the effect of the warrants issued since the exercise of the warrants are contingent upon the occurrence of future events. However, the diluted earnings per share calculation includes the shares subject to forfeiture from the first day of the interim period in which the contingency on such shares was resolved. A reconciliation of net income (loss) per common stock is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2022 ​ ​ Class A Class B Allocation of net income ​ $ 15,386,968 ​ $ 3,846,742 Weighted average shares outstanding, basic and diluted ​ 42,500,000 ​ 10,625,000 Basic and diluted net income per share ​ $ 0.36 ​ $ 0.36 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2021 ​ Class A Class B Allocation of net loss $ (193,470) $ (58,163) Weighted average shares outstanding, basic and diluted ​ 35,224,658 ​ 10,589,629 Basic and diluted net loss per share ​ $ (0.01) ​ $ (0.01)
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The tax provision for the six months ended June 30, 2023 and 2022 is $962,768 and $108,315 , respectively. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company’s effective tax rate was 177% and 0.01% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the six months ended June 30, 2023 and 2022, due to changes in fair value of warrants, FPA, and the valuation allowance on the deferred tax assets. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign stockholder corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to distribute to redeeming stockholders or to complete a Business Combination and could adversely affect the Company’s ability to complete a Business Combination.	Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The tax provision for the years ended December 31, 2022 and 2021 has been disclosed under Note 12, as well as the deferred tax assets as of December 31, 2022 and 2021. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Standards	Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”). 2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.	Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company’s financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2022
Restatement of Previously Issued Financial Statements
Schedule of impact of restatement on statements of operations, statements of changes in stockholders' deficit and statements of cash flows	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ Three months ended September 30, 2022 Reported filed ​ Adjustment ​ Restated Deferred offering cost forgiveness ​ $ 4,462,500 ​ $ (4,312,237) ​ $ 150,263 Net Income ​ $ 5,690,350 ​ $ (4,312,237) ​ $ 1,378,113 Basic and diluted net income per common stock, Class A ​ $ 0.11 ​ $ (0.08) ​ $ 0.03 Basic net income per common stock, Class B ​ $ 0.11 ​ $ (0.08) ​ $ 0.03 Diluted net income per common stock, Class B ​ $ 0.11 ​ $ (0.08) ​ $ 0.03 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ ​ ​ Nine months ended September 30, 2022 Reported filed Adjustment Restated Deferred offering cost forgiveness ​ $ 4,462,500 ​ $ (4,312,237) ​ $ 150,263 Net Income ​ $ 21,242,449 ​ $ (4,312,237) ​ $ 16,930,212 Basic and diluted net income per common stock, Class A ​ $ 0.40 ​ $ (0.08) ​ $ 0.32 Basic net income per common stock, Class B ​ $ 0.40 ​ $ (0.08) ​ $ 0.32 Diluted net income per common stock, Class B ​ $ 0.40 ​ $ (0.08) ​ $ 0.32 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ Three months ended September 30, 2022 Reported filed ​ Adjustment ​ Restated Net Income $ 5,690,350 $ (4,312,237) $ 1,378,113 Deemed dividend – increase in redemption value of Class A common stock subject to redemption $ (1,589,302) ​ $ 4,312,237 ​ $ 2,722,935 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ ​ Reported filed ​ Adjustment ​ Restated Net Income ​ $ 21,242,449 ​ $ (4,312,237) ​ $ 16,930,212 Gain on forgiveness of deferred offering costs ​ $ 4,462,500 ​ $ (4,312,237) ​ $ 150,263 Supplemental Disclosure of noncash activities ​ ​ ​ Extinguishment of deferred underwriting commissions allocated to public shares ​ $ — ​ $ 4,312,237 ​ $ 4,312,237

Summary of Significant Accoun_8

Summary of Significant Accounting Policies (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies
Schedule of reconciliation of net income per common stock	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended ​ For the Three Months Ended ​ ​ For the Six Months Ended ​ For the Six Months Ended ​ June 30, 2023 June 30, 2022 June 30, 2023 June 30, 2022 ​ Class A Class B Class A Class B Class A Class B Class A Class B Allocation of net income (loss) $ (328,630) ​ $ (809,615) ​ $ 18,026,419 ​ $ 10,625,000 ​ $ (264,590) $ (155,953) $ 12,441,680 $ 3,110,420 Weighted average shares outstanding ​ 4,312,774 ​ ​ 10,625,000 ​ ​ 42,500,000 ​ ​ 10,625,000 ​ ​ 18,026,419 ​ 10,625,000 ​ 42,500,000 ​ 10,625,000 Basic and diluted net income (loss) per share ​ $ (0.08) ​ $ (0.08) ​ $ 0.06 ​ $ 0.06 ​ ​ $ (0.01) ​ $ (0.01) ​ $ 0.29 ​ $ 0.29	​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2022 ​ ​ Class A Class B Allocation of net income ​ $ 15,386,968 ​ $ 3,846,742 Weighted average shares outstanding, basic and diluted ​ 42,500,000 ​ 10,625,000 Basic and diluted net income per share ​ $ 0.36 ​ $ 0.36 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, 2021 ​ Class A Class B Allocation of net loss $ (193,470) $ (58,163) Weighted average shares outstanding, basic and diluted ​ 35,224,658 ​ 10,589,629 Basic and diluted net loss per share ​ $ (0.01) ​ $ (0.01)

Class A Common Stock Subject _6

Class A Common Stock Subject to Possible Redemption (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Class A Common Stock Subject to Possible Redemption
Schedule of reconciliation of Class A common stock reflected in the unaudited condensed balance sheets	​ ​ ​ ​ ​ Gross proceeds $ 425,000,000 Less: ​ ​ ​ Proceeds allocated to Public Warrants ​ ​ (14,026,667) Class A common stock issuance costs ​ ​ (23,229,523) Plus: ​ ​ ​ Accretion of carrying value to redemption value ​ ​ 37,691,146 Waiver of Class A shares issuance costs ​ ​ 4,312,237 Class A common stock subject to possible redemption at December 31, 2022 ​ ​ 429,747,193 Redemption of Class A common stock ​ ​ (387,606,834) Accretion of carrying value to redemption value ​ ​ 2,025,746 Class A common stock subject to possible redemption at March 31, 2023 ​ ​ 44,166,105 Accretion of carrying value to redemption value ​ ​ 429,299 Class A common stock subject to possible redemption at June 30, 2023 ​ $ 44,595,404	​ ​ ​ ​ ​ Gross proceeds $ 425,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (14,026,667) Class A common stock issuance costs ​ (23,229,523) Plus: ​ Accretion of carrying value to redemption value ​ 37,256,190 Class A common stock subject to possible redemption at December 31, 2021 ​ ​ 425,000,000 Waiver of Class A shares issuance costs ​ ​ 4,312,237 Accretion of carrying value to redemption value ​ ​ 434,956 Class A common stock subject to possible redemption at December 31, 2022 ​ $ 429,747,193

Fair Value Measurements (Tabl_2

Fair Value Measurements (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Fair Value Measurements
Schedule of assets and liabilities that are measured on a recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Significant Significant ​ ​ Prices in ​ Other ​ Other ​ ​ Active Markets ​ Observable ​ Unobservable ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 44,645,404 ​ $ — ​ $ — Forward Purchase Agreement ​ ​ — ​ ​ — ​ ​ — Fair Value at June 30, 2023 (unaudited) ​ $ 44,645,404 ​ $ — ​ $ — Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ Working capital loan – related party ​ $ — ​ $ — ​ $ 2,690,000 Public Warrant liability ​ ​ 708,333 ​ ​ — ​ ​ — Private Warrant liability ​ ​ — ​ ​ 625,000 ​ ​ — Prepaid forward derivative ​ ​ — ​ ​ — ​ ​ 144,770 Fair Value at June 30, 2023 (unaudited) ​ $ 708,333 ​ $ 625,000 ​ $ 2,834,770 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Significant Significant ​ ​ Prices in ​ Other ​ Other ​ ​ Active Markets ​ Observable ​ Unobservable ​ ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 430,047,193 ​ $ — ​ $ — Forward Purchase Agreement ​ ​ — ​ ​ — ​ ​ 353,731 Fair Value at December 31, 2022 ​ $ 430,047,193 ​ $ — ​ $ 353,731 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ Working capital loan – related party ​ $ — ​ $ — ​ $ 1,500,000 Public Warrant liability ​ ​ 566,667 ​ ​ — ​ ​ — Private Warrant liability ​ ​ — ​ ​ 500,000 ​ ​ — Fair Value at December 31, 2022 ​ $ 566,667 ​ $ 500,000 ​ $ 1,500,000 ​	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ Significant ​ ​ in Active ​ Other ​ Other ​ Markets Observable Unobservable December 31, 2022 (Level 1) (Level 2) (Level 3) Assets: ​ ​ ​ ​ Investments held in Trust Account $ 430,047,193 $ — $ — Forward Purchase Agreements ​ ​ — ​ ​ — ​ ​ 353,731 Fair value at December 31, 2022 $ 430,047,193 $ — $ 353,731 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ Public Warrant liability $ 566,667 $ — $ — Private Warrant liability ​ ​ — ​ ​ 500,000 ​ ​ — Working Capital Loans – related party ​ ​ — ​ ​ — ​ ​ 1,500,000 Fair Value at December 31, 2022 $ 566,667 $ 500,000 $ 1,500,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ Significant ​ ​ in Active ​ Other ​ Other ​ ​ Markets ​ Observable ​ Unobservable December 31, 2021 (Level 1) (Level 2) (Level 3) Assets: ​ ​ ​ Investments held in Trust Account ​ $ 425,037,665 $ — ​ $ — Forward Purchase Agreements ​ ​ — ​ — ​ ​ 1,002,789 Fair value at December 31, 2021 ​ $ 425,037,665 $ — ​ $ 1,002,789 Liabilities: ​ ​ Public Warrant liability ​ $ 11,190,235 $ — ​ $ — Private Warrant liability ​ ​ — ​ 9,873,737 ​ ​ — Fair value at December 31, 2021 ​ $ 11,190,235 $ 9,873,737 ​ $ —
Schedule of roll forward for the Level 3 investments	​ ​ ​ ​ ​ FPA assets at December 31, 2022 ​ $ 353,731 Change in fair value of FPA ​ 681,533 FPA assets at March 31, 2023 (unaudited) ​ ​ 1,035,264 Expiration of FPA asset April 17, 2023 ​ ​ (1,035,264) New FPA – liability April 17, 2023 ​ ​ (144,770) FPA liability at June 30, 2023 (unaudited) ​ $ (144,770) ​ ​ ​ ​ Working capital loan at December 31, 2022 ​ $ 1,500,000 Issuance of loan ​ ​ 734,300 Working capital loan at March 31, 2023 (unaudited) ​ ​ 2,234,300 Issuance of loan ​ ​ 455,700 Working capital loan at June 30, 2023 (unaudited) ​ $ 2,690,000 ​ ​ ​ ​ ​ FPA assets at December 31, 2021 $ 1,002,789 Change in fair value of FPA ​ (649,058) FPA assets at December 31, 2022 ​ $ 353,731 ​ ​ ​ Working capital loan at December 31, 2021 ​ $ — Issuance of loan ​ ​ 1,500,000 Change in fair value of working capital loan ​ ​ — Working capital loan at December 31, 2022 ​ $ 1,500,000 ​	​ ​ ​ ​ ​ FPA assets at December 31, 2021 $ 1,002,789 Change in fair value of FPAs ​ (649,058) FPA assets at December 31, 2022 ​ $ 353,731 Working Capital Loans at December 31, 2021 ​ $ — Issuance of loan ​ 1,500,000 Change in fair value of working capital loan ​ — Working Capital Loans at December 31, 2022 ​ $ 1,500,000 ​ ​ ​ ​ ​ Level 3 Warrant liabilities at March 4, 2021 $ 26,260,000 Change in fair value of warrant liabilities ​ (4,363,000) Transfers from Level 3 to Level 1 investments ​ (14,000,000) Warrants issued on April 12, 2021 ​ ​ 103,000 Transfers from Level 3 to Level 2 investments ​ ​ (8,000,000) Level 3 Warrant liabilities at December 31, 2021 ​ $ — Issuance of FPA assets at December 6, 2021 ​ $ 770,000 Change in fair value of FPAs ​ ​ 232,789 Level 3 investments (at asset position) at December 31, 2021 ​ $ 1,002,789
Schedule of warrant liabilities		​ ​ ​ ​ ​ Warrant liabilities at December 31, 2021 $ 21,063,972 Change in fair value of warrant liabilities ​ (19,997,305) Warrant liabilities at December 31, 2022 ​ $ 1,066,667 Warrant liabilities at March 4, 2021 ​ $ 26,260,000 Warrants issued on April 12, 2021 ​ 269,667 Change in fair value of warrant liabilities ​ (5,465,695) Warrant liabilities at December 31, 2021 ​ $ 21,063,972
Working capital loan - related party
Fair Value Measurements
Schedule of quantitative information regarding Level 3 fair value measurements	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2023 December 31, 2022 Principal Outstanding ​ $ 1,500,000 ​ $ 1,500,000 Expected Remaining Term (in years) ​ 0.25 ​ ​ 0.25 ​ Volatility ​ 37.4 ​ ​ 43.5 % Risk-Free Rate ​ 4.03 ​ ​ 3.91 %	​ ​ ​ ​ ​ ​ ​ December 31, 2022 Principal Outstanding ​ $ 1,500,000 Expected Remaining Term (in years) ​ 0.16 ​ Volatility ​ 43.5 % Risk-Free Rate ​ 3.91 %
Forward Purchase Agreement
Fair Value Measurements
Schedule of quantitative information regarding Level 3 fair value measurements	​ ​ ​ ​ ​ ​ ​ December 31, 2022 Unit Price ​ $ 10.00 ​ Remaining Term (in years) ​ ​ 0.16 ​ Risk-Free Rate ​ ​ 4.18 %	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 December 31, 2021 Unit Price ​ $ 10.00 ​ $ 10.00 ​ Remaining Term (in years) ​ ​ 0.16 ​ 0.50 ​ Risk-Free Rate ​ ​ 4.18 % 0.19 %

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Income Taxes
Schedule of income tax provision	​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, Year Ended December 31, ​ ​ 2022 ​ 2021 Current ​ ​ ​ ​ Federal ​ $ 1,175,834 ​ $ — State ​ ​ 325,880 ​ — Deferred ​ ​ ​ ​ Federal ​ ​ (2,077,550) ​ (1,085,134) State ​ ​ (429,855) ​ — Change in valuation allowance ​ ​ 2,507,405 ​ 1,085,134 Income tax provision ​ $ 1,501,714 ​ $ —
Schedule of company's net deferred tax assets	​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, December 31, ​ ​ 2022 ​ 2021 Deferred tax assets: ​ ​ ​ ​ ​ ​ Net operating loss carryover ​ $ — ​ $ 7,910 Start-up/organization costs ​ ​ (2,507,405) ​ ​ (1,093,044) Total deferred tax assets ​ ​ (2,507,405) ​ ​ (1,085,134) Valuation allowance ​ ​ 2,507,405 ​ ​ 1,085,134 Deferred tax asset, net of allowance ​ $ — ​ $ —
Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate	​ ​ ​ ​ ​ ​ ​ Statutory federal income tax rate 21.00 % 21.00 % Cost allocated to warrants ​ 0.00 % 65.33 % Change in deferred offering costs ​ (0.15) % 0.00 % Change in fair value of warrant liabilities ​ (20.25) % (456.14) % Change in fair value of FPAs ​ 0.66 % (19.43) % Change in valuation allowance ​ 6.82 % 389.24 % Other ​ (0.84) % 0.00 % Effective tax rate ​ 7.24 % 0.00 %

Organization and Business Ope_4

Organization and Business Operations (Details)				6 Months Ended	12 Months Ended
	Apr. 14, 2021 USD ($) $ / shares shares	Mar. 04, 2021 USD ($) $ / shares shares	Dec. 28, 2020 item	Jun. 30, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($) item $ / shares shares	Dec. 31, 2021 USD ($)	Apr. 17, 2023 USD ($)	Mar. 29, 2022 USD ($)	Oct. 31, 2020 USD ($)
Organization and Business Operations
Condition for future business combination number of businesses minimum | item			1
Number of shares in a unit | shares		1
Transaction costs				$ 24,012,335	$ 24,012,335				$ 23,731,835
Underwriting commissions				8,500,000	8,500,000				8,400,000
Deferred underwriters' commissions				14,875,000	14,875,000				14,700,000
Other offering costs				$ 637,335	$ 637,335				$ 631,835
Percentage of redemption required if business combination is not completed by specified date				100%	100%
Threshold business combination fair market value as percent of Trust assets				80%	80%
Minimum net tangible assets of the target.				$ 5,000,001	$ 5,000,001
Redemption period upon closure				10 days	10 days
Maximum allowed dissolution expenses				$ 100,000	$ 100,000
Cash held in operating bank accounts				132,773	107,773	$ 149,845
Working capital deficit				8,949,755	7,089,334	(1,815,006)
Proceeds received from related party to cover certain expense payments in exchange for shares issued				25,000	25,000
Maximum borrowing capacity of related party promissory note				300,000	300,000		$ 10,000,000
Borrowings outstanding				$ 2,690,000	$ 1,500,000
Private Warrants
Organization and Business Operations
Additional units sold of shares | shares	100,000
Sale of Private Placement Warrants (in shares) | shares		12,400,000			12,400,000
Public Warrants
Organization and Business Operations
Exercise price of warrants | $ / shares				$ 10	$ 10
Transaction costs				$ 782,812	$ 782,812
Underwriting commissions				762,300	762,300
Other offering costs				$ 20,512	$ 20,512
Initial Public Offering
Organization and Business Operations
Condition for future business combination number of businesses minimum | item					1
Sale of Units in Initial Public Offering (in shares) | shares		42,000,000
Number of shares in a unit | shares					1
Number of warrants in a unit | shares		1
Exercise price of warrants | $ / shares					$ 11.50
Price per share | $ / shares	$ 10	$ 10			$ 10
Proceeds from issuance initial public offering, gross		$ 425,000,000			$ 425,000,000
Additional units sold of value	$ 5,000,000
Transaction costs		23,731,835
Underwriting commissions		8,400,000			8,500,000
Deferred underwriters' commissions		14,700,000			14,875,000
Other offering costs		631,835			637,335
Payments for investment of cash in Trust Account		$ 420,000,000
Number of shares issuable per warrant | shares		0.33
Initial Public Offering | Public Warrants
Organization and Business Operations
Underwriting commissions					762,300
Other offering costs					$ 20,512
Private Placement | Private Warrants
Organization and Business Operations
Additional units sold of shares | shares	100,000
Price per warrant | $ / shares	$ 1			$ 1	$ 1
Exercise price of warrants | $ / shares	$ 11.50
Sale of Private Placement Warrants (in shares) | shares		12,400,000
Proceeds from issuance of warrants	$ 12,500,000			$ 12,500,000	$ 12,500,000
Number of shares issuable per warrant | shares	1
Over-allotment option
Organization and Business Operations
Sale of Units in Initial Public Offering (in shares) | shares	500,000	6,300,000
Additional units sold of shares | shares	500,000
Price per share | $ / shares	$ 10
Additional units sold of value	$ 5,000,000
Transaction costs	280,500
Underwriting commissions	100,000
Deferred underwriters' commissions	175,000
Other offering costs	$ 5,500
Over-allotment option | Private Warrants
Organization and Business Operations
Sale of Private Placement Warrants (in shares) | shares	100,000
Working capital loan - related party
Organization and Business Operations
Price per warrant | $ / shares				$ 1
Maximum borrowing capacity of related party promissory note								$ 1,500,000
Borrowings outstanding				$ 2,690,000	$ 1,500,000	$ 0
Class A common stock | Initial Public Offering
Organization and Business Operations
Additional units sold of shares | shares	500,000
Number of shares in a unit | shares		1			1
Price per warrant | $ / shares					$ 0.0001
Exercise price of warrants | $ / shares		$ 11.50
Number of shares issuable per warrant | shares		1
Class A common stock | Initial Public Offering | Public Warrants
Organization and Business Operations
Number of warrants in a unit | shares		0.33
Number of shares issuable per warrant | shares		0.33

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements - Statement of operations (Details) - USD ($)	3 Months Ended			6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Restatement of Previously Issued Financial Statements
Deferred offering cost forgiveness		$ 150,263				$ 150,263	$ 150,262
Net income	$ (1,138,245)	1,378,113	$ 3,090,719	$ (420,544)	$ 15,552,100	16,930,212	$ 19,233,710	$ (251,633)
As previously reported
Restatement of Previously Issued Financial Statements
Deferred offering cost forgiveness		4,462,500				4,462,500
Net income		5,690,350				21,242,449
Adjustment
Restatement of Previously Issued Financial Statements
Deferred offering cost forgiveness		(4,312,237)				(4,312,237)
Net income		$ (4,312,237)				$ (4,312,237)
Common Class A [Member]
Restatement of Previously Issued Financial Statements
Basic net income (loss) per share of common stock	$ (0.08)	$ 0.03	$ 0.06	$ (0.01)	$ 0.29	$ 0.32	$ 0.36	$ (0.01)
Diluted net income (loss) per share of common stock	(0.08)	0.03	0.06	(0.01)	0.29	0.32	0.36	(0.01)
Common Class A [Member] | As previously reported
Restatement of Previously Issued Financial Statements
Basic net income (loss) per share of common stock		0.11				0.40
Diluted net income (loss) per share of common stock		0.11				0.40
Common Class A [Member] | Adjustment
Restatement of Previously Issued Financial Statements
Basic net income (loss) per share of common stock		(0.08)				(0.08)
Diluted net income (loss) per share of common stock		(0.08)				(0.08)
Common Class B [Member]
Restatement of Previously Issued Financial Statements
Basic net income (loss) per share of common stock	(0.08)	0.03	0.06	(0.01)	0.29	0.32	0.36	(0.01)
Diluted net income (loss) per share of common stock	$ (0.08)	0.03	$ 0.06	$ (0.01)	$ 0.29	0.32	$ 0.36	$ (0.01)
Common Class B [Member] | As previously reported
Restatement of Previously Issued Financial Statements
Basic net income (loss) per share of common stock		0.11				0.40
Diluted net income (loss) per share of common stock		0.11				0.40
Common Class B [Member] | Adjustment
Restatement of Previously Issued Financial Statements
Basic net income (loss) per share of common stock		(0.08)				(0.08)
Diluted net income (loss) per share of common stock		$ (0.08)				$ (0.08)

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements - Changes in stockholders' deficit (Details) - USD ($)	3 Months Ended			6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Restatement of Previously Issued Financial Statements
Net income	$ (1,138,245)	$ 1,378,113	$ 3,090,719	$ (420,544)	$ 15,552,100	$ 16,930,212	$ 19,233,710	$ (251,633)
Deemed dividend - increase in redemption value of Class A common stock subject to redemption		2,722,935
As previously reported
Restatement of Previously Issued Financial Statements
Net income		5,690,350				21,242,449
Deemed dividend - increase in redemption value of Class A common stock subject to redemption		(1,589,302)
Adjustment
Restatement of Previously Issued Financial Statements
Net income		(4,312,237)				$ (4,312,237)
Deemed dividend - increase in redemption value of Class A common stock subject to redemption		$ 4,312,237

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements - Cash flow (Details) - USD ($)	3 Months Ended				6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Restatement of Previously Issued Financial Statements
Net income (loss)	$ (1,138,245)	$ 717,701	$ 3,090,719	$ 12,461,381	$ (420,544)	$ 15,552,100	$ 16,930,212	$ 19,233,710	$ (251,633)
Gain on forgiveness of deferred offering costs							150,263
Supplemental disclosure of non-cash financing activities:
Extinguishment of deferred underwriting commissions allocated to public shares							4,312,237
As previously reported
Restatement of Previously Issued Financial Statements
Net income (loss)							21,242,449
Gain on forgiveness of deferred offering costs							4,462,500
Adjustment
Restatement of Previously Issued Financial Statements
Net income (loss)							(4,312,237)
Gain on forgiveness of deferred offering costs							(4,312,237)
Supplemental disclosure of non-cash financing activities:
Extinguishment of deferred underwriting commissions allocated to public shares							$ 4,312,237

Summary of Significant Accoun_9

Summary of Significant Accounting Policies (Details) - USD ($)	1 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2022	Jun. 30, 2023	Dec. 31, 2021	Apr. 14, 2021	Mar. 04, 2021	Oct. 31, 2020
Summary of Significant Accounting Policies
Cash equivalents		$ 0	$ 0	$ 0
Transaction Costs		782,812
Underwriting commissions or discounts		8,500,000	8,500,000				$ 8,400,000
Deferred underwriters' commissions		14,875,000	14,875,000				14,700,000
Other offering costs		637,335	$ 637,335				$ 631,835
Deferred offering costs		94,992
Forgiveness of deferred underwriting fees	$ 4,462,500	4,462,500
Initial Public Offering
Summary of Significant Accounting Policies
Transaction Costs		24,012,335
Underwriting commissions or discounts		8,500,000				$ 8,400,000
Deferred underwriters' commissions		14,875,000				14,700,000
Other offering costs		$ 637,335				$ 631,835
Over-allotment option
Summary of Significant Accounting Policies
Transaction Costs					$ 280,500
Underwriting commissions or discounts					100,000
Deferred underwriters' commissions					175,000
Other offering costs					$ 5,500
Forgiveness of deferred underwriting fees	$ 4,462,500

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Schedule of reconciliation of net income per common stock (Details) - USD ($)	3 Months Ended			6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Class A common stock
Summary of Significant Accounting Policies
Allocation of net income	$ (328,630)		$ 18,026,419	$ (264,590)	$ 12,441,680		$ 15,386,968	$ (193,470)
Weighted average shares outstanding, basic (in shares)	4,312,774		42,500,000	18,026,419	42,500,000		42,500,000	35,224,658
Weighted average shares outstanding, diluted (in shares)	4,312,774		42,500,000	18,026,419	42,500,000		42,500,000	35,224,658
Basic net income (loss) per share	$ (0.08)	$ 0.03	$ 0.06	$ (0.01)	$ 0.29	$ 0.32	$ 0.36	$ (0.01)
Diluted net income (loss) per share	$ (0.08)	0.03	$ 0.06	$ (0.01)	$ 0.29	0.32	$ 0.36	$ (0.01)
Class B common stock
Summary of Significant Accounting Policies
Allocation of net income	$ (809,615)		$ 10,625,000	$ (155,953)	$ 3,110,420		$ 3,846,742	$ (58,163)
Weighted average shares outstanding, basic (in shares)	10,625,000		10,625,000	10,625,000	10,625,000		10,625,000	10,589,629
Weighted average shares outstanding, diluted (in shares)	10,625,000		10,625,000	10,625,000	10,625,000		10,625,000	10,589,629
Basic net income (loss) per share	$ (0.08)	0.03	$ 0.06	$ (0.01)	$ 0.29	0.32	$ 0.36	$ (0.01)
Diluted net income (loss) per share	$ (0.08)	$ 0.03	$ 0.06	$ (0.01)	$ 0.29	$ 0.32	$ 0.36	$ (0.01)

Initial Public Offering (Deta_2

Initial Public Offering (Details) - $ / shares			12 Months Ended
	Apr. 14, 2021	Mar. 04, 2021	Dec. 31, 2022	Jun. 30, 2023	Apr. 17, 2023	Dec. 31, 2021
Initial Public Offering
Number of shares in a unit		1
Class A common stock
Initial Public Offering
Common shares, par value (per share)			$ 0.0001	$ 0.0001	$ 0.01	$ 0.0001
Initial Public Offering
Initial Public Offering
Number of units issued		42,000,000
Number of shares in a unit			1
Common shares, par value (per share)		$ 0.0001
Exercise price of warrants			$ 11.50
Number of warrants in a unit		1
Number of shares issuable per warrant		0.33
Initial Public Offering | Class A common stock
Initial Public Offering
Number of shares in a unit		1	1
Common shares, par value (per share)		$ 0.0001
Exercise price of warrants		$ 11.50
Number of shares issuable per warrant		1
Over-allotment option
Initial Public Offering
Number of units issued	500,000	6,300,000
Underwriters options period		45 days

Private Placement (Details)_2

Private Placement (Details) - Private Placement Warrants [Member] - USD ($)		6 Months Ended	12 Months Ended
	Apr. 14, 2021	Jun. 30, 2023	Dec. 31, 2022	Mar. 04, 2021
Private Placement
Number of warrants to purchase shares issued			12,400,000	12,400,000
Over-Allotment Option [Member]
Private Placement
Number of warrants to purchase shares issued	100,000
Private Placement
Private Placement
Number of warrants to purchase shares issued				12,400,000
Price of warrants	$ 1	$ 1	$ 1
Aggregate gross proceeds	$ 12,500,000	$ 12,500,000	$ 12,500,000
Number of shares issuable per warrant	1
Exercise price of warrant	$ 11.50
Threshold period for not to transfer assign or sell any shares or warrants after completion of initial business combination	30 days

Related Party Transactions - _2

Related Party Transactions - Founder Shares (Details) - Common Class B [Member]					12 Months Ended
	Apr. 14, 2021 shares	Mar. 01, 2021 shares	Feb. 19, 2021 shares	Dec. 30, 2020 USD ($) D $ / shares shares	Dec. 31, 2022 shares	Jun. 30, 2023 shares	Dec. 31, 2021 shares
Related Party Transactions
Aggregate number of shares owned			10,062,500
Common shares, shares issued					10,625,000	10,625,000	10,625,000
Common shares, shares outstanding					10,625,000	10,625,000	10,625,000
Sponsor [Member]
Related Party Transactions
Stock dividend		2,012,500	2,875,000
Aggregate number of shares owned		12,075,000
Shares subject to forfeiture		1,575,000
Founder Shares [Member] | Sponsor [Member]
Related Party Transactions
Number of shares issued				7,187,500
Aggregate purchase price | $				$ 25,000
Stock dividend		2,012,500	2,875,000
Aggregate number of shares owned		12,075,000	10,062,500
Shares subject to forfeiture				1,575,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders		20%		20%
Number of shares forfeited	1,450,000
Common shares, shares issued					10,625,000	10,625,000
Common shares, shares outstanding					10,625,000	10,625,000
Restrictions on transfer period of time after completion of business combination				1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares				$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D				20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D				30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences				150 days	150 days

Related Party Transactions - _3

Related Party Transactions - Additional Information (Details) - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 01, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Apr. 17, 2023	Mar. 29, 2022	Dec. 30, 2020
Related Party Transactions
Maximum borrowing capacity of related party promissory note		$ 300,000		$ 300,000		$ 300,000		$ 10,000,000
Borrowings outstanding		2,690,000		2,690,000		1,500,000
Working capital loans warrant [Member]
Related Party Transactions
Outstanding balance of related party note						1,500,000	$ 0
Maximum Loans Convertible into Warrants						$ 1,500,000
Price per warrant						$ 1
Repayment of promissory note - related party						$ 0
Promissory Note - Related Party [Member]
Related Party Transactions
Maximum borrowing capacity of related party promissory note										$ 300,000
Outstanding balance of related party note		0		0		0	0
Administrative Support Agreement [Member]
Related Party Transactions
Expenses per month	$ 40,521
Fees and expenses incurred						486,252	405,210
Diligence Services
Related Party Transactions
Fees and expenses incurred		54,971	$ 142,411	201,549	$ 385,706	623,698	751,916
Amount accrued for service		873,290		873,290		958,429	334,731
Payments for service						0	417,185
2022 Working Capital Loan
Related Party Transactions
Maximum borrowing capacity of related party promissory note									$ 1,500,000
Proceeds held in the Trust Account that would be used to repay loan						0
Borrowings outstanding		2,690,000		2,690,000		1,500,000	$ 0
Borrowings recorded at fair value		$ 2,690,000		$ 2,690,000		$ 1,500,000
2022 Working Capital Loan | Working capital loans warrant [Member]
Related Party Transactions
Price per warrant									$ 1

Commitments and Contingencies_3

Commitments and Contingencies (Details)					1 Months Ended	6 Months Ended	12 Months Ended
	Apr. 17, 2023 shares	Dec. 06, 2021 USD ($) $ / shares shares	Apr. 14, 2021 USD ($) $ / shares shares	Mar. 04, 2021 USD ($) shares	Sep. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) item $ / shares	Dec. 31, 2022 USD ($) item $ / shares shares	Dec. 31, 2021 USD ($)
Commitments and Contingencies
Maximum number of demands for registration of securities | item						3	3
Underwriting discount			$ 100,000	$ 8,400,000
Deferred discount per Unit | $ / shares						$ 0.35	$ 0.35
Aggregate deferred underwriting fee payable							$ 14,875,000
Deferred underwriting liability written off					$ 4,462,500		$ 4,462,500
Issuance of Forward Purchase Agreements								$ 770,000
Common Class A [Member]
Commitments and Contingencies
Number of shares issued | shares	15,000,000
Forward Purchase Agreements [Member] | Maximum [Member]
Commitments and Contingencies
Number of shares issued | shares							120,000,000
Aggregate purchase price						$ 120,000,000
Forward Purchase Agreements [Member] | Unsecured convertible notes [Member]
Commitments and Contingencies
Aggregate unsecured convertible notes		$ 80,000,000
Aggregate proceeds from issuance of Convertible Notes		80,000,000
Forward Purchase Agreements [Member] | Unsecured convertible notes [Member] | Maximum [Member]
Commitments and Contingencies
Aggregate unsecured convertible notes		80,000,000
Aggregate proceeds from issuance of Convertible Notes		$ 80,000,000
Over-allotment option
Commitments and Contingencies
Underwriters options period				45 days
Number of units issued | shares			500,000	6,300,000
Deferred underwriting liability written off					$ 4,462,500
Price per share | $ / shares			$ 10
Forward Purchase Securities [Member] | Forward Purchase Agreements [Member]
Commitments and Contingencies
Price per share | $ / shares		$ 10
Number of shares in a forward purchase securities | shares		1
Number of warrants in a forward purchase securities | shares		1
Number of shares issuable per warrant | shares		1
Exercise price of warrants | $ / shares		$ 11.50
Forward Purchase Securities [Member] | Forward Purchase Agreements [Member] | Common Class A [Member]
Commitments and Contingencies
Number of shares in a forward purchase securities | shares		1
Number of warrants in a forward purchase securities | shares		1
Forward Purchase Securities [Member] | Forward Purchase Agreements [Member] | Maximum [Member]
Commitments and Contingencies
Number of shares issued | shares		4,000,000
Aggregate purchase price		$ 40,000,000
Issuance of Forward Purchase Agreements		$ 40,000,000

Class A Common Stock Subject _7

Class A Common Stock Subject to Possible Redemption (Details) - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Class A Common Stock Subject to Possible Redemption
Gross proceeds			$ 425,000,000	$ 425,000,000
Proceeds allocated to Public Warrants			(14,026,667)	(14,026,667)
Class A common stock issuance costs			(23,229,523)	(23,229,523)
Accretion of carrying value to redemption value	$ 429,299	$ 2,025,746	37,691,146	37,256,190
Waiver of Class A shares issuance costs			4,312,237
Class A common stock subject to possible redemption	$ 44,595,404	$ 44,166,105	$ 429,747,193	$ 425,000,000

Class A Common Stock Subject _8

Class A Common Stock Subject to Possible Redemption - Additional Information (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2023 Vote	Dec. 31, 2022 USD ($) Vote $ / shares shares	Dec. 31, 2021 $ / shares shares
Class A Common Stock Subject to Possible Redemption
Class A common stock subject to possible redemption, shares authorized | shares		400,000,000
Class A common stock subject to possible redemption, par value (in dollars per share) | $ / shares		$ 0.0001
Class A common stock subject to possible redemption, votes per share | Vote	1	1
Class A common stock subject to possible redemption, shares outstanding | shares		42,500,000	42,500,000
Class A common stock subject to possible redemption, price per share | $ / shares		$ 10.11	$ 10
Trust proceeds | $		$ 429,747,193

Stockholders' Deficit - Prefe_2

Stockholders' Deficit - Preferred Stock (Details) - $ / shares	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Stockholders' Deficit
Preferred stock, shares authorized	1,000,000	1,000,000	1,000,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0

Stockholders' Deficit - Commo_2

Stockholders' Deficit - Common Stock (Details)				6 Months Ended	12 Months Ended
	Apr. 14, 2021 shares	Mar. 01, 2021 shares	Feb. 19, 2021 shares	Jun. 30, 2023 Vote $ / shares shares	Dec. 31, 2022 Vote $ / shares shares	Apr. 17, 2023 $ / shares	Feb. 28, 2023 shares	Dec. 31, 2021 $ / shares shares
Stockholders' Equity (Deficit)
Class A common stock subject to possible redemption, shares outstanding					42,500,000			42,500,000
Common Class A [Member]
Stockholders' Equity (Deficit)
Common stock, shares authorized				400,000,000	400,000,000			400,000,000
Common stock, par value (in dollars per share) | $ / shares				$ 0.0001	$ 0.0001	$ 0.01		$ 0.0001
Common stock, votes per share | Vote				1	1
Common stock, shares issued				0	0
Common stock, shares outstanding				0	0		4,312,774
Common Class A Subject to Redemption [Member]
Stockholders' Equity (Deficit)
Class A common stock subject to possible redemption, shares issued				4,312,774	42,500,000			42,500,000
Class A common stock subject to possible redemption, shares outstanding				4,312,774	42,500,000			42,500,000
Common Class B [Member]
Stockholders' Equity (Deficit)
Common stock, shares authorized				40,000,000	40,000,000			40,000,000
Common stock, par value (in dollars per share) | $ / shares				$ 0.0001	$ 0.0001			$ 0.0001
Common stock, votes per share | Vote				1	1
Common stock, shares issued				10,625,000	10,625,000			10,625,000
Common stock, shares outstanding				10,625,000	10,625,000			10,625,000
Aggregate number of shares owned			10,062,500
Conversion ratio				1	1
Number of shares for which forfeiture condition has expired (in shares)	1,450,000
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)				20%	20%
Common Class B [Member] | Sponsor [Member]
Stockholders' Equity (Deficit)
Stock dividend		2,012,500	2,875,000
Aggregate number of shares owned		12,075,000

Fair Value Measurements - Ass_2

Fair Value Measurements - Assets and liabilities that are measured on a recurring basis and quantitative information (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Assets:
Investments held in Trust Account	$ 44,645,404	$ 430,047,193	$ 425,037,665
Recurring | Level 1
Assets:
Investments held in Trust Account	44,645,404	430,047,193	425,037,665
Assets Fair value	44,645,404	430,047,193	425,037,665
Liabilities:
Fair value measurements	708,333	566,667	11,190,235
Recurring | Level 2
Liabilities:
Fair value measurements	625,000	500,000	9,873,737
Recurring | Level 3
Assets:
Forward Purchase Agreement		353,731	1,002,789
Assets Fair value		353,731	1,002,789
Liabilities:
Fair value measurements	2,834,770	1,500,000
Recurring | Public Warrants | Level 1
Liabilities:
Fair value measurements	708,333	566,667	11,190,235
Recurring | Private Warrants | Level 2
Liabilities:
Fair value measurements	625,000	500,000	$ 9,873,737
Recurring | Working capital loan - related party | Level 3
Liabilities:
Fair value measurements	$ 2,690,000	$ 1,500,000

Fair Value Measurements - Rollf

Fair Value Measurements - Rollforward for the Level 3 investments (Details) - USD ($)	1 Months Ended	3 Months Ended		10 Months Ended	12 Months Ended
	Dec. 31, 2021	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2021	Dec. 31, 2022	Dec. 06, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List Not Disclosed Flag					true
FPA assets at December 6, 2021	$ 1,002,789			$ 1,002,789	$ 353,731
Warrant [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Working capital loan at beginning balance			$ 1,066,667	26,260,000	21,063,972
Working capital loan at ending of balance	21,063,972			21,063,972	1,066,667
Warrant liabilities at the beginning	21,063,972			21,063,972	1,066,667
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
FPA assets at the beginning balance		$ 1,035,264	353,731		1,002,789
Change in fair value of FPAs	232,789		681,533		(649,058)
FPA assets at the ending balance	1,002,789		1,035,264	1,002,789	353,731
Working capital loan at beginning balance		2,234,300	1,500,000
Issuance of loan		455,700	734,300		1,500,000
Level 3 Warrant liabilities at March 4, 2021					1,002,789
Change in fair value of warrant liabilities				(4,363,000)
Transfers from Level 3 to Level 1 investments				14,000,000
Warrants issued on April 12, 2021 (unaudited)				103,000
Transfer from Level 3 to Level 2 investments				(8,000,000)
Level 3 Warrant liabilities at December 31, 2021	$ 1,002,789			1,002,789
Working capital loan at ending of balance		2,690,000	2,234,300		1,500,000
Warrant liabilities at the beginning		$ 2,690,000	$ 2,234,300		$ 1,500,000
FPA assets at December 6, 2021						$ 770,000
Level 3 | Warrant [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Working capital loan at beginning balance				$ 26,260,000
Warrant liabilities at the beginning

Fair Value Measurement - Addi_2

Fair Value Measurement - Additional information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2023
2022 Working Capital Loan
Fair Value Measurements
Borrowings recorded at fair value	$ 1,500,000		$ 2,690,000
Warrant | Level 1
Fair Value Measurements
Amount of transfer out of level 3	$ 14,000,000
Warrant | Level 2
Fair Value Measurements
Amount of transfer out of level 3		$ 8,000,000

Fair Value Measurements - Purch

Fair Value Measurements - Purchase agreements and working capital loan (Details) - Level 3	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) Y	Dec. 31, 2021 USD ($) Y
Fair Value Measurements
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	$ 2,690,000	$ 2,234,300	$ 1,500,000
working capital loan			1,500,000
Unit Price
Fair Value Measurements
Forward Purchase Agreements			0.1000	0.1000
Expected Remaining Term (in years)
Fair Value Measurements
Forward Purchase Agreements | Y			0.16	0.50
working capital loan | Y			0.16
Volatility
Fair Value Measurements
working capital loan			43.5
Risk-Free Rate
Fair Value Measurements
Forward Purchase Agreements			4.18	0.19
working capital loan			3.91

Fair value Measurements - Fair

Fair value Measurements - Fair value of the warrant liabilities (Details) - Warrant - USD ($)	10 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022
Change in fair value of the warrant liabilities
Working capital loan at beginning balance	$ 26,260,000	$ 21,063,972
Warrants issued	269,667
Change in fair value of warrant liabilities	(5,465,695)	(19,997,305)
Working capital loan at ending of balance	$ 21,063,972	$ 1,066,667

Warrant Liabilities (Details)_2

Warrant Liabilities (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2023 $ / shares shares	Dec. 31, 2022 $ / shares shares	Dec. 31, 2021 shares	Apr. 14, 2021 $ / shares
Warrant Liabilities
Public warrants expire		5 years
Repurchase of equity percentage		60
Trading days		10 days
Warrants outstanding | shares	26,666,666	26,666,666	0
Series of individually immaterial business acquisitions
Warrant Liabilities
Issue price		$ 9.20
Business combination		$ 9.20
Maximum
Warrant Liabilities
Repurchase of equity percentage		115
Class A common stock equals or exceeds $18.00
Warrant Liabilities
Price per share		$ 18
Written notice period for redemption of warrant		30 days
Class A common stock equals or exceeds $18.00 | Minimum
Warrant Liabilities
Trading days		20 days
Class A common stock equals or exceeds $10.00
Warrant Liabilities
Agreements to repurchase interest rate		180%
Price per share		$ 10
Share price		$ 0.10
Class A common stock equals or exceeds $10.00 | Minimum
Warrant Liabilities
Trading days		30 days
Warrant agreement alternative issuance provision		70%
Class A common stock equals or exceeds $10.00 | Maximum
Warrant Liabilities
Trading days		30 days
Class A common stock
Warrant Liabilities
Class A common stock		20 days
Redemption price per share		$ 10
Threshold period for registered holder of the warrant to exercise warrant, following the public disclosure of the consummation of such Business Combination	30 days
Class A common stock | Minimum
Warrant Liabilities
Threshold period for registered holder of the warrant to exercise warrant, following the public disclosure of the consummation of such Business Combination		30 days
Public Warrants
Warrant Liabilities
Warrants outstanding | shares	14,166,666	14,166,666
Public Warrants | Class A common stock equals or exceeds $18.00
Warrant Liabilities
Share price		$ 0.01
Public Warrants | Class A common stock
Warrant Liabilities
Share price	$ 9.20
Private warrants
Warrant Liabilities
Warrants outstanding | shares	12,500,000	12,500,000
Warrant
Warrant Liabilities
Public warrants exercisable period		30 days
Over-allotment option
Warrant Liabilities
Price per share				$ 10
Warrants outstanding | shares	266,666	266,666

Income Taxes - Income tax provi

Income Taxes - Income tax provision (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Current
Federal					$ 1,175,834
State					325,880
Deferred
Federal					(2,077,550)	$ (1,085,134)
State					(429,855)
Change in valuation allowance					2,507,405	$ 1,085,134
Income tax provision	$ 121,245	$ 108,315	$ 962,768	$ 108,315	$ 1,501,714

Income Taxes - Deferred tax ass

Income Taxes - Deferred tax assets (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Net operating loss carryover		$ 7,910
Start-up/organization costs	$ (2,507,405)	(1,093,044)
Total deferred tax assets	(2,507,405)	(1,085,134)
Valuation allowance	$ 2,507,405	$ 1,085,134

Income Taxes - Statutory federa

Income Taxes - Statutory federal income tax (Details) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Income Taxes
Statutory federal income tax rate			21%	21%
Cost allocated to warrants			0%	65.33%
Change in deferred offering costs			(0.15%)	0%
Change in fair value of warrant liabilities			(20.25%)	(456.14%)
Change in fair value of FPAs			0.66%	(19.43%)
Change in valuation allowance			6.82%	389.24%
Other			(0.84%)	0%
Effective tax rate	177%	0.01%	7.24%	0%
Unrecognized tax benefits			$ 0	$ 0
Unrecognized tax benefits accrued for interest and penalties	$ 0		$ 0	$ 0

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)		1 Months Ended	3 Months Ended
	Feb. 28, 2023	Feb. 28, 2023	Sep. 30, 2022	Jun. 30, 2023	Apr. 03, 2023	Mar. 21, 2023	Dec. 31, 2022	Dec. 31, 2021
Subsequent Events
Outstanding promissory note					$ 734,300
Deemed dividend - increase in redemption value of Class A common stock subject to redemption			$ 2,722,935
Right to withdraw interest from the trust account waived	$ 100,000
Amount remained in the trust account				$ 44,645,404			$ 430,047,193	$ 425,037,665
Class A common stock
Subsequent Events
Number of shares redeemed	38,187,226
Amount removed from the trust account for redemption of shares	$ 387,600,000	$ 387,600,000
Redemption value per share	$ 10.15	$ 10.15
Amount remained in the trust account	$ 44,300,000	$ 44,300,000
Common stock, shares outstanding	4,312,774	4,312,774		0			0
Subsequent Events
Subsequent Events
Deemed dividend - increase in redemption value of Class A common stock subject to redemption		$ 10,412,500
Right to withdraw interest from the trust account waived	$ 100,000
Amount removed from the trust account for redemption of shares	387,600,000	387,600,000
Amount remained in the trust account	$ 45,100,000	$ 45,100,000
Subsequent Events | Sponsor | Unsecured promissory note
Subsequent Events
Working capital loan						$ 1,190,000
Subsequent Events | Class A common stock
Subsequent Events
Number of shares redeemed	38,187,226
Redemption value per share	$ 10.15	$ 10.15
Common stock, shares outstanding	4,312,774	4,312,774